In Re Namenda Direct Purchaser Antitrust Litigation
JM Smith Corporation On behalf of itself and all others similarly situated doing business as Smith Drug Company |
Merz GmbH & Co. KGaA., Actavis, plc, Forest Laboratories LLC, Forest Laboratories, Inc., Merz Pharmaceuticals GmbH, Forest Laboratories Holdings Ltd. and Merz Pharma GmbH & Co. KGaA |
Dr. Reddy's Laboratories, Inc., Teva Pharmaceuticals USA, Inc. and Dr. Reddy's Laboratories, Ltd. |
AmerisourceBergen Drug Corporation, Macleods Pharmaceuticals Ltd., Cardinal Health, Inc., Macleods Pharma USA, Inc., Humana Inc. and Mylan Pharmaceuticals, Inc. |
Rochester Drug Co-Operative, Inc. |
1:2015cv07488 |
September 22, 2015 |
US District Court for the Southern District of New York |
Foley Square Office |
New York |
Robert W Lehrburger |
Colleen McMahon |
Anti-Trust |
15 U.S.C. § 15 |
Both |
Docket Report
This docket was last retrieved on March 3, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
|
Filing 957 NOTICE of No Response or Opposition Having Been Filed in Response to Direct Purchaser Class Plaintiffs' Motion for an Order of Distribution re: #954 MOTION for Disbursement of Funds .. Document filed by JM Smith Corporation..(Gerstein, Bruce) |
Filing 956 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated February 5, 2021 re: Declaration of Phil Mattoon of Rust Consulting, Inc. in Support of Direct Purchaser Class Plaintiffs Motion for an Order of Distribution. Document filed by JM Smith Corporation..(Litvin, Dan) |
Filing 955 MEMORANDUM OF LAW in Support re: #954 MOTION for Disbursement of Funds . . Document filed by JM Smith Corporation..(Gerstein, Bruce) |
Filing 954 MOTION for Disbursement of Funds . Document filed by JM Smith Corporation. (Attachments: #1 Exhibit 1 - Declaration of Phil Mattoon of Rust Consulting, Inc., #2 Exhibit 2 - Proposed Order).(Gerstein, Bruce) |
Filing 953 MOTION for Daniel C. Simons to Withdraw as Attorney for Rochester Drug Co-Operative, Inc. Document filed by Rochester Drug Co-Operative, Inc...(Sorensen, David) |
Filing 952 NOTICE of Withdrawal of Appearance. Document filed by JM Smith Corporation..(Litvin, Dan) |
|
Filing 950 NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 5/27/2020 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM.(McGuirk, Kelly) |
Filing 949 TRANSCRIPT of Proceedings re: CONFERNECE held on 5/27/2020 before Judge Colleen McMahon. Court Reporter/Transcriber: Khristine Sellin, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/23/2020. Redacted Transcript Deadline set for 7/6/2020. Release of Transcript Restriction set for 8/31/2020.Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM.(McGuirk, Kelly) |
|
Terminate Transcript Deadlines. (mml) |
Minute Entry for proceedings held before Judge Colleen McMahon: Final Settlement Approval Hearing held on 5/27/2020. Telephone Hearing: The Court approved the final settlement, and reserved judgment on class counsels motion for fees, expenses, and incentive awards. Class counsel agreed to submit more detailed time records for the Courts review. Submitted By: Alex Zuckerman. (Court Reporter Khris Sellin) (mde) |
|
Case Stay Lifted. (mml) |
|
|
Filing 944 NOTICE of Notice of Withdrawal of Objection to Class Counsel's Motion for Attorneys' Fees re: (932 in 1:15-cv-07488-CM-RWL) Objection (non-motion). Document filed by AmerisourceBergen Drug Corporation. Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM.(Southall, Samantha) |
Filing 943 NOTICE of Withdrawal of Objection re: #930 Objection (non-motion). Document filed by Humana Inc...(Fiebig, Rebecca) |
Filing 942 MEMORANDUM OF LAW in Support re: #941 MOTION to Approve Final Approval of Settlement . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order [PROPOSED] ORDER GRANTING FINAL JUDGMENT AND ORDER OF DISMISSAL APPROVING DIRECT PURCHASER CLASS SETTLEMENT AND DISMISSING DIRECT PURCHASER CLASS CLAIMS, #2 Affidavit DECLARATION OF CLAIMS ADMINISTRATOR CONCERNING PROVISION OF SETTLEMENT NOTICE TO CLASS MEMBERS).(Gerstein, Bruce) |
Filing 941 MOTION to Approve Final Approval of Settlement . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc...(Gerstein, Bruce) |
Filing 940 REPLY AFFIDAVIT of Bruce E. Gerstein in Support re: #925 MOTION for Attorney Fees .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N).(Gerstein, Bruce) |
Filing 939 REPLY MEMORANDUM OF LAW in Support re: #925 MOTION for Attorney Fees . CLASS COUNSELS NOTICE OF NATIONAL WHOLESALERS FEE OBJECTION WITHDRAWAL AND BRIEF IN FURTHER SUPPORT OF CLASS COUNSELS FEE REQUEST. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc...(Gerstein, Bruce) |
|
Filing 937 RESPONSE re: #930 Objection (non-motion) of Humana, Inc. to the Proposed Class Action Settlement. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc...(Litvin, Dan) |
Filing 936 MOTION for Robert James Tucker to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-19315294. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Cardinal Health, Inc.. (Attachments: #1 Declaration of Robert J. Tucker in Support of Motion to Appear Pro Hac Vice, #2 Certificate of Good Standing from the Supreme Court of Ohio, #3 Text of Proposed Order).(Tucker, Robert) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #936 MOTION for Robert James Tucker to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-19315294. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (ad) |
|
Filing 934 NOTICE OF APPEARANCE by Victoria Morton Rutherfurd on behalf of Cardinal Health, Inc...(Rutherfurd, Victoria) |
Filing 933 NOTICE of of Motion for Extension re: (925 in 1:15-cv-07488-CM-RWL) MOTION for Attorney Fees .. Document filed by AmerisourceBergen Drug Corporation. Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM.(Southall, Samantha) |
Filing 932 Objection re: (925 in 1:15-cv-07488-CM-RWL) MOTION for Attorney Fees . . Document filed by AmerisourceBergen Drug Corporation. Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM.(Southall, Samantha) |
Filing 931 NOTICE OF APPEARANCE by Samantha Lee Southall on behalf of AmerisourceBergen Drug Corporation. Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM.(Southall, Samantha) |
Filing 930 Objection to the Proposed Class Action Settlement. Document filed by Humana Inc.. (Attachments: #1 Notice of Intention to Appear, #2 Summary Statement).(Fiebig, Rebecca) |
Filing 929 RESPONSE to Motion re: #925 MOTION for Attorney Fees . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc...(Wilkinson, Beth) |
Filing 928 DECLARATION of Charles Silver in Support re: #925 MOTION for Attorney Fees .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc...(Gerstein, Bruce) |
Filing 927 DECLARATION of Bruce E. Gerstein in Support re: #925 MOTION for Attorney Fees .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H).(Gerstein, Bruce) |
Filing 926 MEMORANDUM OF LAW in Support re: #925 MOTION for Attorney Fees . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc...(Gerstein, Bruce) |
Filing 925 MOTION for Attorney Fees . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc...(Gerstein, Bruce) |
|
Filing 923 LETTER addressed to Magistrate Judge Robert W. Lehrburger from Bruce E. Gerstein dated 1/29/2020 re: Letter Dated January 28, 2020. Document filed by JM Smith Corporation. (Attachments: #1 Exhibit)(Gerstein, Bruce) |
Filing 922 NOTICE of Service Pursuant to 28 U.S.C. 1715. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 - Proof of Service, #2 Exhibit 2 - CAFA Letter)(Wilkinson, Beth) |
|
|
Set/Reset Deadlines: (Brief due by 4/21/2020.) Set/Reset Hearings: (Fairness Hearing set for 5/27/2020 at 10:00 AM in Courtroom 24A, 500 Pearl Street, New York, NY 10007 before Judge Colleen McMahon.) (mml) |
Case Stayed. (mml) |
Filing 919 DECLARATION of Bruce E. Gerstein in Support re: #917 MOTION to Approve Preliminary Approval of Settlement .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Settlement Agreement, #2 Exhibit Proposed Plan of Allocation, #3 Exhibit Declaration of Dr. Russell L. Lamb)(Gerstein, Bruce) |
Filing 918 MEMORANDUM OF LAW in Support re: #917 MOTION to Approve Preliminary Approval of Settlement . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit)(Gerstein, Bruce) |
Filing 917 MOTION to Approve Preliminary Approval of Settlement . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
|
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. (870 in 1:15-cv-07488-CM-RWL, 34 in 1:15-cv-10083-CM) MOTION for Andrew W. Kelly to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number NYSDC-17467278. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM(wb) |
Filing 915 NOTICE OF CHANGE OF ADDRESS by David C Raphael, Jr on behalf of JM Smith Corporation. New Address: Smith Segura Raphael & Leger, LLP, 221 Ansley Blvd., Alexandria, Louisiana, United States 71303, 318-445-4480. (Raphael, David) |
Filing 914 NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 10/28/19 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...(McGuirk, Kelly) |
Filing 913 TRANSCRIPT of Proceedings re: CONFERENCE held on 10/28/2019 before Judge Colleen McMahon. Court Reporter/Transcriber: Kristen Carannante, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/26/2019. Redacted Transcript Deadline set for 12/6/2019. Release of Transcript Restriction set for 2/3/2020.(McGuirk, Kelly) |
Minute Entry for proceedings held before Judge Colleen McMahon: Settlement hearing held on 10/28/2019. Notice of Settlement Hearing: The parties advised the Court of their preliminary settlement agreement, as well as the logistics of noticing all class members. The parties agreed to submit schedule proposal for a hearing at which the Court could hear objections to the settlement terms. Submitted By: Alex Zuckerman. (Court Reporter Pamela Utter). (mde) |
Filing 912 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 26, 2019 re: Response to Plaintiffs' Letter ECF No. 911. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Wilkinson, Beth) |
Filing 911 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated October 26, 2019 re: Admissibility of PX-0174, PX-0175, PX-0632, PX-1095, PX-1520 and PX-1636. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 910 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 25, 2019 re: Proposed Voir Dire Questions. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Wilkinson, Beth) |
Filing 909 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated October 25, 2019 re: Proposed Amended Voir Dire Questions. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 908 JOINT LETTER addressed to Judge Colleen McMahon from Dan Litvin dated October 25, 2019 re: Objections to Deposition Designations of Seth Silber and Eric Agovino. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E)(Litvin, Dan) |
|
|
Filing 905 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated October 24, 2019 re: Responding to Forest's Letter dated 10/23/2019. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7)(Gerstein, Bruce) |
|
Filing 903 PROPOSED STIPULATION AND ORDER. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Gerstein, Bruce) |
|
Filing 901 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 23, 2019 re: Outstanding Pretrial Matters. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Wilkinson, Beth) |
Filing 900 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated 10/23/2019 re: Permission to Use the Court's Wireless Internet Network. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 899 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 21, 2019 re: admissibility of cumulative patent-related testimony. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Wilkinson, Beth) |
Filing 898 MOTION for James M. Rosenthal to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number BNYSDC-17804572. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Affidavit of James M. Rosenthal, #2 Exhibit A - DC Certificate of Good Standing, #3 Exhibit B - MD Certificate of Good Standing, #4 Text of Proposed Order)(Rosenthal, James) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #898 MOTION for James M. Rosenthal to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number BNYSDC-17804572. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
Filing 897 LETTER addressed to Judge Colleen McMahon from Russell A. Chorush dated October 18, 2019 re: Admissability of Testimony of Patent Technical Experts. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10)(Chorush, Russell) |
Filing 896 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 18, 2019 re: ECF No. 887 (Briefing Order). Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F)(Wilkinson, Beth) |
Filing 895 TRIAL BRIEF Plaintiffs Trial Brief Concerning The Meaning Of Large Under FTC V. Actavis, Inc.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Affidavit Declaration Of Bruce Gerstein In Support Of Plaintiffs Trial Brief Concerning The Meaning Of Large Under FTC V. Actavis, Inc., #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5)(Gerstein, Bruce) |
Filing 894 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 18, 2019 re: Request for Approval for Courtroom Connect and Aquipt. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A)(Wilkinson, Beth) |
|
Filing 892 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated October 18, 2019 re: Request for Approval for Courtroom Connect Services. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
Filing 890 NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a HEARING proceeding held on 10/10/19 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...(McGuirk, Kelly) |
Filing 889 TRANSCRIPT of Proceedings re: HEARING held on 10/10/2019 before Judge Colleen McMahon. Court Reporter/Transcriber: Pamela Utter, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/7/2019. Redacted Transcript Deadline set for 11/18/2019. Release of Transcript Restriction set for 1/15/2020.(McGuirk, Kelly) |
Filing 888 JOINT LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 16, 2019 re: Admitted Exhibits. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Wilkinson, Beth) |
Filing 887 REQUEST FOR BRIEFING: Counsel, I really meant it when I told Mr. Gerstein that I would hate to have you brief the issue of "large in relation to what." But I am exercising my prerogative to change my mind. If you can, by the end of the week, get me something on this question. And whatever you do, don't send me a brief that quotes a lot of language from Justice Breyer's opinion inActavis. I fear I have teased everything that I can out of the language of Actavis. I would rather know what other judges have done on this issue since Actavis (if anyone has done anything). I am also interested in your thoughts on whether Forest's decision not to waive attorney-client privilege plays into this issue. Also, please do not parse my earlier opinions looking for "rulings" that you think I might have made on this issue. I assure you that I never gave it much thought until Mr. Gerstein raised it at the Final Pre-Trial Conference. (Signed by Judge Colleen McMahon on 10/15/2019) (mml) |
|
Minute Entry for proceedings held before Judge Colleen McMahon: Final Pretrial Conference held on 10/10/2019. Final Pretrial Conference: The court heard argument and made rulings on the parties Phase 1 witnesses and proposed exhibits. The parties agreed to defer argument on disputed phase 2 witnesses and exhibits. The parties discussed trial scheduling logistics. Submitted By: Alex Zuckerman (Court Reporter Pamela Utter). (mde) |
Filing 885 LETTER addressed to Judge Colleen McMahon from Beth A. Wilkinson dated 10/9/2019 re: Updated Exhibits and Objections. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Wilkinson, Beth) |
Filing 884 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated October 9, 2019 re: Summary Tables of Exhibit Objections. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
Filing 883 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated October 7, 2019 re: Application of Collateral Estoppel. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
Filing 882 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 4, 2019 re: Electronic Device Authorization. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A)(Wilkinson, Beth) |
Filing 881 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated October 3, 2019 re: Forest's Exhibit Lists. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A - Forest's Phase 1 Exhibit List, #2 Exhibit B - Forest's Phase 2 Exhibit List)(Wilkinson, Beth) |
Filing 880 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated October 3, 2019 re: Plaintiffs' and Joint Exhibits. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 879 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated October 2, 2019 re: Pretrial Conference Matters. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
Filing 878 LETTER addressed to Judge Colleen McMahon from Beth A. Wilkinson dated 10/2/2019 re: Pretrial Conference Matters. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Wilkinson, Beth) |
Filing 877 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated October 1, 2019 re: Electronic Devices. Document filed by JM Smith Corporation.(Litvin, Dan) |
|
Filing 875 PROPOSED STIPULATION AND ORDER. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Gerstein, Bruce) |
Filing 874 JOINT LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated September 20, 2019 re: Certain Pre-Trial Issues. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
Filing 873 NOTICE OF APPEARANCE by Aakruti Govind Vakharia on behalf of JM Smith Corporation. (Vakharia, Aakruti) |
|
Filing 871 MOTION for Susan C. Segura to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-17523700. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Affidavit, #2 Text of Proposed Order)(Segura, Susan) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #871 MOTION for Susan C. Segura to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-17523700. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
Filing 870 MOTION for Andrew W. Kelly to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number NYSDC-17467278. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation.Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM(Kelly, Andrew) |
Filing 869 MEMO ENDORSEMENT on re: #866 Letter, filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc. ENDORSEMENT: The final pre-trial conference is now set for Thursday, 10/10/19 at 10:00a.m. Trial is scheduled for Monday, 10/28/19 at 9:30a.m. (Jury Trial set for 10/28/2019 at 09:30 AM before Judge Colleen McMahon.) (Signed by Judge Colleen McMahon on 8/13/2019) (mml) |
Filing 868 MEMO ENDORSEMENT on re: #865 Letter filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation. ENDORSEMENT: The final pre-trial conference is re-scheduled to Thursday, 10/10/19 at 10:00a.m. (Final Pretrial Conference set for 10/10/2019 at 10:00 AM before Judge Colleen McMahon.) (Signed by Judge Colleen McMahon on 8/13/2019) (mml) |
|
Filing 866 LETTER addressed to Judge Colleen McMahon from Beth Wilkinson dated August 13, 2019 re: Final Pre-Trial Conference. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Wilkinson, Beth) |
Filing 865 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated August 13, 2019 re: Final Pre-Trial Conference. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 864 REPLY MEMORANDUM OF LAW in Support re: #860 MOTION For Clarification Concerning Trial Phasing . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
|
Filing 862 MEMORANDUM OF LAW in Opposition re: #860 MOTION For Clarification Concerning Trial Phasing . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Wilkinson, Beth) |
Filing 861 TRANSCRIPT of Proceedings re: CONFERENCE held on 6/4/2019 before Judge Colleen McMahon. Court Reporter/Transcriber: Martha Martin, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 8/30/2019. Redacted Transcript Deadline set for 9/9/2019. Release of Transcript Restriction set for 11/7/2019.(McGuirk, Kelly) |
Filing 860 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION For Clarification Concerning Trial Phasing . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Memorandum of Law, #2 Proposed Order)(Hennings, Kimberly) Modified on 10/11/2019 (ldi). |
|
|
Filing 857 MOTION for Miranda Y. Jones to Withdraw as Attorney . Document filed by JM Smith Corporation.(Chorush, Russell) |
Filing 856 RESPONSE to Motion re: #855 MOTION for Leave to File Reply Memorandum of Law in Further Support of Plaintiffs' Motion in Limine No. 1 . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 855 MOTION for Leave to File Reply Memorandum of Law in Further Support of Plaintiffs' Motion in Limine No. 1 . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1 - Proposed Reply Memorandum)(Litvin, Dan) |
Filing 854 DECLARATION of Martin Toto in Opposition re: #721 MOTION in Limine No. 1: Preclude Forest from Asserting Subjective Beliefs Concerning the '703 Patent That It Blocked During Discovery on Privilege And Work-Product Grounds.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9)(Toto, Martin) |
Filing 853 MEMORANDUM OF LAW in Opposition re: #721 MOTION in Limine No. 1: Preclude Forest from Asserting Subjective Beliefs Concerning the '703 Patent That It Blocked During Discovery on Privilege And Work-Product Grounds. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 852 DECLARATION of Heather M. Burke in Opposition re: #732 MOTION in Limine No. 12: Exclude Evidence of any Party's Size or Financial Condition.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Burke, Heather) |
Filing 851 MEMORANDUM OF LAW in Opposition re: #732 MOTION in Limine No. 12: Exclude Evidence of any Party's Size or Financial Condition. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Burke, Heather) |
Filing 850 DECLARATION of Heather M. Burke in Opposition re: #730 MOTION in Limine No. 10: Exclude Hearsay Statements from the New York Attorney General.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Burke, Heather) |
Filing 849 MEMORANDUM OF LAW in Opposition re: #730 MOTION in Limine No. 10: Exclude Hearsay Statements from the New York Attorney General. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Burke, Heather) |
Filing 848 DECLARATION of Martin M. Toto in Opposition re: #728 MOTION in Limine No. 8: Preclude Forest from Asserting Improper Arguments Concerning the Size of Its Reverse Payment and Purported Saved Litigation Costs.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7)(Toto, Martin) |
Filing 847 MEMORANDUM OF LAW in Opposition re: #728 MOTION in Limine No. 8: Preclude Forest from Asserting Improper Arguments Concerning the Size of Its Reverse Payment and Purported Saved Litigation Costs. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 846 DECLARATION of Martin M. Toto in Opposition re: #727 MOTION in Limine No. 7: Preclude Improper Justifications for the Lexapro Amendment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1)(Toto, Martin) |
Filing 845 MEMORANDUM OF LAW in Opposition re: #727 MOTION in Limine No. 7: Preclude Improper Justifications for the Lexapro Amendment. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 844 DECLARATION of Martin M. Toto in Opposition re: #726 MOTION in Limine No. 6: Preclude "Litigation Risk" or "Risk Aversion" or Purported "Early Entry" as Procompetitive Justifications.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1)(Toto, Martin) |
Filing 843 MEMORANDUM OF LAW in Opposition re: #726 MOTION in Limine No. 6: Preclude "Litigation Risk" or "Risk Aversion" or Purported "Early Entry" as Procompetitive Justifications. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 842 DECLARATION of Joseph Opper in Opposition re: #784 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 11., #756 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 2 to Exclude General Statistical Evidence of Outcomes in Unrelated Pharmaceutical Patent Litigations., #766 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 5 to Exclude DPP Wholesalers' Overcharge Damages Methodology., #737 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 1 to Exclude Expert Testimony that Forest's Post-Injunction Notifications Created Doubt and Confusion About the Continued Availability of Namenda IR., #759 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 3 to Exclude Irrelevant Evidence of Foreign Tribunals' Findings of Patent Invalidity for Foreign Patents Not at Issue., #792 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 13 to Preclude Prejudicial and Irrelevant Evidence and Argument Regarding Forest's Medicaid Rebate Savings., #772 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 7 to Expedite Trial by Requiring that all Live and Designated Witnesses Testify Only Once., #799 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 16 to Prevent Improper Use of the Court's Collateral Estoppel Order., #781 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 10 to Exclude Evidence and Argument Regarding the Post-Agreement Subsequent Sales History of the Lexapro Authorized Generic., #763 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 4 to Require Class Representative Rochester Drug Co-Operative to Testify at Trial or Withdraw as a Class Representative., #778 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 9 to Preclude Evidence of Speculative Less Restrictive Alternatives., #775 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 8 to Remove Privilege Redaction Labels from Trial Exhibits., #769 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 6 to Preclude Testimony by Russell Lamb Regarding Undisclosed Damages Opinions Based on Alternative Entry Dates., #787 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 12 to Preclude Plaintiffs' Expert Dr. Herrmann from Using a Claim Construction Contrary to the Settled Claim Construction of the Patent Court., #795 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 14 to Exclude the Use of Inflammatory Evidence and Argument Regarding Drug Pricing Trends and Patent Settlement Agreements., #789 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 15 to Exclude the NYAG Namenda Decisions.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40, #41 Exhibit 41, #42 Exhibit 42, #43 Exhibit 43, #44 Exhibit 44, #45 Exhibit 45, #46 Exhibit 46, #47 Exhibit 47, #48 Exhibit 48, #49 Exhibit 49, #50 Exhibit 50, #51 Exhibit 51, #52 Exhibit 52, #53 Exhibit 53, #54 Exhibit 54, #55 Exhibit 55, #56 Exhibit 56)(Opper, Joseph) |
Filing 841 MEMORANDUM OF LAW in Opposition re: #799 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 16 to Prevent Improper Use of the Court's Collateral Estoppel Order. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 840 MEMORANDUM OF LAW in Opposition re: #789 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 15 to Exclude the NYAG Namenda Decisions. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 839 MEMORANDUM OF LAW in Opposition re: #795 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 14 to Exclude the Use of Inflammatory Evidence and Argument Regarding Drug Pricing Trends and Patent Settlement Agreements. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 838 MEMORANDUM OF LAW in Opposition re: #792 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 13 to Preclude Prejudicial and Irrelevant Evidence and Argument Regarding Forest's Medicaid Rebate Savings. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 837 MEMORANDUM OF LAW in Opposition re: #787 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 12 to Preclude Plaintiffs' Expert Dr. Herrmann from Using a Claim Construction Contrary to the Settled Claim Construction of the Patent Court. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 836 MEMORANDUM OF LAW in Opposition re: #784 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 11. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 835 MEMORANDUM OF LAW in Opposition re: #781 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 10 to Exclude Evidence and Argument Regarding the Post-Agreement Subsequent Sales History of the Lexapro Authorized Generic. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 834 MEMORANDUM OF LAW in Opposition re: #778 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 9 to Preclude Evidence of Speculative Less Restrictive Alternatives. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 833 MEMORANDUM OF LAW in Opposition re: #775 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 8 to Remove Privilege Redaction Labels from Trial Exhibits. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 832 MEMORANDUM OF LAW in Opposition re: #772 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 7 to Expedite Trial by Requiring that all Live and Designated Witnesses Testify Only Once. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 831 MEMORANDUM OF LAW in Opposition re: #769 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 6 to Preclude Testimony by Russell Lamb Regarding Undisclosed Damages Opinions Based on Alternative Entry Dates. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 830 MEMORANDUM OF LAW in Opposition re: #766 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 5 to Exclude DPP Wholesalers' Overcharge Damages Methodology. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 829 MEMORANDUM OF LAW in Opposition re: #763 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 4 to Require Class Representative Rochester Drug Co-Operative to Testify at Trial or Withdraw as a Class Representative. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 828 MEMORANDUM OF LAW in Opposition re: #759 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 3 to Exclude Irrelevant Evidence of Foreign Tribunals' Findings of Patent Invalidity for Foreign Patents Not at Issue. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 827 MEMORANDUM OF LAW in Opposition re: #756 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 2 to Exclude General Statistical Evidence of Outcomes in Unrelated Pharmaceutical Patent Litigations. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 826 MEMORANDUM OF LAW in Opposition re: #737 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 1 to Exclude Expert Testimony that Forest's Post-Injunction Notifications Created Doubt and Confusion About the Continued Availability of Namenda IR. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 825 MEMORANDUM OF LAW in Opposition re: #729 MOTION in Limine No. 9: Exclude Evidence and Argument that the FTC or the Patent Court "Approved" of the Namenda Agreements. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 824 DECLARATION of Martin M. Toto in Opposition re: #723 MOTION in Limine No. 3: Preclude Forest from Offering Fact Witnesses to Change or Supplement the Rule 30(b)(6) Deposition Testimony Provided By Charles Ryan and David Solomon with Respect to Certain Key Documents.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5)(Toto, Martin) |
Filing 823 MEMORANDUM OF LAW in Opposition re: #723 MOTION in Limine No. 3: Preclude Forest from Offering Fact Witnesses to Change or Supplement the Rule 30(b)(6) Deposition Testimony Provided By Charles Ryan and David Solomon with Respect to Certain Key Documents. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 822 MEMORANDUM OF LAW in Opposition re: #722 MOTION in Limine No. 2: Preclude Use in This Case of Discovery Forest Took in The End-Payor Action Years After the Close of Discovery. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 821 DECLARATION of John Chung in Opposition re: #734 MOTION in Limine No. 14: Exclude Mention of Treble Damages, Attorneys Fees, or Costs.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 1 - Part 2, #3 Exhibit 1 - Part 3)(Chung, John) |
Filing 820 MEMORANDUM OF LAW in Opposition re: #734 MOTION in Limine No. 14: Exclude Mention of Treble Damages, Attorneys Fees, or Costs. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Chung, John) |
Filing 819 DECLARATION of John Chung in Opposition re: #733 MOTION in Limine No. 13: Exclude Mention of Downstream Effects.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Chung, John) |
Filing 818 MEMORANDUM OF LAW in Opposition re: #733 MOTION in Limine No. 13: Exclude Mention of Downstream Effects. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Chung, John) |
Filing 817 MEMORANDUM OF LAW in Opposition re: #731 MOTION in Limine No. 11: Exclude Evidence and/or Argument Regarding the Opioid Crisis and Past or Present Litigation Involving Plaintiffs. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 816 DECLARATION of Eric E. Lancaster in Opposition re: #736 MOTION in Limine No. 16: Preclude Reference to Forest's Expert Roderick McKelvie as "Judge" or "The Honorable".. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Excerpt from the Expert Report of Roderick McKelvie, dated October 1, 2017, #2 Exhibit 2- Excerpts from the Expert Report of George W. Johnston, dated September 15, 2017, #3 Exhibit 3- Plaintiff Merit Industries, Inc.s Response to JVLs In Limine Motion No. 2)(Lancaster, Eric) |
Filing 815 MEMORANDUM OF LAW in Opposition re: #736 MOTION in Limine No. 16: Preclude Reference to Forest's Expert Roderick McKelvie as "Judge" or "The Honorable". . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
Filing 814 MEMORANDUM OF LAW in Opposition re: #735 MOTION in Limine No. 15: Preclude Forest from Relying Upon Patents Other Than the '703 Patent as Affecting Generic Namenda IR. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
Filing 813 MEMORANDUM OF LAW in Opposition re: #725 MOTION in Limine No. 5: To Exclude Deposition Testimony from Witnesses Deposed Only in the Namenda Patent Litigation. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
Filing 812 DECLARATION of Eric E. Lancaster in Opposition re: #724 MOTION in Limine No. 4: Preclude or Limit Forest's Use of Expert Opinion Testimony as a Proxy for Forest's Alleged Subjective Beliefs Regarding the Strength of the '703 Patent Where Forest Blocked All Discovery Regarding Its Subjec. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Excerpts from the Expert Report of Roderick McKelvie, dated October 1, 2017, #2 Exhibit 2- Excerpts from the Expert Report of Roderick McKelvie in Response to John R. Thomas, dated December 12, 2017)(Lancaster, Eric) |
Filing 811 MEMORANDUM OF LAW in Opposition re: #724 MOTION in Limine No. 4: Preclude or Limit Forest's Use of Expert Opinion Testimony as a Proxy for Forest's Alleged Subjective Beliefs Regarding the Strength of the '703 Patent Where Forest Blocked All Discovery Regarding Its Subjec . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
|
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #809 MOTION for Rakesh Kilaru to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-17063296. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
Filing 809 MOTION for Rakesh Kilaru to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-17063296. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A, #2 Affidavit of Rakesh Kilaru, #3 Text of Proposed Order)(Kilaru, Rakesh) |
Set/Reset Hearings: Jury Selection set for 10/28/2019 at 9:30 AM in Courtroom 24A, 500 Pearl Street, New York, NY 10007 before Judge Colleen McMahon. (mde) |
Minute Entry for proceedings held before Judge Colleen McMahon and Magistrate Judge Lehrburger: Status Conference held on 6/4/2019. Decision: Status conference with attorneys held. Trial in the direct purchaser action (15-cv-7488) is rescheduled to begin October 28, 2019. Motion for leave to supplement the expert reports of the Hon. Roderick McKelvie and Dr. Lona Fowdur (15-cv-7488, Dkt. No. 694) is DENIED. Further, the parties in the direct purchaser case (15-cv-7488) may not use, introduce, or allude to the Dr. Reddys document in the direct purchaser trial. Motion to bifurcate trial into two phases (15-cv-7488, Dkt. No. 691) is GRANTED IN PART. In phase one, the parties will litigate pay-to-delay liability, causation and damages. In phase two, which will be shorter, the parties will litigate the remaining elements of hard-switch liability and damages. The Clerk of Court is respectfully directed to remove Dkt. Nos. 691 and 694 from the Courts list of open motions.Submitted by: Elizabeth Brody. (Court Reporter Martha Martin). (mde) |
Filing 808 NOTICE OF APPEARANCE by Chanakya Arjun Sethi on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Sethi, Chanakya) |
Filing 807 NOTICE OF APPEARANCE by Kieran Gavin Gostin on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Gostin, Kieran) |
Filing 806 NOTICE OF APPEARANCE by Beth A. Wilkinson on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Wilkinson, Beth) |
Filing 805 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated May 29, 2019 re: Privilege Assertions. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
Filing 804 LETTER addressed to Judge Colleen McMahon from Heather K. McDevitt dated May 29, 2019 re: the Court's May 17, 2019 letter #719 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(McDevitt, Heather) |
Filing 803 LETTER addressed to Judge Colleen McMahon from Jonathan Berman dated May 29, 2019 re: Dr. Reddy's Deal Memo. Document filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Berman, Jonathan) |
Filing 802 LETTER addressed to Judge Colleen McMahon from Sarah K. Frederick dated May 29, 2019 re: discovery of the generic manufacturers in the Direct Purchaser action. Document filed by Teva Pharmaceuticals USA, Inc..(Frederick, Sarah) |
Filing 801 DECLARATION of Martin M. Toto in Support re: #799 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 16 to Prevent Improper Use of the Court's Collateral Estoppel Order.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6)(Toto, Martin) |
Filing 800 MEMORANDUM OF LAW in Support re: #799 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 16 to Prevent Improper Use of the Court's Collateral Estoppel Order. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 799 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 16 to Prevent Improper Use of the Court's Collateral Estoppel Order. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) |
Filing 798 DECLARATION of Heather M. Burke in Support re: #789 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 15 to Exclude the NYAG Namenda Decisions.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- PX-0904, #2 Exhibit 1- Part 2, #3 Exhibit 1- Part 3, #4 Exhibit 2- PX-0903, #5 Exhibit 3- DTX-026)(Burke, Heather) |
Filing 797 DECLARATION of Heather M. Burke in Support re: #795 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 14 to Exclude the Use of Inflammatory Evidence and Argument Regarding Drug Pricing Trends and Patent Settlement Agreements.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, Part 1, #3 Exhibit 2, Part 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7)(Burke, Heather) |
Filing 796 MEMORANDUM OF LAW in Support re: #795 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 14 to Exclude the Use of Inflammatory Evidence and Argument Regarding Drug Pricing Trends and Patent Settlement Agreements. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Burke, Heather) |
Filing 795 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 14 to Exclude the Use of Inflammatory Evidence and Argument Regarding Drug Pricing Trends and Patent Settlement Agreements. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
Filing 794 DECLARATION of Martin M. Toto in Support re: #792 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 13 to Preclude Prejudicial and Irrelevant Evidence and Argument Regarding Forest's Medicaid Rebate Savings.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Toto, Martin) |
Filing 793 MEMORANDUM OF LAW in Support re: #792 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 13 to Preclude Prejudicial and Irrelevant Evidence and Argument Regarding Forest's Medicaid Rebate Savings. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 792 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 13 to Preclude Prejudicial and Irrelevant Evidence and Argument Regarding Forest's Medicaid Rebate Savings. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) |
Filing 791 DECLARATION of Eric E. Lancaster in Support re: #787 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 12 to Preclude Plaintiffs' Expert Dr. Herrmann from Using a Claim Construction Contrary to the Settled Claim Construction of the Patent Court.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Lancaster, Eric) |
Filing 790 MEMORANDUM OF LAW in Support re: #789 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 15 to Exclude the NYAG Namenda Decisions. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Burke, Heather) |
Filing 789 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 15 to Exclude the NYAG Namenda Decisions. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
Filing 788 MEMORANDUM OF LAW in Support re: #787 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 12 to Preclude Plaintiffs' Expert Dr. Herrmann from Using a Claim Construction Contrary to the Settled Claim Construction of the Patent Court. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
Filing 787 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 12 to Preclude Plaintiffs' Expert Dr. Herrmann from Using a Claim Construction Contrary to the Settled Claim Construction of the Patent Court. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Lancaster, Eric) |
Filing 786 DECLARATION of Eric E. Lancaster in Support re: #784 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 11.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Excerpts from the Report of Dr. Nathan Herrmann, dated September 13, 2017, #2 Exhibit 2- Pages from the November 2, 2017 deposition of Dr. Nathan Herrmann, #3 Exhibit 3- Mylan ANDA Module 1.14.2.3 Final Labeling Text, #4 Exhibit 4- Excerpt from the Declaration of James J. Lah, M.D., Ph.D., dated September 8, 2014, #5 Exhibit 5- Excerpt from the Declaration of Alan R. Jacobs, M.D., dated October 20, 2014, #6 Exhibit 6- Excerpt from the Declaration of Dr. Bruce D. Kohrman, M.D., dated October 17, 2014, #7 Exhibit 7- Excerpt from the Declaration of Barry Reisberg, M.D., dated October 20, 2014, #8 Exhibit 8- Excerpt from the Declaration of Barry Rovner, M.D., dated October 20, 2014)(Lancaster, Eric) |
Filing 785 MEMORANDUM OF LAW in Support re: #784 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 11. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
Filing 784 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 11. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Lancaster, Eric) |
Filing 783 DECLARATION of Martin M. Toto in Support re: #781 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 10 to Exclude Evidence and Argument Regarding the Post-Agreement Subsequent Sales History of the Lexapro Authorized Generic.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1)(Toto, Martin) |
Filing 782 MEMORANDUM OF LAW in Support re: #781 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 10 to Exclude Evidence and Argument Regarding the Post-Agreement Subsequent Sales History of the Lexapro Authorized Generic. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 781 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 10 to Exclude Evidence and Argument Regarding the Post-Agreement Subsequent Sales History of the Lexapro Authorized Generic. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) |
Filing 780 DECLARATION of Martin M. Toto in Support re: #778 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 9 to Preclude Evidence of Speculative Less Restrictive Alternatives.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Errata 4)(Toto, Martin) |
Filing 779 MEMORANDUM OF LAW in Support re: #778 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 9 to Preclude Evidence of Speculative Less Restrictive Alternatives. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 778 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 9 to Preclude Evidence of Speculative Less Restrictive Alternatives. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) |
Filing 777 DECLARATION of Heather M. Burke in Support re: #775 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 8 to Remove Privilege Redaction Labels from Trial Exhibits.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- PX-0206 (FRX-AT-04617640), #2 Exhibit 2- DTX-311 (FRX-AT-04283764))(Burke, Heather) |
Filing 776 MEMORANDUM OF LAW in Support re: #775 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 8 to Remove Privilege Redaction Labels from Trial Exhibits. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Burke, Heather) |
Filing 775 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 8 to Remove Privilege Redaction Labels from Trial Exhibits. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
Filing 774 DECLARATION of Heather M. Burke in Support re: #772 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 7 to Expedite Trial by Requiring that all Live and Designated Witnesses Testify Only Once.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1)(Burke, Heather) |
Filing 773 MEMORANDUM OF LAW in Support re: #772 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 7 to Expedite Trial by Requiring that all Live and Designated Witnesses Testify Only Once. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Burke, Heather) |
Filing 772 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 7 to Expedite Trial by Requiring that all Live and Designated Witnesses Testify Only Once. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
Filing 771 DECLARATION of John Chung in Support re: #769 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 6 to Preclude Testimony by Russell Lamb Regarding Undisclosed Damages Opinions Based on Alternative Entry Dates.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Chung, John) |
Filing 770 MEMORANDUM OF LAW in Support re: #769 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 6 to Preclude Testimony by Russell Lamb Regarding Undisclosed Damages Opinions Based on Alternative Entry Dates. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Chung, John) |
Filing 769 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 6 to Preclude Testimony by Russell Lamb Regarding Undisclosed Damages Opinions Based on Alternative Entry Dates. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Chung, John) |
Filing 768 DECLARATION of John Chung in Support re: #766 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 5 to Exclude DPP Wholesalers' Overcharge Damages Methodology.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Excerpts of the Expert Report of Pierre-Yves Cremieux, dated October 9, 2017, #2 Exhibit 2- Excerpts from the deposition of Jim Benton, dated July 19, 2017, #3 Exhibit 3- Prime Vendor Agreement between Cardinal Health and Freds Stores of Tennessee)(Chung, John) |
Filing 767 MEMORANDUM OF LAW in Support re: #766 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 5 to Exclude DPP Wholesalers' Overcharge Damages Methodology. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Chung, John) |
Filing 766 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 5 to Exclude DPP Wholesalers' Overcharge Damages Methodology. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Chung, John) |
Filing 765 DECLARATION of Michael E. Hamburger in Support re: #763 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 4 to Require Class Representative Rochester Drug Co-Operative to Testify at Trial or Withdraw as a Class Representative.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, Part 1, #2 Exhibit 1, Part 2, #3 Exhibit 1, Part 3, #4 Exhibit 1, Part 4, #5 Exhibit 2, #6 Exhibit 3, #7 Exhibit 4, #8 Exhibit 5)(Hamburger, Michael) |
Filing 764 MEMORANDUM OF LAW in Support re: #763 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 4 to Require Class Representative Rochester Drug Co-Operative to Testify at Trial or Withdraw as a Class Representative. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 763 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 4 to Require Class Representative Rochester Drug Co-Operative to Testify at Trial or Withdraw as a Class Representative. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Hamburger, Michael) |
Filing 762 DECLARATION of Eric E. Lancaster in Support re: #759 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 3 to Exclude Irrelevant Evidence of Foreign Tribunals' Findings of Patent Invalidity for Foreign Patents Not at Issue.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1)(Lancaster, Eric) |
Filing 761 DECLARATION of Dan Litvin in Support re: #723 MOTION in Limine No. 3: Preclude Forest from Offering Fact Witnesses to Change or Supplement the Rule 30(b)(6) Deposition Testimony Provided By Charles Ryan and David Solomon with Respect to Certain Key Documents., #732 MOTION in Limine No. 12: Exclude Evidence of any Party's Size or Financial Condition., #726 MOTION in Limine No. 6: Preclude "Litigation Risk" or "Risk Aversion" or Purported "Early Entry" as Procompetitive Justifications., #731 MOTION in Limine No. 11: Exclude Evidence and/or Argument Regarding the Opioid Crisis and Past or Present Litigation Involving Plaintiffs., #725 MOTION in Limine No. 5: To Exclude Deposition Testimony from Witnesses Deposed Only in the Namenda Patent Litigation., #733 MOTION in Limine No. 13: Exclude Mention of Downstream Effects., #722 MOTION in Limine No. 2: Preclude Use in This Case of Discovery Forest Took in The End-Payor Action Years After the Close of Discovery., #729 MOTION in Limine No. 9: Exclude Evidence and Argument that the FTC or the Patent Court "Approved" of the Namenda Agreements., #724 MOTION in Limine No. 4: Preclude or Limit Forest's Use of Expert Opinion Testimony as a Proxy for Forest's Alleged Subjective Beliefs Regarding the Strength of the '703 Patent Where Forest Blocked All Discovery Regarding Its Subjec, #728 MOTION in Limine No. 8: Preclude Forest from Asserting Improper Arguments Concerning the Size of Its Reverse Payment and Purported Saved Litigation Costs., #730 MOTION in Limine No. 10: Exclude Hearsay Statements from the New York Attorney General., #721 MOTION in Limine No. 1: Preclude Forest from Asserting Subjective Beliefs Concerning the '703 Patent That It Blocked During Discovery on Privilege And Work-Product Grounds., #734 MOTION in Limine No. 14: Exclude Mention of Treble Damages, Attorneys Fees, or Costs., #736 MOTION in Limine No. 16: Preclude Reference to Forest's Expert Roderick McKelvie as "Judge" or "The Honorable"., #735 MOTION in Limine No. 15: Preclude Forest from Relying Upon Patents Other Than the '703 Patent as Affecting Generic Namenda IR., #727 MOTION in Limine No. 7: Preclude Improper Justifications for the Lexapro Amendment.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Ex 1, #2 Ex 2, #3 Ex 3, #4 Ex 4, #5 Ex 5, #6 Ex 6, #7 Ex 7, #8 Ex 8, #9 Ex 9, #10 Ex 10, #11 Ex 11, #12 Ex 12, #13 Ex 13, #14 Ex 14, #15 Ex 15, #16 Ex 16, #17 Ex 17, #18 Ex 18, #19 Ex 19, #20 Ex 20, #21 Ex 21, #22 Ex 22, #23 Ex 23, #24 Ex 24, #25 Ex 25, #26 Ex 26, #27 Ex 27, #28 Ex 28, #29 Ex 29, #30 Ex 30, #31 Ex 31, #32 Ex 32, #33 Ex 33, #34 Ex 34, #35 Ex 35, #36 Ex 36, #37 Ex 37, #38 Ex 38, #39 Ex 39, #40 Ex 40, #41 Ex 41, #42 Ex 42, #43 Ex 43, #44 Ex 44, #45 Ex 45)(Litvin, Dan) |
Filing 760 MEMORANDUM OF LAW in Support re: #759 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 3 to Exclude Irrelevant Evidence of Foreign Tribunals' Findings of Patent Invalidity for Foreign Patents Not at Issue. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
Filing 759 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 3 to Exclude Irrelevant Evidence of Foreign Tribunals' Findings of Patent Invalidity for Foreign Patents Not at Issue. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Lancaster, Eric) |
Filing 758 DECLARATION of Eric E. Lancaster in Support re: #756 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 2 to Exclude General Statistical Evidence of Outcomes in Unrelated Pharmaceutical Patent Litigations.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Excerpts from the Expert Report of George W. Johnston, dated September 15, 2017)(Lancaster, Eric) |
Filing 757 MEMORANDUM OF LAW in Support re: #756 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 2 to Exclude General Statistical Evidence of Outcomes in Unrelated Pharmaceutical Patent Litigations. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Lancaster, Eric) |
Filing 756 MOTION in Limine /Forest's Notice of Motion and Motion in Limine 2 to Exclude General Statistical Evidence of Outcomes in Unrelated Pharmaceutical Patent Litigations. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Lancaster, Eric) |
Filing 755 DECLARATION of John Chung in Support re: #737 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 1 to Exclude Expert Testimony that Forest's Post-Injunction Notifications Created Doubt and Confusion About the Continued Availability of Namenda IR.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10)(Chung, John) |
Filing 754 MEMORANDUM OF LAW in Support re: #736 MOTION in Limine No. 16: Preclude Reference to Forest's Expert Roderick McKelvie as "Judge" or "The Honorable". . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 753 MEMORANDUM OF LAW in Support re: #735 MOTION in Limine No. 15: Preclude Forest from Relying Upon Patents Other Than the '703 Patent as Affecting Generic Namenda IR. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 752 MEMORANDUM OF LAW in Support re: #734 MOTION in Limine No. 14: Exclude Mention of Treble Damages, Attorneys Fees, or Costs. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 751 MEMORANDUM OF LAW in Support re: #733 MOTION in Limine No. 13: Exclude Mention of Downstream Effects. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 750 MEMORANDUM OF LAW in Support re: #732 MOTION in Limine No. 12: Exclude Evidence of any Party's Size or Financial Condition. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 749 MEMORANDUM OF LAW in Support re: #731 MOTION in Limine No. 11: Exclude Evidence and/or Argument Regarding the Opioid Crisis and Past or Present Litigation Involving Plaintiffs. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 748 MEMORANDUM OF LAW in Support re: #730 MOTION in Limine No. 10: Exclude Hearsay Statements from the New York Attorney General. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 747 MEMORANDUM OF LAW in Support re: #729 MOTION in Limine No. 9: Exclude Evidence and Argument that the FTC or the Patent Court "Approved" of the Namenda Agreements. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 746 MEMORANDUM OF LAW in Support re: #728 MOTION in Limine No. 8: Preclude Forest from Asserting Improper Arguments Concerning the Size of Its Reverse Payment and Purported Saved Litigation Costs. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 745 MEMORANDUM OF LAW in Support re: #727 MOTION in Limine No. 7: Preclude Improper Justifications for the Lexapro Amendment. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 744 MEMORANDUM OF LAW in Support re: #726 MOTION in Limine No. 6: Preclude "Litigation Risk" or "Risk Aversion" or Purported "Early Entry" as Procompetitive Justifications. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 743 MEMORANDUM OF LAW in Support re: #725 MOTION in Limine No. 5: To Exclude Deposition Testimony from Witnesses Deposed Only in the Namenda Patent Litigation. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 742 MEMORANDUM OF LAW in Support re: #724 MOTION in Limine No. 4: Preclude or Limit Forest's Use of Expert Opinion Testimony as a Proxy for Forest's Alleged Subjective Beliefs Regarding the Strength of the '703 Patent Where Forest Blocked All Discovery Regarding Its Subjec . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 741 MEMORANDUM OF LAW in Support re: #723 MOTION in Limine No. 3: Preclude Forest from Offering Fact Witnesses to Change or Supplement the Rule 30(b)(6) Deposition Testimony Provided By Charles Ryan and David Solomon with Respect to Certain Key Documents. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 740 MEMORANDUM OF LAW in Support re: #722 MOTION in Limine No. 2: Preclude Use in This Case of Discovery Forest Took in The End-Payor Action Years After the Close of Discovery. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 739 MEMORANDUM OF LAW in Support re: #721 MOTION in Limine No. 1: Preclude Forest from Asserting Subjective Beliefs Concerning the '703 Patent That It Blocked During Discovery on Privilege And Work-Product Grounds. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 738 MEMORANDUM OF LAW in Support re: #737 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 1 to Exclude Expert Testimony that Forest's Post-Injunction Notifications Created Doubt and Confusion About the Continued Availability of Namenda IR. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Chung, John) |
Filing 737 MOTION in Limine / Forest's Notice of Motion and Motion in Limine 1 to Exclude Expert Testimony that Forest's Post-Injunction Notifications Created Doubt and Confusion About the Continued Availability of Namenda IR. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Chung, John) |
Filing 736 MOTION in Limine No. 16: Preclude Reference to Forest's Expert Roderick McKelvie as "Judge" or "The Honorable". Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 735 MOTION in Limine No. 15: Preclude Forest from Relying Upon Patents Other Than the '703 Patent as Affecting Generic Namenda IR. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 734 MOTION in Limine No. 14: Exclude Mention of Treble Damages, Attorneys Fees, or Costs. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 733 MOTION in Limine No. 13: Exclude Mention of Downstream Effects. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 732 MOTION in Limine No. 12: Exclude Evidence of any Party's Size or Financial Condition. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 731 MOTION in Limine No. 11: Exclude Evidence and/or Argument Regarding the Opioid Crisis and Past or Present Litigation Involving Plaintiffs. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 730 MOTION in Limine No. 10: Exclude Hearsay Statements from the New York Attorney General. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 729 MOTION in Limine No. 9: Exclude Evidence and Argument that the FTC or the Patent Court "Approved" of the Namenda Agreements. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 728 MOTION in Limine No. 8: Preclude Forest from Asserting Improper Arguments Concerning the Size of Its Reverse Payment and Purported Saved Litigation Costs. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 727 MOTION in Limine No. 7: Preclude Improper Justifications for the Lexapro Amendment. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 726 MOTION in Limine No. 6: Preclude "Litigation Risk" or "Risk Aversion" or Purported "Early Entry" as Procompetitive Justifications. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 725 MOTION in Limine No. 5: To Exclude Deposition Testimony from Witnesses Deposed Only in the Namenda Patent Litigation. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 724 MOTION in Limine No. 4: Preclude or Limit Forest's Use of Expert Opinion Testimony as a Proxy for Forest's Alleged Subjective Beliefs Regarding the Strength of the '703 Patent Where Forest Blocked All Discovery Regarding Its Subjective Beliefs or State of Mind. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 723 MOTION in Limine No. 3: Preclude Forest from Offering Fact Witnesses to Change or Supplement the Rule 30(b)(6) Deposition Testimony Provided By Charles Ryan and David Solomon with Respect to Certain Key Documents. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 722 MOTION in Limine No. 2: Preclude Use in This Case of Discovery Forest Took in The End-Payor Action Years After the Close of Discovery. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 721 MOTION in Limine No. 1: Preclude Forest from Asserting Subjective Beliefs Concerning the '703 Patent That It Blocked During Discovery on Privilege And Work-Product Grounds. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
|
Filing 718 DECLARATION of Declaration of Martin M. Toto in Support re: #694 MOTION for Leave to Supplement the Expert Reports of the Honorable Roderick McKelvie and Dr. Lona Fowdur .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit J, #2 Exhibit K, #3 Exhibit L, #4 Exhibit M, #5 Exhibit N, #6 Exhibit O)(Toto, Martin) |
Filing 717 REPLY MEMORANDUM OF LAW in Support re: #694 MOTION for Leave to Supplement the Expert Reports of the Honorable Roderick McKelvie and Dr. Lona Fowdur . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 716 DECLARATION of Martin M. Toto in Support re: #691 MOTION to Bifurcate /Forest's Motion to Bifurcate Trial into Two Phases.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Toto, Martin) |
Filing 715 REPLY MEMORANDUM OF LAW in Support re: #691 MOTION to Bifurcate /Forest's Motion to Bifurcate Trial into Two Phases. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 714 DECLARATION of Dan Litvin in Opposition re: #694 MOTION for Leave to Supplement the Expert Reports of the Honorable Roderick McKelvie and Dr. Lona Fowdur .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16)(Litvin, Dan) |
Filing 713 MEMORANDUM OF LAW in Opposition re: #694 MOTION for Leave to Supplement the Expert Reports of the Honorable Roderick McKelvie and Dr. Lona Fowdur . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 712 DECLARATION of Dan Litvin [REFILED TO CORRECT PREVIOUSLY MISFILED DECLARATION (ECF NO 711)) in Opposition re: #691 MOTION to Bifurcate /Forest's Motion to Bifurcate Trial into Two Phases.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15)(Litvin, Dan) |
Filing 711 DECLARATION of Dan Litvin in Opposition re: #691 MOTION to Bifurcate /Forest's Motion to Bifurcate Trial into Two Phases.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15)(Litvin, Dan) |
Filing 710 MEMORANDUM OF LAW in Opposition re: #691 MOTION to Bifurcate /Forest's Motion to Bifurcate Trial into Two Phases. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
|
|
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #707 MOTION for Eric Grannon to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-16803580. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
Filing 707 MOTION for Eric Grannon to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-16803580. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Affidavit, #2 DC Certificate of Good Standing, #3 Maryland Certificate of Good Standing, #4 Text of Proposed Order)(Grannon, Eric) |
|
Filing 705 MOTION for Eric E. Lancaster to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-16799848. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Affidavit in Support of Motion for Admission of Eric E. Lancaster Pro Hac Vice, #2 Certificate of Good Standing, #3 Text of Proposed Order)(Lancaster, Eric) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #705 MOTION for Eric E. Lancaster to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number ANYSDC-16799848. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
Filing 704 NOTICE of Proposed Verdict Form and Jury Charges. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 to Proposed Verdict Form and Jury Charges, #2 Exhibit 2 to Proposed Verdict Form and Jury Charges, #3 Exhibit A to Exhibit 2, #4 Exhibit B to Exhibit 2, #5 Exhibit C to Exhibit 2, #6 Exhibit D to Exhibit 2, #7 Exhibit E to Exhibit 2, #8 Exhibit F to Exhibit 2, #9 Exhibit G to Exhibit 2, #10 Exhibit H to Exhibit 2, #11 Exhibit I to Exhibit 2, #12 Exhibit J to Exhibit 2)(Toto, Martin) |
Filing 703 PROPOSED VOIR DIRE QUESTIONS. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(O'Shaughnessy, Kristen) |
Filing 702 NOTICE of Filing of Proposed Verdict Form. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1 - Plaintiffs' Proposed Verdict Form)(Litvin, Dan) |
Filing 701 PROPOSED JURY INSTRUCTIONS. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 700 PROPOSED VOIR DIRE QUESTIONS. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 699 PROPOSED PRE-TRIAL ORDER. Document filed by JM Smith Corporation, Mylan Pharmaceuticals, Inc.. (Attachments: #1 Exhibit 1 - Plaintiffs' Contentions, #2 Exhibit 2 - Defendants' Contentions, #3 Exhibit 3 - Plaintiffs Exhibit List, #4 Exhibit 4 - Defendants' Exhibit List, #5 Exhibit 5 - Deposition Designations and Objections) (Litvin, Dan) |
Filing 698 NOTICE OF APPEARANCE by Christopher Mark Curran on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Curran, Christopher) |
|
Filing 696 DECLARATION of Martin M. Toto in Support re: #694 MOTION for Leave to Supplement the Expert Reports of the Honorable Roderick McKelvie and Dr. Lona Fowdur .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I)(Toto, Martin) |
Filing 695 MEMORANDUM OF LAW in Support re: #694 MOTION for Leave to Supplement the Expert Reports of the Honorable Roderick McKelvie and Dr. Lona Fowdur . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 694 MOTION for Leave to Supplement the Expert Reports of the Honorable Roderick McKelvie and Dr. Lona Fowdur . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) |
Filing 693 JOINT LETTER addressed to Judge Colleen McMahon from Martin M. Toto dated April 29, 2019 re: Stipulation and Proposed Order Regarding Use of Expert Reliance Materials at Trial. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A- Stipulation and Proposed Order Regarding Use of Expert Reliance Materials at Trial)(Toto, Martin) |
Filing 692 MEMORANDUM OF LAW in Support re: #691 MOTION to Bifurcate /Forest's Motion to Bifurcate Trial into Two Phases. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 691 MOTION to Bifurcate /Forest's Motion to Bifurcate Trial into Two Phases. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Toto, Martin) |
Filing 690 NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a CONFERENCE proceeding held on 3/15/19 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...(McGuirk, Kelly) |
Filing 689 TRANSCRIPT of Proceedings re: CONFERENCE held on 3/15/2019 before Judge Colleen McMahon. Court Reporter/Transcriber: Sonya Ketter Moore, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/17/2019. Redacted Transcript Deadline set for 4/29/2019. Release of Transcript Restriction set for 6/25/2019.(McGuirk, Kelly) |
|
Minute Entry for proceedings held before Judge Colleen McMahon: Status Conference held on 3/15/2019. Decision: Status conference held; trial scheduled. Please refer to Scheduling Order.Submitted by: Elizabeth Brody. (Court Reporter Sonya Moore). (mde) |
Filing 687 MEMORANDUM OF LAW in Support re: #685 MOTION TO ENFORCE FORESTS ELECTION AGAINST RELYING ON ITS SUBJECTIVE BELIEFS AND TO PRECLUDE AN ELEVENTH-HOUR CHANGE . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 686 DECLARATION of Dan Litvin in Support re: #685 MOTION TO ENFORCE FORESTS ELECTION AGAINST RELYING ON ITS SUBJECTIVE BELIEFS AND TO PRECLUDE AN ELEVENTH-HOUR CHANGE .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14)(Litvin, Dan) |
Filing 685 MOTION TO ENFORCE FORESTS ELECTION AGAINST RELYING ON ITS SUBJECTIVE BELIEFS AND TO PRECLUDE AN ELEVENTH-HOUR CHANGE . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
***DELETED DOCUMENT. Deleted document number #688 Notice of Motion. The document was incorrectly filed in this case. (mml) |
|
Filing 682 JOINT LETTER MOTION for Conference addressed to Judge Colleen McMahon from Martin M. Toto dated March 7, 2019. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) |
Filing 681 DECLARATION of Joseph Opper [REFILED WITH PUBLIC EXHIBITS] in Opposition re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge ., #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon ., #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages ., #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. ., #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #2 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #3 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #4 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #5 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #6 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #7 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #8 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #9 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #10 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #11 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #12 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #13 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #14 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #15 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #16 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #17 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #18 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #19 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #20 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #21 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #22 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #23 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #24 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #25 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #26 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #27 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #28 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #29 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #30 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #31 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #32 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #33 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #34 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE, #35 PUBLIC EXHIBITS TO OPPER DECLARATION IN OPPOSITION TO MOTIONS TO EXCLUDE)(Opper, Joseph) |
Filing 680 DECLARATION of Dan Litvin [REFILED WITH PUBLIC EXHIBITS] in Opposition re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 PUBLIC EXHIBITS TO DECLARATION OF DAN LITVIN IN OPPOSITION TO FOREST'S MOTION FOR SUMMARY JUDGMENT, #2 PUBLIC EXHIBITS, #3 PUBLIC EXHIBITS, #4 PUBLIC EXHIBITS, #5 PUBLIC EXHIBITS, #6 PUBLIC EXHIBITS, #7 PUBLIC EXHIBITS, #8 PUBLIC EXHIBITS, #9 PUBLIC EXHIBITS, #10 PUBLIC EXHIBITS, #11 PUBLIC EXHIBITS, #12 PUBLIC EXHIBITS, #13 PUBLIC EXHIBITS, #14 PUBLIC EXHIBITS, #15 PUBLIC EXHIBITS, #16 PUBLIC EXHIBITS, #17 PUBLIC EXHIBITS, #18 PUBLIC EXHIBITS, #19 PUBLIC EXHIBITS, #20 PUBLIC EXHIBITS, #21 PUBLIC EXHIBITS, #22 PUBLIC EXHIBITS, #23 PUBLIC EXHIBITS, #24 PUBLIC EXHIBITS, #25 PUBLIC EXHIBITS, #26 PUBLIC EXHIBITS, #27 PUBLIC EXHIBITS, #28 PUBLIC EXHIBITS, #29 PUBLIC EXHIBITS, #30 PUBLIC EXHIBITS, #31 PUBLIC EXHIBITS, #32 PUBLIC EXHIBITS, #33 PUBLIC EXHIBITS, #34 PUBLIC EXHIBITS, #35 PUBLIC EXHIBITS, #36 PUBLIC EXHIBITS, #37 PUBLIC EXHIBITS, #38 PUBLIC EXHIBITS, #39 PUBLIC EXHIBITS, #40 PUBLIC EXHIBITS, #41 PUBLIC EXHIBITS, #42 PUBLIC EXHIBITS, #43 PUBLIC EXHIBITS, #44 PUBLIC EXHIBITS, #45 PUBLIC EXHIBITS, #46 PUBLIC EXHIBITS, #47 PUBLIC EXHIBITS, #48 PUBLIC EXHIBITS, #49 PUBLIC EXHIBITS, #50 PUBLIC EXHIBITS, #51 PUBLIC EXHIBITS, #52 PUBLIC EXHIBITS, #53 PUBLIC EXHIBITS, #54 PUBLIC EXHIBITS, #55 PUBLIC EXHIBITS, #56 PUBLIC EXHIBITS, #57 PUBLIC EXHIBITS, #58 PUBLIC EXHIBITS, #59 PUBLIC EXHIBITS, #60 PUBLIC EXHIBITS, #61 PUBLIC EXHIBITS, #62 PUBLIC EXHIBITS, #63 PUBLIC EXHIBITS, #64 PUBLIC EXHIBITS, #65 PUBLIC EXHIBITS, #66 PUBLIC EXHIBITS, #67 PUBLIC EXHIBITS, #68 PUBLIC EXHIBITS, #69 PUBLIC EXHIBITS, #70 PUBLIC EXHIBITS, #71 PUBLIC EXHIBITS, #72 PUBLIC EXHIBITS, #73 PUBLIC EXHIBITS, #74 PUBLIC EXHIBITS, #75 PUBLIC EXHIBITS, #76 PUBLIC EXHIBITS, #77 PUBLIC EXHIBITS, #78 PUBLIC EXHIBITS, #79 PUBLIC EXHIBITS, #80 PUBLIC EXHIBITS)(Litvin, Dan) |
Filing 679 NOTICE of Declaration of Rust Consulting Regarding Transmission of Notice to the Direct Purchaser Class. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 678 DECLARATION of Michael E. Hamburger #438 , #440 , #442 , #444 , #446 [Refiled Publicly per Order of the Court] in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge ., #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon ., #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages ., #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. ., #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 41, #2 Exhibit 42, #3 Exhibit 43, #4 Exhibit 44, #5 Exhibit 45, #6 Exhibit 46, Part 1, #7 Exhibit 46, Part 2, #8 Exhibit 46, Part 3, #9 Exhibit 46, Part 4, #10 Exhibit 46, Part 5, #11 Exhibit 46, Part 6, #12 Exhibit 46, Part 7, #13 Exhibit 46, Part 8, #14 Exhibit 46, Part 9, #15 Exhibit 46, Part 10, #16 Exhibit 46, Part 11, #17 Exhibit 46, Part 12, #18 Exhibit 46, Part 13, #19 Exhibit 47, Part 1, #20 Exhibit 47, Part 2, #21 Exhibit 47, Part 3, #22 Exhibit 47, Part 4, #23 Exhibit 47, Part 5, #24 Exhibit 47, Part 6, #25 Exhibit 47, Part 7, #26 Exhibit 47, Part 8, #27 Exhibit 47, Part 9, #28 Exhibit 47, Part 10, #29 Exhibit 47, Part 11, #30 Exhibit 47, Part 12, #31 Exhibit 47, Part 13, #32 Exhibit 47, Part 14, #33 Exhibit 47, Part 15, #34 Exhibit 47, Part 16, #35 Exhibit 47, Part 17, #36 Exhibit 47, Part 18, #37 Exhibit 47, Part 19, #38 Exhibit 48, Part 1, #39 Exhibit 48, Part 2, #40 Exhibit 48, Part 3, #41 Exhibit 48, Part 4, #42 Exhibit 48, Part 5, #43 Exhibit 48, Part 6, #44 Exhibit 48, Part 7, #45 Exhibit 48, Part 8, #46 Exhibit 48, Part 9, #47 Exhibit 48, Part 10, #48 Exhibit 48, Part 11, #49 Exhibit 48, Part 12, #50 Exhibit 49, Part 1, #51 Exhibit 49, Part 2, #52 Exhibit 49, Part 3, #53 Exhibit 49, Part 4, #54 Exhibit 49, Part 5, #55 Exhibit 49, Part 6, #56 Exhibit 49, Part 7, #57 Exhibit 49, Part 8, #58 Exhibit 49, Part 9, #59 Exhibit 49, Part 10, #60 Exhibit 49, Part 11, #61 Exhibit 49, Part 12, #62 Exhibit 49, Part 13, #63 Exhibit 50, #64 Exhibit 51)(Hamburger, Michael) |
Filing 677 DECLARATION of Michael E. Hamburger #438 , #440 , #442 , #444 , #446 [Refiled Publicly per Order of the Court] in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge ., #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon ., #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages ., #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. ., #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Exhibit 30, #31 Exhibit 31, #32 Exhibit 32, #33 Exhibit 33, #34 Exhibit 34, #35 Exhibit 35, #36 Exhibit 36, #37 Exhibit 37, #38 Exhibit 38, #39 Exhibit 39, #40 Exhibit 40)(Hamburger, Michael) |
Filing 676 DECLARATION of Kristen OShaughnessy [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 376, #2 Exhibit 377, #3 Exhibit 378, #4 Exhibit 379, #5 Exhibit 380, #6 Exhibit 381, #7 Exhibit 382, #8 Exhibit 383, #9 Exhibit 384, #10 Exhibit 385, #11 Exhibit 386, #12 Exhibit 387, #13 Exhibit 388, Part 1, #14 Exhibit 388, Part 2, #15 Exhibit 389, #16 Exhibit 390, #17 Exhibit 391, #18 Exhibit 392, #19 Exhibit 393, Part 1, #20 Exhibit 393, Part 2, #21 Exhibit 393, Part 3, #22 Exhibit 394, #23 Exhibit 395, #24 Exhibit 396, #25 Exhibit 397, #26 Exhibit 398, #27 Exhibit 399, #28 Exhibit 400, #29 Exhibit 401, #30 Exhibit 402, #31 Exhibit 403, #32 Exhibit 404, #33 Exhibit 405, #34 Exhibit 406, #35 Exhibit 407, #36 Exhibit 408, Part 1, #37 Exhibit 408, Part 2, #38 Exhibit 408, Part 3, #39 Exhibit 408, Part 4, #40 Exhibit 409, #41 Exhibit 410, #42 Exhibit 411, Part 1, #43 Exhibit 411, Part 2, #44 Exhibit 411, Part 3, #45 Exhibit 411, Part 4, #46 Exhibit 411, Part 5, #47 Exhibit 411, Part 6, #48 Exhibit 411, Part 7, #49 Exhibit 411, Part 8, #50 Exhibit 411, Part 9, #51 Exhibit 411, Part 10, #52 Exhibit 411, Part 11, #53 Exhibit 411, Part 12, #54 Exhibit 411, Part 13, #55 Exhibit 411, Part 14, #56 Exhibit 411, Part 15, #57 Exhibit 411, Part 16, #58 Exhibit 411, Part 17, #59 Exhibit 412, #60 Exhibit 413, #61 Exhibit 414, #62 Exhibit 415, #63 Exhibit 416, #64 Exhibit 417)(O'Shaughnessy, Kristen) |
Filing 675 DECLARATION of Kristen O'Shaughnessy (Supplemental to #666 enclosing exhibits 351-375) [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 351, #2 Exhibit 352, #3 Exhibit 353, #4 Exhibit 354, #5 Exhibit 355, #6 Exhibit 356, #7 Exhibit 359, #8 Exhibit 361, #9 Exhibit 362, #10 Exhibit 363, #11 Exhibit 364, #12 Exhibit 365, #13 Exhibit 366, #14 Exhibit 367, #15 Exhibit 368, #16 Exhibit 370, #17 Exhibit 371, #18 Exhibit 372, #19 Exhibit 373, #20 Exhibit 374, #21 Exhibit 375)(O'Shaughnessy, Kristen) |
Filing 674 DECLARATION of Kristen O'Shaughnessy (Supplemental to #666 enclosing exhibits 301-350) [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 301, #2 Exhibit 302, #3 Exhibit 303, #4 Exhibit 304, #5 Exhibit 305, #6 Exhibit 306, #7 Exhibit 307, #8 Exhibit 308, #9 Exhibit 309, #10 Exhibit 310, #11 Exhibit 311, #12 Exhibit 312, #13 Exhibit 313, #14 Exhibit 314, #15 Exhibit 315, #16 Exhibit 316, #17 Exhibit 317, #18 Exhibit 318, #19 Exhibit 319, #20 Exhibit 320, #21 Exhibit 321, #22 Exhibit 322, #23 Exhibit 323, #24 Exhibit 324, #25 Exhibit 325, #26 Exhibit 326, #27 Exhibit 327, #28 Exhibit 328, #29 Exhibit 329, #30 Exhibit 330, #31 Exhibit 331, #32 Exhibit 332, #33 Exhibit 333, #34 Exhibit 334, #35 Exhibit 335, #36 Exhibit 336, #37 Exhibit 337, #38 Exhibit 338, #39 Exhibit 339, #40 Exhibit 340, #41 Exhibit 341, #42 Exhibit 342, #43 Exhibit 343, #44 Exhibit 344, #45 Exhibit 345, #46 Exhibit 346, #47 Exhibit 347, #48 Exhibit 348, #49 Exhibit 349, #50 Exhibit 350)(O'Shaughnessy, Kristen) |
Filing 673 DECLARATION of Kristen O'Shaughnessy (Supplemental to #666 enclosing exhibits 251-300) [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 251, #2 Exhibit 252, #3 Exhibit 253, #4 Exhibit 254, #5 Exhibit 255, #6 Exhibit 256, #7 Exhibit 257, #8 Exhibit 258, #9 Exhibit 259, #10 Exhibit 260, #11 Exhibit 261, #12 Exhibit 262, #13 Exhibit 263, #14 Exhibit 264, #15 Exhibit 265, #16 Exhibit 266, #17 Exhibit 267, #18 Exhibit 268, #19 Exhibit 269, #20 Exhibit 270, #21 Exhibit 271, #22 Exhibit 272, #23 Exhibit 273, #24 Exhibit 274, #25 Exhibit 275, #26 Exhibit 276, #27 Exhibit 277, #28 Exhibit 278, #29 Exhibit 279, #30 Exhibit 280, #31 Exhibit 281, #32 Exhibit 282, #33 Exhibit 283, #34 Exhibit 284, #35 Exhibit 285, Part 1, #36 Exhibit 285, Part 2, #37 Exhibit 285, Part 3, #38 Exhibit 285, Part 4, #39 Exhibit 286, #40 Exhibit 287, #41 Exhibit 288, #42 Exhibit 289, #43 Exhibit 290, #44 Exhibit 291, #45 Exhibit 292, #46 Exhibit 293, #47 Exhibit 294, #48 Exhibit 295, #49 Exhibit 296, #50 Exhibit 297, #51 Exhibit 298, Part 1, #52 Exhibit 298, Part 2, #53 Exhibit 299, #54 Exhibit 300)(O'Shaughnessy, Kristen) |
Filing 672 DECLARATION of Kristen O'Shaughnessy (Supplemental to #666 enclosing exhibits 201-250) [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 201, #2 Exhibit 202, #3 Exhibit 203, #4 Exhibit 204, #5 Exhibit 205, #6 Exhibit 206, #7 Exhibit 207, #8 Exhibit 208, Part 1, #9 Exhibit 208, Part 2, #10 Exhibit 208, Part 3, #11 Exhibit 208, Part 4, #12 Exhibit 208, Part 5, #13 Exhibit 208, Part 6, #14 Exhibit 208, Part 7, #15 Exhibit 209, #16 Exhibit 210, #17 Exhibit 211, #18 Exhibit 212, #19 Exhibit 213, #20 Exhibit 214, #21 Exhibit 215, #22 Exhibit 216, #23 Exhibit 217, #24 Exhibit 218, #25 Exhibit 219, Part 1, #26 Exhibit 219, Part 2, #27 Exhibit 220, Part 1, #28 Exhibit 220 Part 2, #29 Exhibit 221, #30 Exhibit 222, #31 Exhibit 223, #32 Exhibit 224, Part 1, #33 Exhibit 224, Part 1, #34 Exhibit 224, Part 3, #35 Exhibit 225, #36 Exhibit 226, #37 Exhibit 227, #38 Exhibit 228, Part 1, #39 Exhibit 228, Part 2, #40 Exhibit 229, #41 Exhibit 230, #42 Exhibit 231, #43 Exhibit 232, #44 Exhibit 233, #45 Exhibit 234, #46 Exhibit 235, #47 Exhibit 236, #48 Exhibit 237, #49 Exhibit 238, #50 Exhibit 239, #51 Exhibit 240, #52 Exhibit 241, #53 Exhibit 242, #54 Exhibit 243, #55 Exhibit 244, #56 Exhibit 245, #57 Exhibit 246, #58 Exhibit 247, #59 Exhibit 248, #60 Exhibit 249, #61 Exhibit 250)(O'Shaughnessy, Kristen) |
Filing 671 DECLARATION of Joseph Opper [REFILED WITH PUBLIC EXHIBITS] in Support re: #400 MOTION to Certify Class .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit PUBLIC EXHIBITS TO OPPER CLASS CERTIFICATION REPLY DECLARATION - VOLUME I, #2 Exhibit PUBLIC EXHIBITS TO OPPER CLASS CERTIFICATION REPLY DECLARATION - VOLUME II, #3 Exhibit PUBLIC EXHIBITS TO OPPER CLASS CERTIFICATION REPLY DECLARATION - VOLUME III, #4 Exhibit PUBLIC EXHIBITS TO OPPER CLASS CERTIFICATION REPLY DECLARATION - VOLUME IV)(Opper, Joseph) |
Filing 670 DECLARATION of Kristen OShaughnessy (Supplemental to #666 enclosing exhibits 151-200) [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 151, #2 Exhibit 152, #3 Exhibit 153, #4 Exhibit 154, #5 Exhibit 155, #6 Exhibit 156, #7 Exhibit 157, #8 Exhibit 158, #9 Exhibit 159, #10 Exhibit 160, #11 Exhibit 161, #12 Exhibit 162, #13 Exhibit 163, #14 Exhibit 164, Part 1, #15 Exhibit 164, Part 2, #16 Exhibit 164, Part 3, #17 Exhibit 164, Part 4, #18 Exhibit 165, #19 Exhibit 166, Part 1, #20 Exhibit 166, Part 2, #21 Exhibit 166, Part 3, #22 Exhibit 166, Part 4, #23 Exhibit 166, Part 5, #24 Exhibit 166, Part 6, #25 Exhibit 166, Part 7, #26 Exhibit 166, Part 8, #27 Exhibit 166, Part 9, #28 Exhibit 166, Part 10, #29 Exhibit 166, Part 11, #30 Exhibit 166, Part 12, #31 Exhibit 166, Part 13, #32 Exhibit 166, Part 14, #33 Exhibit 166, Part 15, #34 Exhibit 166, Part 16, #35 Exhibit 166, Part 17, #36 Exhibit 166, Part 18, #37 Exhibit 167, #38 Exhibit 168, Part 1, #39 Exhibit 168, Part 2, #40 Exhibit 168, Part 3, #41 Exhibit 168, Part 4, #42 Exhibit 168, Part 5, #43 Exhibit 169, #44 Exhibit 170, Part 1, #45 Exhibit 170, Part 2, #46 Exhibit 170, Part 3, #47 Exhibit 170, Part 4, #48 Exhibit 171, Part 1, #49 Exhibit 171, Part 2, #50 Exhibit 172, #51 Exhibit 173, Part 1, #52 Exhibit 173, Part 2, #53 Exhibit 173, Part 3, #54 Exhibit 173, Part 4, #55 Exhibit 173, Part 5, #56 Exhibit 173, Part 6, #57 Exhibit 173, Part 7, #58 Exhibit 173, Part 8, #59 Exhibit 173, Part 9, #60 Exhibit 174, #61 Exhibit 175, #62 Exhibit 176, #63 Exhibit 177, Part 1, #64 Exhibit 177, Part 2, #65 Exhibit 178, Part 1, #66 Exhibit 178, Part 2, #67 Exhibit 178, Part 3, #68 Exhibit 178, Part 4, #69 Exhibit 179, Part 1, #70 Exhibit 179, Part 2, #71 Exhibit 179, Part 3, #72 Exhibit 180, Part 1, #73 Exhibit 180, Part 2, #74 Exhibit 180, Part 3, #75 Exhibit 181, Part 1, #76 Exhibit 181, Part 2, #77 Exhibit 182, Part 1, #78 Exhibit 182, Part 2, #79 Exhibit 182, Part 3, #80 Exhibit 182, Part 4, #81 Exhibit 182, Part 5, #82 Exhibit 182, Part 6, #83 Exhibit 182, Part 7, #84 Exhibit 182, Part 8, #85 Exhibit 182, Part 9, #86 Exhibit 182, Part 10, #87 Exhibit 183, Part 1, #88 Exhibit 183, Part 2, #89 Exhibit 183, Part 3, #90 Exhibit 183, Part 4, #91 Exhibit 183, Part 5, #92 Exhibit 183, Part 6, #93 Exhibit 183, Part 7, #94 Exhibit 184, Part 1, #95 Exhibit 184, Part 2, #96 Exhibit 184, Part 3, #97 Exhibit 184, Part 4, #98 Exhibit 184, Part 5, #99 Exhibit 184, Part 6, #100 Exhibit 184, Part 7, #101 Exhibit 184, Part 8, #102 Exhibit 184, Part 9, #103 Exhibit 184, Part 10, #104 Exhibit 184, Part 11, #105 Exhibit 184, Part 12, #106 Exhibit 184, Part 13, #107 Exhibit 184, Part 14, #108 Exhibit 184, Part 15, #109 Exhibit 184, Part 16, #110 Exhibit 184, Part 17, #111 Exhibit 185, #112 Exhibit 186, #113 Exhibit 187, #114 Exhibit 188, #115 Exhibit 189, Part 1, #116 Exhibit 189, Part 2, #117 Exhibit 189, Part 3, #118 Exhibit 190, #119 Exhibit 191, #120 Exhibit 192, #121 Exhibit 193, Part 1, #122 Exhibit 193, Part 2, #123 Exhibit 193, Part 3, #124 Exhibit 193, Part 4, #125 Exhibit 193, Part 5, #126 Exhibit 193, Part 6, #127 Exhibit 194, #128 Exhibit 195, #129 Exhibit 196, Part 1, #130 Exhibit 196, Part 2, #131 Exhibit 196, Part 3, #132 Exhibit 196, Part 4, #133 Exhibit 196, Part 5, #134 Exhibit 197, #135 Exhibit 198, Part 1, #136 Exhibit 198, Part 2, #137 Exhibit 199, Part 1, #138 Exhibit 199, Part 2, #139 Exhibit 200)(O'Shaughnessy, Kristen) |
Filing 669 DECLARATION of Dan Litvin [REFILED WITH PUBLIC EXHIBITS] in Support re: #400 MOTION to Certify Class .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit PUBLIC EXHIBITS TO LITVIN CLASS CERTIFICATION DECLARATION - VOLUME I, #2 Exhibit PUBLIC EXHIBITS TO LITVIN CLASS CERTIFICATION DECLARATION - VOLUME II, #3 Exhibit PUBLIC EXHIBITS TO LITVIN CLASS CERTIFICATION DECLARATION - VOLUME III, #4 Exhibit PUBLIC EXHIBITS TO LITVIN CLASS CERTIFICATION DECLARATION - VOLUME IV, #5 Exhibit PUBLIC EXHIBITS TO LITVIN CLASS CERTIFICATION DECLARATION - VOLUME V, #6 Exhibit PUBLIC EXHIBITS TO LITVIN CLASS CERTIFICATION DECLARATION - VOLUME VI, #7 Exhibit PUBLIC EXHIBITS TO LITVIN CLASS CERTIFICATION DECLARATION - VOLUME VII)(Litvin, Dan) |
Filing 668 DECLARATION of Kristen OShaughnessy (Supplemental to #666 enclosing exhibits 101-150) [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 101, #2 Exhibit 102, #3 Exhibit 103, #4 Exhibit 104, #5 Exhibit 105, #6 Exhibit 106, #7 Exhibit 107, #8 Exhibit 108, #9 Exhibit 109, #10 Exhibit 110, #11 Exhibit 111, #12 Exhibit 112, #13 Exhibit 113, #14 Exhibit 114, #15 Exhibit 115, #16 Exhibit 116, #17 Exhibit 117, #18 Exhibit 118, #19 Exhibit 119, #20 Exhibit 120, #21 Exhibit 121, #22 Exhibit 122, #23 Exhibit 123, #24 Exhibit 124, #25 Exhibit 125, #26 Exhibit 126, #27 Exhibit 127, #28 Exhibit 128, #29 Exhibit 129, #30 Exhibit 130, #31 Exhibit 131, #32 Exhibit 132, #33 Exhibit 133, #34 Exhibit 134, #35 Exhibit 135, #36 Exhibit 136, #37 Exhibit 137, #38 Exhibit 138, #39 Exhibit 139, #40 Exhibit 140, #41 Exhibit 141, #42 Exhibit 142, #43 Exhibit 143, #44 Exhibit 144, #45 Exhibit 145, #46 Exhibit 146, #47 Exhibit 147, #48 Exhibit 148, #49 Exhibit 149, #50 Exhibit 150)(O'Shaughnessy, Kristen) |
Filing 667 DECLARATION of Kristen OShaughnessy (Supplemental to #666 enclosing exhibits 51-100) [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 51, Part 1, #2 Exhibit 51, Part 2, #3 Exhibit 52, #4 Exhibit 53, Part 1, #5 Exhibit 53, Part 2, #6 Exhibit 54, #7 Exhibit 55, #8 Exhibit 56, Part 1, #9 Exhibit 56, Part 2, #10 Exhibit 56, Part 3, #11 Exhibit 56, Part 4, #12 Exhibit 56, Prat 5, #13 Exhibit 57, #14 Exhibit 58, #15 Exhibit 59, #16 Exhibit 60, #17 Exhibit 61, Part 1, #18 Exhibit 61, Part 2, #19 Exhibit 62, #20 Exhibit 63, #21 Exhibit 64, #22 Exhibit 65, #23 Exhibit 66, #24 Exhibit 67, #25 Exhibit 68, #26 Exhibit 69, #27 Exhibit 70, #28 Exhibit 71, #29 Exhibit 72, #30 Exhibit 73, #31 Exhibit 74, #32 Exhibit 75, #33 Exhibit 76, #34 Exhibit 77, #35 Exhibit 78, #36 Exhibit 79, #37 Exhibit 80, #38 Exhibit 81, Part 1, #39 Exhibit 81, Part 2, #40 Exhibit 82, #41 Exhibit 83, #42 Exhibit 84, #43 Exhibit 85, #44 Exhibit 86, #45 Exhibit 87, #46 Exhibit 88, #47 Exhibit 89, #48 Exhibit 90, #49 Exhibit 91, #50 Exhibit 92, #51 Exhibit 93, #52 Exhibit 94, #53 Exhibit 95, #54 Exhibit 96, #55 Exhibit 97, #56 Exhibit 98, #57 Exhibit 99, #58 Exhibit 100)(O'Shaughnessy, Kristen) |
Filing 666 DECLARATION of Kristen OShaughnessy [Refiled Publicly per Order of the Court] in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1, Part 1, #2 Exhibit 1, Part 2, #3 Exhibit 1, Part 3, #4 Exhibit 1, Part 4, #5 Exhibit 1, Part 5, #6 Exhibit 1, Part 6, #7 Exhibit 2, #8 Exhibit 3, #9 Exhibit 4, Part 1, #10 Exhibit 4, Part 2, #11 Exhibit 4, Part 3, #12 Exhibit 4, Part 4, #13 Exhibit 4, Part 5, #14 Exhibit 4, Part 6, #15 Exhibit 5, #16 Exhibit 6, Part 1, #17 Exhibit 6, Part 2, #18 Exhibit 6, Part 3, #19 Exhibit 6, Part 4, #20 Exhibit 6, Part 5, #21 Exhibit 7, Part 1, #22 Exhibit 7, Part 2, #23 Exhibit 8, #24 Exhibit 9, #25 Exhibit 10, #26 Exhibit 11, Part 1, #27 Exhibit 11, Part 2, #28 Exhibit 11, Part 3, #29 Exhibit 11, Part 4, #30 Exhibit 11, Part 5, #31 Exhibit 11, Part 6, #32 Exhibit 12, #33 Exhibit 13, Part 1, #34 Exhibit 13, Part 2, #35 Exhibit 14, #36 Exhibit 15, Part 1, #37 Exhibit 15, Part 2, #38 Exhibit 15, Part 3, #39 Exhibit 15, Part 4, #40 Exhibit 16, #41 Exhibit 17, Part 1, #42 Exhibit 17, Part 2, #43 Exhibit 17, Part 3, #44 Exhibit 18, Part 1, #45 Exhibit 18, Part 2, #46 Exhibit 18, Part 3, #47 Exhibit 19, #48 Exhibit 20, #49 Exhibit 21, #50 Exhibit 22, #51 Exhibit 23, #52 Exhibit 24, #53 Exhibit 25, #54 Exhibit 26, #55 Exhibit 27, #56 Exhibit 28, #57 Exhibit 29, #58 Exhibit 30, #59 Exhibit 31, #60 Exhibit 32, #61 Exhibit 33, #62 Exhibit 34, #63 Exhibit 35, #64 Exhibit 36, #65 Exhibit 37, #66 Exhibit 38, #67 Exhibit 39, #68 Exhibit 40, #69 Exhibit 41, #70 Exhibit 42, #71 Exhibit 43, #72 Exhibit 44, Part 1, #73 Exhibit 44, Part 2, #74 Exhibit 45, #75 Exhibit 46, #76 Exhibit 47, Part 1, #77 Exhibit 47, Part 2, #78 Exhibit 47, Part 3, #79 Exhibit 48, #80 Exhibit 49, #81 Exhibit 50)(O'Shaughnessy, Kristen) |
Filing 665 MEMORANDUM OF LAW in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment. [Refiled Publicly per Order of the Court]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 664 MEMORANDUM OF LAW in Support re: #400 MOTION to Certify Class . [REFILED PUBLICLY WITHOUT REDACTIONS PER ORDER OF THE COURT]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 663 FILING ERROR - DEFICIENT DOCKET ENTRY (SEE #664 Memorandum) - MEMORANDUM OF LAW in Opposition re: #400 MOTION to Certify Class . [REFILED PUBLICLY WITHOUT REDACTIONS PER ORDER OF THE COURT]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) Modified on 2/22/2019 (db). |
Filing 662 MEMO ENDORSEMENT on re: #661 Letter filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation. ENDORSEMENT: Ok. (Signed by Judge Colleen McMahon on 2/19/2019) (mml) |
Filing 661 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated February 15, 2019 re: Sealed Record. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
Filing 659 MOTION Remove Document from Public Docket re: 658 Response, . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)(Litvin, Dan) |
***STRICKEN DOCUMENT. Deleted document number 658 from the case record. The document was stricken from this case pursuant to #660 Order on Motion for Miscellaneous Relief. (mml) |
REMARK. Problematic pdfs on labelled CDs attached to corresponding unsealed envelopes, specifically for envelope nos. 448, 456, 474 and 478 only. Envelopes no. 412, 421 had no disks. Envelopes no. 460, 480, 482, 484, 504, 510, 511 and 513 had no problems associated with their respective corresponding disks. (rjm) |
Filing 657 DIRECT PURCHASER CLASS PLAINTIFFS' MEMORANDUM IN OPPOSITION TO DEFENDANT'S MOTION FOR SUMMARY JUDGMENT. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 656 DECLARATION OF DAN LITVIN IN OPPOSITION TO DEFENDANTS' MOTION FOR SUMMARY JUDGMENT. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 655 DIRECT PURCHASER CLASS PLAINTIFFS' MEMORANDUM IN OPPOSITION TO FOREST'S MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF DR. RUSSELL LAMB. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 654 PLAINTIFFS' OPPOSITION TO FOREST'S MOTION TO EXCLUDE THE TESTIMONY OF MR. GEORGE W. JOHNSTON. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 653 DIRECT PURCHASER CLASS PLAINTIFFS' MEMORANDUM IN OPPOSITION TO FOREST'S MOTION TO EXCLUDE OPINIONS AND TESTIMONY OF DR. ERNST BERNDT AND DR. RUSSELL LAMB REGARDING FORECAST AVERAGES. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 652 DIRECT PURCHASER CLASS PLAINTIFFS' MEMORANDUM OF LAW IN OPPOSITION TO FOREST'S MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF PROF. EINER ELHAUGE. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 651 DIRECT PURCHASER CLASS PLAINTIFFS' MEMORANDUM OF LAW IN OPPOSITION TO FOREST'S MOTION TO EXCLUDE OPINIONS AND TESTIMONY OF JANET K. DELEON. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 650 DECLARATION OF JOSEPH OPPER IN OPPOSITION TO MEMORANDA OF LAW IN SUPPORT OF FOREST'S MOTIONS TO EXCLUDE EXPERT TESTIMONY. This document was previously filed under seal in envelope doc. no. 456. (rjm) |
Filing 649 DECLARATION OF KRISTEN O'SHAUGHNESSY IN SUPPORT OF FORREST'S MOTION FOR SUMMARY JUDGMENT. This document was previously filed under seal in envelope doc. no. 448. (This document submission in paper format only. Ex. 1-373 pdf format only/oversize) (rjm) |
Filing 648 MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND TESTIMONY OF JANET K. DELEON. This document was previously filed under seal in envelope doc. no. 448. (rjm) |
Filing 647 MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF PROF. EINER ELHAUGE. This document was previously filed under seal in envelope doc. no. 448. (rjm) |
Filing 646 DECLARATION OF MICHAEL E. HAMBURGER IN SUPPORT OF MEMORANDA OF LAW SUPPORTING FOREST'S MOTIONS TO EXCLUDE EXPERT TESTIMONY. This document was previously filed under seal in envelope doc. no. 448. (rjm) |
Filing 645 MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND TESTIMONY OF DR. ERNST BERNDT AND DR. RUSSELL LAMB REGARDING FORECAST AVERAGES. This document was previously filed under seal in envelope doc. no. 448. (rjm) |
Filing 644 MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF GEORGE W. JOHNSTON, ESQ. This document was previously filed under seal in envelope doc. no. 448. (rjm) |
Filing 643 MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF DR. RUSSELL LAMB. This document was previously filed under seal in envelope doc. no. 448. (rjm) |
Filing 642 DEFENDANTS' MEMORANDUM IN SUPPORT OF THEIR MOTION FOR SUMMARY JUDGMENT. This document was previously filed under seal in envelope doc. no. 448. (Paper format-oversized pdf). (rjm) |
Filing 641 FOREST'S NOTICE OF MOTION AND MOTION FOR LEAVE TO FILE A SUR-REPLY IN FURTHER OPPOSITION TO DIRECT PURCHASER PLAINTIFFS' MOTION FOR CLASS CERTIFICATION. (Attachments: #1 Ex 1). This document was previously filed under seal in envelope doc. no. 513. (rjm) |
Filing 640 DECLARATION OF MICHAEL E. HAMBURGER IN SUPPORT OF FOREST'S SUR-REPLY IN FURTHER OPPOSITION TO DIRECT PURCHASER PLAINTIFFS' MOTION FOR CLASS CERTIFICATION. (Attachments: #1 Ex A) This document was previously filed under seal in envelope doc. no. 513. (rjm) |
Filing 639 REPLY IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF JOHN R. THOMAS, ESQ. This document was previously filed under seal in envelope doc. no. 511. (rjm) |
Filing 638 DECLARATION OF DAN LITVIN IN OPPOSITION TO FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF JOHN R. THOMAS, ESQ. This document was previously filed under seal in envelope doc. no. 510. (Non-paper format. Submitted only in pdf format for this envelope) (rjm) |
Filing 637 DIRECT PURCHASER CLASS PLAINTIFFS' MEMORANDUM IN OPPOSITION TO FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF JOHN R. THOMAS, ESQ. (Attachments: #1 Ex 1, #2 Ex 2, #3 Ex 3). This document was previously filed under seal in envelope doc. no. 510. (rjm) |
Filing 636 DECLARATION OF RYAN P. JOHNSON IN SUPPORT OF MEMORANDUM OF LAW SUPPORTING FORREST'S MOTION TO EXCLUDE EXPERT TESTIMONY. This document was previously filed under seal in envelope doc. no. 504. (Submission in paper format only). (rjm) |
Filing 635 MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF JOHN R. THOMAS. ESQ. (Attachments: #1 Ex 1, #2 Ex 2) This document was previously filed under seal in envelope doc. no. 504. (rjm) |
Filing 634 PROPOSED MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF JOHN R. THOMAS, ESQ.. This document was previously filed under seal in envelope doc. no. 484. (rjm) (Additional attachment(s) added on 1/30/2019: #1 Ex 1, #2 Ex 2) (rjm). |
Filing 633 PROPOSED DECLARATION OF RYAN P. JOHNSON IN SUPPORT OF MEMORANDUM OF LAW SUPPORTING FOREST'S MOTIONS TO EXCLUDE EXPERT TESTIMONY. (Attachments: #1 Ex 1, #2 Ex 2) This document was previously filed under seal in envelope doc. no. 484.(rjm) |
Filing 632 FOREST'S OPPOSITION TO DIRECT PURCHASER CLASS PLAINTIFFS' MOTION FOR LEA VE TO FILE A SUR-REPLY IN FURTHER OPPOSITION TO FOREST'S MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF PROF. EINER ELHAUGE. This document was previously filed under seal in envelope doc. no. 482. (rjm) |
Filing 631 DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR LEAVE TO FILE A SURREPLY IN FURTHER OPPOSITION TO FORESTS MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF PROF. EINER ELHAUGE. (Attachments: #1 Ex 1) This document was previously filed under seal in envelope doc. no. 480. (rjm) |
Filing 630 DEFENDANTS' REPLY MEMORANDUM IN SUPPORT OF THEIR MOTION FOR SUMMARY JUDGMENT. This document was previously filed under seal in envelope doc. no. 478. (rjm) |
Filing 629 DECLARATION OF KRISTEN O'SHAUGHNESSY IN FURTHER SUPPORT OF FOREST'S MOTION FOR SUMMARY JUDGMENT. This document was previously filed under seal in envelope doc. no. 478. (rjm) |
Filing 628 DECLARATION OF MICHAEL E. HAMBURGER IN SUPPORT OF REPLY MEMORANDA OF LAW SUPPORTING FOREST'S MOTION TO EXCLUDE EXPERT TESTIMONY. This document was previously filed under seal in envelope doc. no. 474. (Submission of this document in paper format only). (rjm) |
Filing 627 REPLY MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF PROF. EINER ELHAUGE. This document was previously filed under seal in envelope doc. no. 474. (rjm) |
Filing 626 REPLY MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF JANET K. DELEON. This document was previously filed under seal in envelope doc. no. 474. (rjm) |
Filing 625 REPLY MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE CERTAIN OPINIONS AND PROPOSED TESTIMONY OF DR. RUSSELL LAMB. This document was previously filed under seal in envelope doc. no. 474. (rjm) |
Filing 624 REPLY MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND PROPOSED TESTIMONY OF GEORGE W. JOHNSTON, ESQ. This document was previously filed under seal in envelope doc. no. 474. (rjm) |
Filing 623 REPLY MEMORANDUM OF LAW IN SUPPORT OF FOREST'S MOTION TO EXCLUDE OPINIONS AND TESTIMONY OF DR. ERNST BERNDT AND DR. RUSSELL LAMB REGARDING FORECAST AVERAGES. This document was previously filed under seal in envelope doc. no. 474. (rjm) |
Filing 622 DIRECT PURCHASER CLASS PLAINTIFFS' OPPOSITION TO FORESTS EMERGENCY MOTION TO STRIKE PLAINTIFFS' AFFIRMATIVE STATEMENT OF MATERIAL FACTS IN OPPOSITION TO FOREST'S MOTION FOR SUMMARY JUDGMENT. This document was previously filed under seal in envelope doc. no. 460. (rjm) |
Filing 621 DECLARATION OF JOSEPH OPPER IN SUPPPORT OF DIRECT PURCHASER CLASS PLAINTIFFS' MOTION FOR CLASS CERTIFICATION. This document was previously filed under seal in envelope doc. no. 421. (rjm) |
Filing 620 REPLY MEMORANDUM OF LAW IN SUPPORT OF DIRECT PURCHASER CLASS PLAINTIFFS' MOTION FOR CLASS CERTIFICATION. This document was previously filed under seal in envelope doc. no. 421. (rjm) |
Filing 619 FOREST'S OPPOSITION TO DIRECT PURCHASER PLAINTIFFS' MOTION FOR CLASS CERTIFICATION. This document was previously filed under seal in envelope doc. no. 412. (Attachments: #1 Ex 1, #2 EX 2, #3 Ex 3, #4 Ex 4, #5 Ex 5, #6 Ex 6, #7 Ex 7, #8 Ex 8, #9 Ex 9, #10 Ex 10, #11 Ex 11, #12 Ex 12, #13 Ex 13) (rjm) |
Filing 618 REPLY / Forest's Reply to Plaintiffs' Responses and Objections to Defendants' Statement of Undisputed Facts in Support of Defendants' Motion for Summary Judgment [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 617 Objection / Forest's Objections and Responses to Plaintiffs' Affirmative Statement of Material Facts in Opposition to Forest's Motion for Summary Judgment [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 616 RULE 56.1 STATEMENT. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
|
Filing 614 Objection PLAINTIFFS RESPONSES AND OBJECTIONS TO DEFENDANTS STATEMENT OF UNDISPUTED FACTS IN SUPPORT OF DEFENDANTS MOTION FOR SUMMARY JUDGMENT [PUBLIC VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 613 RULE 56.1 STATEMENT. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 612 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated January 20, 2019 re: the sealed record on various motions. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
Filing 610 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated January 17, 2019 re: the sealed record on various motions. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
Filing 608 MEMO ENDORSEMENT on re: #607 Letter, filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation. ENDORSEMENT: All papers that have not been filed in redacted form must be UNSEALED IMMEDIATELY. Counsel for Plaintiffs and Defendants shall meet with or direct the Clerk which documents this includes. This should have been called to my attention MONTHS ago. (Signed by Judge Colleen McMahon on 1/11/2019) (mml) Transmission to Sealed Records Clerk for processing. |
Filing 607 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated January 9, 2019 re: Status of the Sealed Record on Class Certification and Summary Judgment Motions. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 606 NOTICE of Declaration of Rust Consulting. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Exhibit A - Declaration of Notice Administrator Concerning Provision of Notice to Class Members)(Litvin, Dan) |
Filing 605 MEMO ENDORSEMENT on re: #604 Letter, filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc. ENDORSEMENT: This matter has been referred to Judge Lehrburger. (Signed by Judge Colleen McMahon on 12/13/2018) (mml) |
Filing 604 LETTER addressed to Judge Colleen McMahon from Heather K. McDevitt dated December 12, 2018 re: The letter filed by Bruce E. Gerstein, counsel for Direct Purchaser Plaintiffs dated December 12, 2018 #603 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(McDevitt, Heather) |
Filing 603 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated December 12, 2018 re: Discovery Dispute. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
|
Filing 601 LETTER addressed to Magistrate Judge Robert W. Lehrburger from Dan Litvin dated December 5, 2018 re: Notice to the Direct Purchaser Class. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 600 MANDATE of USCA (Certified Copy) USCA Case Number 18-2421. Petitioners request, pursuant to Federal Rule of Civil Procedure 23(f), leave to appeal the district court's order granting the Respondents' motion for class certification. Petitioners also move to file a reply, and Respondents move to file a sur-reply. Upon due consideration, it is hereby ORDERED that the motions to file a reply and sur-reply are GRANTED. It is further ORDERED that the Rule 23(f) petition is DENIED because an immediate appeal is not warranted. See Sumitomo Copper Litig. v. Credit Lyonnais Rouse, Ltd., 262 F.3d 134, 139-40 (2d Cir. 2001).. Catherine O'Hagan Wolfe, Clerk USCA for the Second Circuit. Issued As Mandate: 11/20/2018. (nd) |
Filing 599 STIPULATION REGARDING FORM, MANNER, AND TIMING OF NOTICE TO THE DIRECT PURCHASER CLASS: NOW, THEREFORE, it is hereby stipulated by and between the undersigned parties through their respective counsel, as follows: 1. Defendants do not oppose Plaintiffs' proposed form or manner of notice to the direct purchaser class; 2. Plaintiffs will not disseminate notice to the direct purchaser class until the earlier of either: (a) a denial of Defendants' Rule 23(f) petition to appeal, or (b) December 3, 2018, in the event that the Second Circuit has not yet ruled on Defendants' Rule 23(f) petition by that date; and 3. If the Second Circuit grants Defendants' Rule 23(f) petition to appeal prior to December 3, 2018, Plaintiffs will delay dissemination of the notice to the direct purchaser class pending resolution of Defendants' prospective motion to stay the district court proceedings during the pendency of the appeal. Motions terminated: #589 MOTION to Approve the Form and Manner of Notice to the Direct Purchaser Class filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation. (Signed by Magistrate Judge Robert W. Lehrburger on 9/18/2018) (mml) |
Filing 598 PROPOSED STIPULATION AND ORDER. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 597 SEALED DOCUMENT placed in vault.(mhe) |
Filing 596 NOTICE OF CHANGE OF ADDRESS by Peter Russell Kohn on behalf of Rochester Drug Co-Operative, Inc.. New Address: Faruqi & Faruqi, LLP, 1617 JFK Blvd., Suite 1550, Philadelphia, PA, United States 19103, 2152775770. (Kohn, Peter) |
Filing 595 NOTICE OF CHANGE OF ADDRESS by Joseph Thomas Lukens on behalf of Rochester Drug Co-Operative, Inc.. New Address: Faruqi & Faruqi, LLP, 1617 JFK Blvd., Suite 1550, Philadelphia, PA, United States 19103, 2152775770. (Lukens, Joseph) |
|
|
Minute Entry for proceedings held before Judge Colleen McMahon: Pretrial Conference held on 9/7/2018. Decision: The case is referred to the Honorable Robert W. Lehrburger for specific non-dispositive motion/dispute. Submitted By: Eric Silverberg. (mde) |
Filing 592 SEALED DOCUMENT placed in vault.(rz) |
Filing 591 SEALED DOCUMENT placed in vault.(rz) |
Filing 590 MEMORANDUM OF LAW in Support re: #589 MOTION to Approve the Form and Manner of Notice to the Direct Purchaser Class . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 589 MOTION to Approve the Form and Manner of Notice to the Direct Purchaser Class . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Proposed Notice, #2 Text of Proposed Order Proposed Order)(Litvin, Dan) |
|
Filing 581 MOTION TO REMOVE DOCUMENT FROM PUBLIC DOCKET . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order Proposed Order)(Litvin, Dan) |
Filing 587 EXHIBIT 360 O'Shaughnessy Declaration (Redacted) re: ECF 436. Document filed by JM Smith Corporation. ***Docketed pursuant to Judge McMahon's order (ECF #580)***(tro) |
Filing 586 EXHIBIT 358 O'Shaughnessy Declaration (Redacted) re: ECF 436. Document filed by JM Smith Corporation. ***Docketed pursuant to Judge McMahon's order (ECF #580)***(tro) |
Filing 585 EXHIBIT 357 O'Shaughnessy Declaration (Plaintiffs' Letter Ex. 8) re: ECF 436. Document filed by JM Smith Corporation. ***Docketed pursuant to Judge McMahon's order (ECF #580)***(tro) |
Filing 584 EXHIBIT 14 Hamburger Declaration (Plaintiffs' Letter Ex. 1, 2...re: ECF 411) Document filed by JM Smith Corporation. ***Docketed pursuant to Judge McMahon's order (ECF #580)***(tro) Modified on 1/15/2019 (tro). Modified on 1/15/2019 (tro). (Main Document 584 replaced on 1/17/2019) (tro). |
Filing 583 EXHIBIT 15 Hamburger Declaration (Plaintiff's Letter Exhibits 10... re: ECF 411. Document filed by JM Smith Corporation. ***Docketed pursuant to Judge McMahon's order (ECF #580)***(tro) |
Filing 582 EXHIBIT 14 Opper Declaration (Plaintiff's Letter Ex. 9) re: ECF 420. Document filed by JM Smith Corporation. ***Docketed pursuant to Judge McMahons order (ECF #580)***(tro) Modified on 8/30/2018 (tro). |
|
Filing 579 DECLARATION of Dan Litvin [DECLARATION RE-FILED TO ATTACH PUBLIC VERSIONS OF EXHIBITS, WITH CONSENT OF THIRD PARTY MYLAN] in Support re: #214 MOTION to Compel Third Party Mylan Pharmaceuticals, Inc. to Produce Documents Responsive to Subpoena Request No. 12 .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit EXHIBIT B - PUBLICLY REFILED WITH CONSENT OF THIRD PARTY MYLAN, #2 Exhibit EXHIBIT C - PUBLICLY REFILED WITH CONSENT OF THIRD PARTY MYLAN)(Litvin, Dan) |
Filing 578 NOTICE OF CHANGE OF ADDRESS by Nicholas Urban on behalf of All Plaintiffs. New Address: Berger Montague PC, 1818 Market Street, Suite 3600, Philadelphia, PA, United States 19103, 215-875-5701. (Urban, Nicholas) |
Filing 577 NOTICE OF CHANGE OF ADDRESS by David Francis Sorensen on behalf of All Plaintiffs. New Address: Berger Montague PC, 1818 Market Street, Suite 3600, Philadelphia, PA, United States 19103, 215-875-5705. (Sorensen, David) |
Filing 576 NOTICE OF CHANGE OF ADDRESS by Daniel C. Simons on behalf of All Plaintiffs. New Address: Berger Montague PC, 1818 Market Street, Suite 3600, Philadelphia, PA, United States 19103, 215-875-4675. (Simons, Daniel) |
Filing 575 NOTICE OF CHANGE OF ADDRESS by Phyllis Maza Parker on behalf of All Plaintiffs. New Address: Berger Montague PC, 1818 Market Street, Suite 3600, Philadelphia, PA, United States 19103, 215-875-4647. (Parker, Phyllis) |
Filing 574 NOTICE OF CHANGE OF ADDRESS by Ellen Noteware on behalf of All Plaintiffs. New Address: Berger Montague PC, 1818 Market Street, Suite 3600, Philadelphia, PA, United States 19103, 215-875-3051. (Noteware, Ellen) |
Filing 573 NOTICE of Withdrawal of Attorney. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 572 NOTICE of Withdrawal of Attorney. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 571 NOTICE of Withdrawal of Attorney. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
|
|
Filing 568 LETTER addressed to Judge Colleen McMahon from Morris J. Fodeman dated 08/15/2018 re: Court's August 15, 2018 Order. Document filed by Mylan Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A)(Fodeman, Morris) |
|
Filing 566 SEALED DOCUMENT placed in vault.(mhe) |
Filing 565 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated August 13, 2018 re: Response to the Court's August 2, 2018 Order Regarding Settlement Agreements. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
***STRICKEN DOCUMENT. Deleted document number [564-1] from the case record. The document was stricken from this case pursuant to #588 Order on Motion. (mml) |
Filing 564 LETTER addressed to Judge Colleen McMahon from Michael Hamburger dated August 10, 2018 re: Exhibit No. 358 to the Declaration of Kristen O'Shaughnessy in Support of Forest's Motion for Summary Judgment #467 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: # 1 Exhibit A)(Hamburger, Michael) |
|
Filing 562 SEALED DOCUMENT placed in vault.(rz) |
***Motion(s) terminated: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc, #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc, #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc, #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc, #400 MOTION to Certify Class filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation, #561 MOTION for Leave to File a Letter of Supplemental Authority in Support of Forest's Opposition to DPPs' Motion for Class Certification #417 filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc, #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc, #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc, #505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc. (ft) |
Filing 561 MOTION for Leave to File a Letter of Supplemental Authority in Support of Forest's Opposition to DPPs' Motion for Class Certification #417 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Toto, Martin) |
Filing 560 FILING ERROR - DEFICIENT DOCKET ENTRY - LETTER addressed to Judge Colleen McMahon from Martin M. Toto dated July 17, 2018 re: notice of supplemental authority in support of Forest's Opposition to DPPs' Motion for Class Certification #417 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) Modified on 7/17/2018 (ka). |
|
Filing 558 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated July 5, 2018 re: (PUBLIC VERSION) in response to the Courts July 3, 2018 Letter to Counsel (ECF No. 551). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 557 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated June 18, 2018 re: (PUBLIC VERSION) Supplemental AuthorityIn re AndroGel Antitrust Litig. (No. II), 1:09-md-02084, (N.D. Ga. June 14, 2018). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
***STRICKEN DOCUMENT. Deleted document number 556 from the case record. The document was stricken from this case pursuant to #559 Order Striking Document from Record. (anc) |
***STRICKEN DOCUMENT. Deleted document number 555 from the case record. The document was stricken from this case pursuant to #559 Order Striking Document from Record. (anc) |
Filing 554 NOTICE of Filing Under Seal re: #551 Letter, 553 Sealed Document. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 553 SEALED DOCUMENT placed in vault.(rz) |
Filing 552 LETTER addressed to Judge Colleen McMahon from Martin M. Toto dated July 5, 2018 re: Letter to Counsel dated July 3, 2018 regarding class certification #551 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Toto, Martin) |
Filing 551 LETTER addressed to Counsel from Judge Colleen McMahon dated 7/3/2018 re: Clarification - Class Certification Motion. (tro) |
Filing 550 NOTICE of Filing Under Seal of Defendants' June 22, 2018 Letter in Response to DPP's June 18, 2018 Letter to Supplemental Authority. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 549 SEALED DOCUMENT placed in vault.(rz) |
Filing 548 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated May 31, 2018 re: Response to Defendants' May 23, 2018 letter regarding supplemental authority (PUBLIC VERSION). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 547 SEALED DOCUMENT placed in vault.(mhe) |
Filing 546 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 545 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 544 SEALED DOCUMENT placed in vault.(rz) |
Filing 543 LETTER addressed to Judge Colleen McMahon from Martin M. Toto dated May 23, 2018 re: supplemental authority in support of Defendants' Motion for Summary Judgment #434 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A)(Toto, Martin) |
Filing 542 REPLY / Forest's Reply to Plaintiffs' Responses and Objections to Defendants' Statement of Undisputed Facts in Support of Defendants' Motion for Summary Judgment [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 541 DECLARATION of Kristen O'Shaughnessy in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 376, #2 Exhibit 379, #3 Exhibit 380, #4 Exhibit 382, #5 Exhibit 383, #6 Exhibit 385, #7 Exhibit 389, #8 Exhibit 390, #9 Exhibit 398, #10 Exhibit 399, #11 Exhibit 400, #12 Exhibit 403, #13 Exhibit 404, #14 Exhibit 406, #15 Exhibit 409, #16 Exhibit 412, #17 Exhibit 413, #18 Exhibit 415, #19 Exhibit 416)(O'Shaughnessy, Kristen) |
Filing 540 Objection /Forest's Objections and Responses to Plaintiffs' Affirmative Statement of Material Facts in Opposition to Forest's Motion for Summary Judgment [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 539 REPLY MEMORANDUM OF LAW in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment. [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 538 DECLARATION of Michael E. Hamburger in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge ., #505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. ., #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb ., #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages ., #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. ., #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 45 [Redacted], #2 Exhibit 49)(O'Shaughnessy, Kristen) |
Filing 537 REPLY MEMORANDUM OF LAW in Support re: #505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 536 REPLY MEMORANDUM OF LAW in Support re: #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages . [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 535 REPLY MEMORANDUM OF LAW in Support re: #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. . [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 534 REPLY MEMORANDUM OF LAW in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge . [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 533 REPLY MEMORANDUM OF LAW in Support re: #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon . [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 532 REPLY MEMORANDUM OF LAW in Support re: #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb . [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 531 PROPOSED JURY INSTRUCTIONS. Document filed by JM Smith Corporation, Teva Pharmaceuticals USA, Inc..(Litvin, Dan) |
Filing 530 NOTICE of / Forest's Proposed Verdict Form and Jury Charges. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 - Defendants' Proposed Verdict Form, #2 Exhibit 2 - Forest's Proposed Jury Charges)(O'Shaughnessy, Kristen) |
Filing 529 PRETRIAL MEMORANDUM. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Exhibit 1 - Plaintiffs' Contentions [REDACTED], #2 Exhibit Exhibit 2 - Defendants' Contentions [REDACTED], #3 Exhibit Exhibit 3 - Plaintiffs' Ex. List [WITHHELD IN FULL], #4 Exhibit Exhibit 4 - Defendants' Ex. List [WITHHELD IN FULL], #5 Exhibit Exhibit 5 - Deposition designations)(Litvin, Dan) |
Filing 528 COUNTER STATEMENT TO #466 Rule 56.1 Statement. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 527 RULE 56.1 STATEMENT. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 526 MEMORANDUM OF LAW in Opposition re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment. [RE-FILED PUBLIC REDACTED VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 525 MEMORANDUM OF LAW in Opposition re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge . [RE-FILED PUBLIC REDACTED VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 524 MEMORANDUM OF LAW in Opposition re: #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. . [RE-FILED PUBLIC REDACTED VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 523 RESPONSE in Support of Motion re: #400 MOTION to Certify Class . RESPONSE TO FORESTS MOTION FOR LEAVE TO FILE A SUR-REPLY IN FURTHER OPPOSITION TO DIRECT PURCHASER CLASS PLAINTIFFS MOTION FOR CLASS CERTIFICATION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
|
***DELETED DOCUMENT. Deleted document number 495 Memorandum of Law. As per Order of 2/15/2018, at Dkt. No. #522 (ap) |
***DELETED DOCUMENT. Deleted document number 498 Memorandum of Law. As per Order of 2/15/2018, at Dkt. No. #522 (ap) |
***DELETED DOCUMENT. Deleted document number 499 Rule 56.1 Statement. As per Order of 2/15/2018, at Dkt. No. #522 (ap) |
***DELETED DOCUMENT. Deleted document number 500 Counter Statement. As per Order of 2/15/2018, at Dkt. No. #522 (ap) |
Filing 521 LETTER MOTION to Seal Document 498 Memorandum of Law in Opposition to Motion, 493 Memorandum of Law in Opposition to Motion, 500 Counter Statement to Rule 56.1, 499 Rule 56.1 Statement, 495 Memorandum of Law in Opposition to Motion addressed to Magistrate Judge Robert W. Lehrburger from Dan Litvin dated February 14, 2018. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
Filing 519 LETTER MOTION to Seal Document 517 Pretrial Memorandum, addressed to Magistrate Judge Robert W. Lehrburger from Dan Litvin dated February 9, 2018. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
***DELETED DOCUMENT. Deleted document number 517 PRETRIAL MEMORANDUM. Document and entry removed pursuant to Judge's Order, see entry 520. (anc) Modified on 2/12/2018 (anc). |
Filing 516 MOTION for Stuart E. Des Roches to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14674065. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Affidavit, #2 Text of Proposed Order)(Des Roches, Stuart) |
Filing 515 FILING ERROR - WRONG EVENT TYPE SELECTED FROM MENU (SEE #516 Motion) - NOTICE OF APPEARANCE by Stuart Edward Des Roches on behalf of JM Smith Corporation. (Attachments: #1 Affidavit, #2 Text of Proposed Order)(Des Roches, Stuart) Modified on 2/8/2018 (db). |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #516 MOTION for Stuart E. Des Roches to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14674065. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (jc) |
Filing 514 NOTICE of Filing Under Seal of Forest's Notice of Motion and Motion for Leave to File a Sur-Reply in Further Opposition to Direct Purchaser Plaintiffs' Motion for Class Certification. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 - Forest's Sur-Reply in Further Opposition to Direct Purchaser Plaintiffs' Motion for Class Certification [Redacted], #2 Exhibit A to Declaration of Michael E. Hamburger in Support of Forest's Sur-Reply in Further Opposition to Direct Purchaser Plaintiffs' Motion for Class Certification)(Hamburger, Michael) |
Filing 513 SEALED DOCUMENT placed in vault.(mps) |
Filing 512 NOTICE of Filing Under Seal re: #505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Johnson, Ryan) |
Filing 511 SEALED DOCUMENT placed in vault.(mps) |
Filing 510 SEALED DOCUMENT placed in vault.(rz) |
Filing 509 DECLARATION of Dan Litvin in Opposition re: #505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1 - filed under seal, #2 Exhibit 2 - filed under seal, #3 Exhibit 3 - filed under seal)(Litvin, Dan) |
Filing 508 NOTICE of FILING UNDER SEAL. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 507 NOTICE of Filing Under Seal re: #506 Declaration in Support of Motion, #505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Johnson, Ryan) |
Filing 506 DECLARATION of Ryan P. Johnson in Support re: #505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 (Filed Under Seal), #2 Exhibit 2 (Filed Under Seal), #3 Exhibit 3- Excerpts from the deposition transcript of John R. Thomas, dated Oct. 30, 2013)(Johnson, Ryan) |
Filing 505 MOTION to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Johnson, Ryan) |
Filing 504 SEALED DOCUMENT placed in vault.(mps) |
Filing 503 MEMO ENDORSEMENT granting #485 Letter Motion for Leave to File Document. ENDORSEMENT: OK, file the motion. (Signed by Judge Colleen McMahon on 1/23/2018) (kgo) |
***DELETED DOCUMENT. Deleted document number 493 Memorandum of Law. As per Order of 2/15/2018, at Dkt. No. #522 (ap) |
Filing 502 DECLARATION of Dan Litvin in Opposition re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 PUBLIC EXHIBITS PART 1, #2 PUBLIC EXHIBITS PART 2, #3 PUBLIC EXHIBITS PART 3, #4 PUBLIC EXHIBITS PART 4, #5 PUBLIC EXHIBITS PART 5, #6 PUBLIC EXHIBITS PART 6, #7 PUBLIC EXHIBITS PART 7, #8 PUBLIC EXHIBITS PART 8, #9 PUBLIC EXHIBITS PART 9, #10 PUBLIC EXHIBITS PART 10)(Litvin, Dan) |
Filing 501 DECLARATION of Joseph Opper in Opposition re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 8, #2 Exhibit 9, #3 Exhibit 10, #4 Exhibit 18, #5 Exhibit 19, #6 Exhibit 21, #7 Exhibit 22, #8 Exhibit 30)(Litvin, Dan) |
Filing 500 COUNTER STATEMENT TO #466 Rule 56.1 Statement. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 499 RULE 56.1 STATEMENT. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 498 MEMORANDUM OF LAW in Opposition re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment. PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 497 MEMORANDUM OF LAW in Opposition re: #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb . PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 496 MEMORANDUM OF LAW in Opposition re: #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages . PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 495 MEMORANDUM OF LAW in Opposition re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge . PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 494 MEMORANDUM OF LAW in Opposition re: #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon . PUBLIC VERSION. Document filed by Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 493 MEMORANDUM OF LAW in Opposition re: #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. . PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 492 SEALED DOCUMENT placed in vault.(mps) |
Filing 491 PROPOSED VOIR DIRE QUESTIONS. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(O'Shaughnessy, Kristen) |
Filing 490 NOTICE of Filing Under Seal. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Proposed Verdict Form and Jury Charges, #2 Exhibit 1 to Proposed Verdict Form and Jury Charges (Filed Under Seal), #3 Exhibit 2 to Proposed Verdict Form and Jury Charges (Filed Under Seal), #4 Exhibit A to Exhibit 2, #5 Exhibit B to Exhibit 2, #6 Exhibit C to Exhibit 2, #7 Exhibit D to Exhibit 2, #8 Exhibit E to Exhibit 2, #9 Exhibit F to Exhibit 2, #10 Exhibit G to Exhibit 2, #11 Exhibit H to Exhibit 2, #12 Exhibit I to Exhibit 2, #13 Exhibit J to Exhibit 2)(O'Shaughnessy, Kristen) |
Filing 489 SEALED DOCUMENT placed in vault.(mps) |
Filing 488 PROPOSED VOIR DIRE QUESTIONS. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 487 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 486 NOTICE of of Filing Under Seal re: #485 MOTION for Leave to File Motion to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Johnson, Ryan) |
Filing 485 MOTION for Leave to File Motion to Exclude Opinions and Proposed Testimony of John R. Thomas, Esq. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A- Proposed Motion, #2 Exhibit B- Filed Under Seal, #3 Exhibit C- Proposed Declaration, #4 Exhibit 1 to Proposed Declaration (Filed Under Seal), #5 Exhibit 2 to Proposed Declaration (Filed Under Seal), #6 Exhibit 3 to Proposed Declaration)(Johnson, Ryan) |
Filing 484 SEALED DOCUMENT placed in vault.(mps) |
Filing 483 NOTICE of Filing Under Seal re: #481 Notice (Other),. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
Filing 482 SEALED DOCUMENT placed in vault.(mps) |
Filing 481 NOTICE of Filing Under Seal - Sur-reply in Further Opposition re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 480 SEALED DOCUMENT placed in vault.(mps) |
Filing 479 DECLARATION of Kristen O'Shaughnessy in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 376 - Filed Under Seal, #2 Exhibit 377 - Filed Under Seal, #3 Exhibit 378 - Filed Under Seal, #4 Exhibit 379 - Filed Under Seal, #5 Exhibit 380 - Filed Under Seal, #6 Exhibit 381 - Filed Under Seal, #7 Exhibit 382 - Filed Under Seal, #8 Exhibit 383 - Filed Under Seal, #9 Exhibit 384 - Filed Under Seal, #10 Exhibit 385 - Filed Under Seal, #11 Exhibit 386 - Filed Under Seal, #12 Exhibit 387 - Filed Under Seal, #13 Exhibit 388 - Filed Under Seal, #14 Exhibit 389 - Filed Under Seal, #15 Exhibit 390 - Filed Under Seal, #16 Exhibit 391 - Filed Under Seal, #17 Exhibit 392 - Filed Under Seal, #18 Exhibit 393 - Filed Under Seal, #19 Exhibit 394 - Filed Under Seal, #20 Exhibit 395 - Filed Under Seal, #21 Exhibit 396 - Filed Under Seal, #22 Exhibit 397 - Filed Under Seal, #23 Exhibit 398 - Filed Under Seal, #24 Exhibit 399 - Filed Under Seal, #25 Exhibit 400 - Filed Under Seal, #26 Exhibit 401 - Filed Under Seal, #27 Exhibit 402 - Filed Under Seal, #28 Exhibit 403 - Filed Under Seal, #29 Exhibit 404 - Filed Under Seal, #30 Exhibit 405 - Filed Under Seal, #31 Exhibit 406 - Filed Under Seal, #32 Exhibit 407 - Filed Under Seal, #33 Exhibit 408 - Filed Under Seal, #34 Exhibit 409 - Filed Under Seal, #35 Exhibit 410 - Filed Under Seal, #36 Exhibit 411 - Filed Under Seal, #37 Exhibit 412 - Filed Under Seal, #38 Exhibit 413 - Filed Under Seal, #39 Exhibit 414 - Filed Under Seal, #40 Exhibit 415 - Filed Under Seal, #41 Exhibit 416 - Filed Under Seal, #42 Exhibit 417 - Filed Under Seal)(O'Shaughnessy, Kristen) |
Filing 478 SEALED DOCUMENT placed in vault.(rz) |
Filing 477 NOTICE of Filing Under Seal re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 476 DECLARATION of Michael E. Hamburger in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge ., #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages ., #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. ., #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon ., #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 41 - Filed Under Seal, #2 Exhibit 42 - Filed Under Seal, #3 Exhibit 43 - Filed Under Seal, #4 Exhibit 44 - Filed Under Seal, #5 Exhibit 45 - Filed Under Seal, #6 Exhibit 46 - Filed Under Seal, #7 Exhibit 47 - Filed Under Seal, #8 Exhibit 48 - Filed Under Seal, #9 Exhibit 49 - Filed Under Seal, #10 Exhibit 50 - Filed Under Seal, #11 Exhibit 51 - Filed Under Seal)(O'Shaughnessy, Kristen) |
Filing 475 NOTICE of Filing Under Seal re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge ., #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb ., #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages ., #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. ., #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 474 SEALED DOCUMENT placed in vault.(rz) |
Filing 473 DECLARATION of Michael E. Hamburger in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge ., #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages ., #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. ., #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon ., #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 List of Exhibits File Under Seal, #2 Exhibit 17 to the Declaration of Michael E. Hamburger (Redacted), #3 Exhibit 18 to the Declaration of Michael E. Hamburger, #4 Exhibit 24 to the Declaration of Michael E. Hamburger, #5 Exhibit 28 to the Declaration of Michael E. Hamburger (Redacted), #6 Exhibit 29 to the Declaration of Michael E. Hamburger (Redacted), #7 Exhibit 30 to the Declaration of Michael E. Hamburger (Redacted))(Hamburger, Michael) |
Filing 472 MEMORANDUM OF LAW in Support re: #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb . [Public Redacted]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 471 MEMORANDUM OF LAW in Support re: #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. . [Public Redacted]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 470 MEMORANDUM OF LAW in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge . [Public Redacted]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 469 MEMORANDUM OF LAW in Support re: #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon . [Public Redacted]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 468 MEMORANDUM OF LAW in Support re: #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages . [Public Redacted]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 467 DECLARATION of Kristen O'Shaughnessy in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 List of Exhibits Filed Under Seal, #2 Exhibit 1 to the Declaration of Kristen O'Shaughnessy, #3 Exhibit 2 to the Declaration of Kristen O'Shaughnessy, #4 Exhibit 6 to the Declaration of Kristen O'Shaughnessy (Redacted), #5 Exhibit 7-1 to the Declaration of Kristen O'Shaughnessy, #6 Exhibit 7-2 to the Declaration of Kristen O'Shaughnessy, #7 Exhibit 7-3 to the Declaration of Kristen O'Shaughnessy, #8 Exhibit 10 to the Declaration of Kristen O'Shaughnessy, #9 Exhibit 11 to the Declaration of Kristen O'Shaughnessy (Redacted), #10 Exhibit 14 to the Declaration of Kristen O'Shaughnessy, #11 Exhibit 15 to the Declaration of Kristen O'Shaughnessy, #12 Exhibit 17 to the Declaration of Kristen O'Shaughnessy (Redacted), #13 Exhibit 18 to the Declaration of Kristen O'Shaughnessy, #14 Exhibit 19 to the Declaration of Kristen O'Shaughnessy, #15 Exhibit 20 to the Declaration of Kristen O'Shaughnessy, #16 Exhibit 21 to the Declaration of Kristen O'Shaughnessy, #17 Exhibit 61 to the Declaration of Kristen O'Shaughnessy (Redacted), #18 Exhibit 81 to the Declaration of Kristen O'Shaughnessy, #19 Exhibit 123 to the Declaration of Kristen O'Shaughnessy (Redacted), #20 Exhibit 133 to the Declaration of Kristen O'Shaughnessy, #21 Exhibit 134 to the Declaration of Kristen O'Shaughnessy, #22 Exhibit 135 to the Declaration of Kristen O'Shaughnessy, #23 Exhibit 136 to the Declaration of Kristen O'Shaughnessy, #24 Exhibit 137 to the Declaration of Kristen O'Shaughnessy, #25 Exhibit 138 to the Declaration of Kristen O'Shaughnessy, #26 Exhibit 139 to the Declaration of Kristen O'Shaughnessy, #27 Exhibit 141 to the Declaration of Kristen O'Shaughnessy, #28 Exhibit 142 to the Declaration of Kristen O'Shaughnessy, #29 Exhibit 143 to the Declaration of Kristen O'Shaughnessy, #30 Exhibit 144 to the Declaration of Kristen O'Shaughnessy, #31 Exhibit 145 to the Declaration of Kristen O'Shaughnessy, #32 Exhibit 146 to the Declaration of Kristen O'Shaughnessy, #33 Exhibit 147 to the Declaration of Kristen O'Shaughnessy, #34 Exhibit 148 to the Declaration of Kristen O'Shaughnessy, #35 Exhibit 149 to the Declaration of Kristen O'Shaughnessy, #36 Exhibit 150 to the Declaration of Kristen O'Shaughnessy, #37 Exhibit 151 to the Declaration of Kristen O'Shaughnessy, #38 Exhibit 152 to the Declaration of Kristen O'Shaughnessy, #39 Exhibit 153 to the Declaration of Kristen O'Shaughnessy, #40 Exhibit 154 to the Declaration of Kristen O'Shaughnessy, #41 Exhibit 155 to the Declaration of Kristen O'Shaughnessy, #42 Exhibit 156 to the Declaration of Kristen O'Shaughnessy, #43 Exhibit 157 to the Declaration of Kristen O'Shaughnessy, #44 Exhibit 158 to the Declaration of Kristen O'Shaughnessy, #45 Exhibit 159 to the Declaration of Kristen O'Shaughnessy, #46 Exhibit 160 to the Declaration of Kristen O'Shaughnessy, #47 Exhibit 161 to the Declaration of Kristen O'Shaughnessy, #48 Exhibit 162 to the Declaration of Kristen O'Shaughnessy, #49 Exhibit 163 to the Declaration of Kristen O'Shaughnessy, #50 Exhibit 164 to the Declaration of Kristen O'Shaughnessy, #51 Exhibit 165 to the Declaration of Kristen O'Shaughnessy, #52 Exhibit 167 to the Declaration of Kristen O'Shaughnessy, #53 Exhibit 183 to the Declaration of Kristen O'Shaughnessy, #54 Exhibit 185 to the Declaration of Kristen O'Shaughnessy, #55 Exhibit 186 to the Declaration of Kristen O'Shaughnessy, #56 Exhibit 187 to the Declaration of Kristen O'Shaughnessy, #57 Exhibit 188 to the Declaration of Kristen O'Shaughnessy, #58 Exhibit 189 to the Declaration of Kristen O'Shaughnessy (Redacted), #59 Exhibit 197 to the Declaration of Kristen O'Shaughnessy, #60 Exhibit 198 to the Declaration of Kristen O'Shaughnessy (Redacted), #61 Exhibit 199 to the Declaration of Kristen O'Shaughnessy (Redacted), #62 Exhibit 200 to the Declaration of Kristen O'Shaughnessy, #63 Exhibit 202 to the Declaration of Kristen O'Shaughnessy (Redacted), #64 Exhibit 209 to the Declaration of Kristen O'Shaughnessy, #65 Exhibit 210 to the Declaration of Kristen O'Shaughnessy, #66 Exhibit 211 to the Declaration of Kristen O'Shaughnessy, #67 Exhibit 212 to the Declaration of Kristen O'Shaughnessy, #68 Exhibit 213 to the Declaration of Kristen O'Shaughnessy, #69 Exhibit 214 to the Declaration of Kristen O'Shaughnessy, #70 Exhibit 215 to the Declaration of Kristen O'Shaughnessy, #71 Exhibit 216 to the Declaration of Kristen O'Shaughnessy, #72 Exhibit 217 to the Declaration of Kristen O'Shaughnessy, #73 Exhibit 218 to the Declaration of Kristen O'Shaughnessy, #74 Exhibit 230 to the Declaration of Kristen O'Shaughnessy, #75 Exhibit 284 to the Declaration of Kristen O'Shaughnessy (Redacted), #76 Exhibit 285 to the Declaration of Kristen O'Shaughnessy (Redacted), #77 Exhibit 288 to the Declaration of Kristen O'Shaughnessy, #78 Exhibit 289 to the Declaration of Kristen O'Shaughnessy, #79 Exhibit 290 to the Declaration of Kristen O'Shaughnessy, #80 Exhibit 291 to the Declaration of Kristen O'Shaughnessy, #81 Exhibit 293 to the Declaration of Kristen O'Shaughnessy, #82 Exhibit 294 to the Declaration of Kristen O'Shaughnessy, #83 Exhibit 295 to the Declaration of Kristen O'Shaughnessy, #84 Exhibit 296 to the Declaration of Kristen O'Shaughnessy (Redacted), #85 Exhibit 297 to the Declaration of Kristen O'Shaughnessy, #86 Exhibit 298 to the Declaration of Kristen O'Shaughnessy, #87 Exhibit 299 to the Declaration of Kristen O'Shaughnessy, #88 Exhibit 300 to the Declaration of Kristen O'Shaughnessy, #89 Exhibit 301 to the Declaration of Kristen O'Shaughnessy, #90 Exhibit 302 to the Declaration of Kristen O'Shaughnessy, #91 Exhibit 306 to the Declaration of Kristen O'Shaughnessy, #92 Exhibit 307 to the Declaration of Kristen O'Shaughnessy, #93 Exhibit 308 to the Declaration of Kristen O'Shaughnessy, #94 Exhibit 310 to the Declaration of Kristen O'Shaughnessy, #95 Exhibit 316 to the Declaration of Kristen O'Shaughnessy, #96 Exhibit 317 to the Declaration of Kristen O'Shaughnessy, #97 Exhibit 318 to the Declaration of Kristen O'Shaughnessy, #98 Exhibit 319 to the Declaration of Kristen O'Shaughnessy, #99 Exhibit 320 to the Declaration of Kristen O'Shaughnessy, #100 Exhibit 321 to the Declaration of Kristen O'Shaughnessy (Redacted), #101 Exhibit 322 to the Declaration of Kristen O'Shaughnessy, #102 Exhibit 323 to the Declaration of Kristen O'Shaughnessy, #103 Exhibit 325 to the Declaration of Kristen O'Shaughnessy (Redacted), #104 Exhibit 326 to the Declaration of Kristen O'Shaughnessy, #105 Exhibit 327 to the Declaration of Kristen O'Shaughnessy (Redacted), #106 Exhibit 330 to the Declaration of Kristen O'Shaughnessy (Redacted), #107 Exhibit 331 to the Declaration of Kristen O'Shaughnessy (Redacted), #108 Exhibit 353 to the Declaration of Kristen O'Shaughnessy (Redacted), #109 Exhibit 354 to the Declaration of Kristen O'Shaughnessy (Redacted), #110 Exhibit 359 to the Declaration of Kristen O'Shaughnessy (Redacted), #111 Exhibit 361 to the Declaration of Kristen O'Shaughnessy (Redacted), #112 Exhibit 362 to the Declaration of Kristen O'Shaughnessy, #113 Exhibit 365 to the Declaration of Kristen O'Shaughnessy (Redacted), #114 Exhibit 373 to the Declaration of Kristen O'Shaughnessy)(O'Shaughnessy, Kristen) |
Filing 466 RULE 56.1 STATEMENT. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 465 MEMORANDUM OF LAW in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment. /Defendants' Corrected Memorandum of Law in Support [Redacted]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Toto, Martin) |
|
Set/Reset Deadlines: Replies due by 1/5/2018. (kgo) |
Filing 463 RESPONSE in Opposition to Motion re: #462 MOTION for Leave to File SUR-REPLY IN FURTHER OPPOSITION TO FORESTS EMERGENCY MOTION TO STRIKE PLAINTIFFS AFFIRMATIVE STATEMENT OF MATERIAL FACTS IN OPPOSITION TO FORESTS MOTION FOR SUMMARY JUDGMENT . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 462 MOTION for Leave to File SUR-REPLY IN FURTHER OPPOSITION TO FORESTS EMERGENCY MOTION TO STRIKE PLAINTIFFS AFFIRMATIVE STATEMENT OF MATERIAL FACTS IN OPPOSITION TO FORESTS MOTION FOR SUMMARY JUDGMENT . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1 [proposed sur-reply])(Litvin, Dan) |
Filing 461 REPLY MEMORANDUM OF LAW in Support re: #457 EMERGENCY MOTION to Strike Document No. 456 /Forest's Notice of Motion and Emergency Motion to Strike Plaintiffs' Affirmative Statement of Material Facts in Opposition to Forest's Motion for Summary Judgment. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 460 SEALED DOCUMENT placed in vault.(rz) |
Filing 459 NOTICE of of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 458 MEMORANDUM OF LAW in Support re: #457 EMERGENCY MOTION to Strike Document No. 456 /Forest's Notice of Motion and Emergency Motion to Strike Plaintiffs' Affirmative Statement of Material Facts in Opposition to Forest's Motion for Summary Judgment. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 457 EMERGENCY MOTION to Strike Document No. 456 /Forest's Notice of Motion and Emergency Motion to Strike Plaintiffs' Affirmative Statement of Material Facts in Opposition to Forest's Motion for Summary Judgment. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Hamburger, Michael) |
Filing 456 SEALED DOCUMENT placed in vault.(rz) |
Filing 455 NOTICE of of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 454 MEMO ENDORSEMENT on re: #453 Letter filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation. ENDORSEMENT: OK. (Signed by Judge Colleen McMahon on 12/7/2017) (cf) |
Filing 453 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated December 6, 2017 re: permission to submit multiple CDs; permission to use slip sheets. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 452 MEMO ENDORSEMENT on re: #451 Letter, filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc. ENDORSEMENT: Just submit a completed corrected copy. (Signed by Judge Colleen McMahon on 12/5/2017) (kgo) |
Filing 451 LETTER addressed to Judge Colleen McMahon from Heather Burke dated December 4, 2017 re: Permission to submit corrections to Defendants' motion for summary judgment and accompanying documents filed on November 17, 2017. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
Filing 450 NOTICE OF APPEARANCE by William Harold Bave, III on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Bave, William) |
Filing 449 NOTICE OF APPEARANCE by John Hail Chung on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Chung, John) |
Filing 448 SEALED DOCUMENT placed in vault.(mps) |
Filing 447 NOTICE of of Filing Under Seal Forest's Daubert Motions. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 446 DECLARATION of Michael E. Hamburger in Support re: #445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Filed Under Seal, #2 Exhibit 2- Filed Under Seal, #3 Exhibit 3- Filed Under Seal, #4 Exhibit 4- Filed Under Seal, #5 Exhibit 5- Filed Under Seal, #6 Exhibit 6- Filed Under Seal, #7 Exhibit 7- Filed Under Seal, #8 Exhibit 8- Filed Under Seal, #9 Exhibit 9- Filed Under Seal, #10 Exhibit 10- Filed Under Seal, #11 Exhibit 11- Filed Under Seal, #12 Exhibit 12- Filed Under Seal, #13 Exhibit 13- Filed Under Seal, #14 Exhibit 14- Filed Under Seal, #15 Exhibit 15- Filed Under Seal, #16 Exhibit 16- Filed Under Seal, #17 Exhibit 17- Filed Under Seal, #18 Exhibit 18- Filed Under Seal, #19 Exhibit 19- Filed Under Seal, #20 Exhibit 20- Filed Under Seal, #21 Exhibit 21- Filed Under Seal, #22 Exhibit 22- Filed Under Seal, #23 Exhibit 23- Filed Under Seal, #24 Exhibit 24- Filed Under Seal, #25 Exhibit 25- Filed Under Seal, #26 Exhibit 26- Filed Under Seal, #27 Exhibit 27- Filed Under Seal, #28 Exhibit 28- Filed Under Seal, #29 Exhibit 29- Filed Under Seal, #30 Exhibit 30- Filed Under Seal, #31 Exhibit 31- Filed Under Seal, #32 Exhibit 32- Filed Under Seal, #33 Exhibit 33- Filed Under Seal, #34 Exhibit 34- Filed Under Seal, #35 Exhibit 35- Filed Under Seal, #36 Exhibit 36- Filed Under Seal, #37 Exhibit 37- Filed Under Seal, #38 Exhibit 38- Filed Under Seal, #39 Exhibit 39- Filed Under Seal, #40 Exhibit 40- Filed Under Seal)(Hamburger, Michael) |
Filing 445 MOTION to Exclude Opinions and Proposed Testimony of Dr. Russell Lamb . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Hamburger, Michael) |
Filing 444 DECLARATION of Michael E. Hamburger in Support re: #443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Filed Under Seal, #2 Exhibit 2- Filed Under Seal, #3 Exhibit 3- Filed Under Seal, #4 Exhibit 4- Filed Under Seal, #5 Exhibit 5- Filed Under Seal, #6 Exhibit 6- Filed Under Seal, #7 Exhibit 7- Filed Under Seal, #8 Exhibit 8- Filed Under Seal, #9 Exhibit 9- Filed Under Seal, #10 Exhibit 10- Filed Under Seal, #11 Exhibit 11- Filed Under Seal, #12 Exhibit 12- Filed Under Seal, #13 Exhibit 13- Filed Under Seal, #14 Exhibit 14- Filed Under Seal, #15 Exhibit 15- Filed Under Seal, #16 Exhibit 16- Filed Under Seal, #17 Exhibit 17- Filed Under Seal, #18 Exhibit 18- Filed Under Seal, #19 Exhibit 19- Filed Under Seal, #20 Exhibit 20- Filed Under Seal, #21 Exhibit 21- Filed Under Seal, #22 Exhibit 22- Filed Under Seal, #23 Exhibit 23- Filed Under Seal, #24 Exhibit 24- Filed Under Seal, #25 Exhibit 25- Filed Under Seal, #26 Exhibit 26- Filed Under Seal, #27 Exhibit 27- Filed Under Seal, #28 Exhibit 28- Filed Under Seal, #29 Exhibit 29- Filed Under Seal, #30 Exhibit 30- Filed Under Seal, #31 Exhibit 31- Filed Under Seal, #32 Exhibit 32- Filed Under Seal, #33 Exhibit 33- Filed Under Seal, #34 Exhibit 34- Filed Under Seal, #35 Exhibit 35- Filed Under Seal, #36 Exhibit 36- Filed Under Seal, #37 Exhibit 37- Filed Under Seal, #38 Exhibit 38- Filed Under Seal, #39 Exhibit 39- Filed Under Seal, #40 Exhibit 40- Filed Under Seal)(Hamburger, Michael) |
Filing 443 MOTION To Exclude Opinions and Proposed Testimony of George W. Johnston, Esq. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Hamburger, Michael) |
Filing 442 DECLARATION of Michael E. Hamburger in Support re: #441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Filed Under Seal, #2 Exhibit 2- Filed Under Seal, #3 Exhibit 3- Filed Under Seal, #4 Exhibit 4- Filed Under Seal, #5 Exhibit 5- Filed Under Seal, #6 Exhibit 6- Filed Under Seal, #7 Exhibit 7- Filed Under Seal, #8 Exhibit 8- Filed Under Seal, #9 Exhibit 9- Filed Under Seal, #10 Exhibit 10- Filed Under Seal, #11 Exhibit 11- Filed Under Seal, #12 Exhibit 12- Filed Under Seal, #13 Exhibit 13- Filed Under Seal, #14 Exhibit 14- Filed Under Seal, #15 Exhibit 15- Filed Under Seal, #16 Exhibit 16- Filed Under Seal, #17 Exhibit 17- Filed Under Seal, #18 Exhibit 18- Filed Under Seal, #19 Exhibit 19- Filed Under Seal, #20 Exhibit 20- Filed Under Seal, #21 Exhibit 21- Filed Under Seal, #22 Exhibit 22- Filed Under Seal, #23 Exhibit 23- Filed Under Seal, #24 Exhibit 24- Filed Under Seal, #25 Exhibit 25- Filed Under Seal, #26 Exhibit 26- Filed Under Seal, #27 Exhibit 27- Filed Under Seal, #28 Exhibit 28- Filed Under Seal, #29 Exhibit 29- Filed Under Seal, #30 Exhibit 30- Filed Under Seal, #31 Exhibit 31- Filed Under Seal, #32 Exhibit 32- Filed Under Seal, #33 Exhibit 33- Filed Under Seal, #34 Exhibit 34- Filed Under Seal, #35 Exhibit 35- Filed Under Seal, #36 Exhibit 36- Filed Under Seal, #37 Exhibit 37- Filed Under Seal, #38 Exhibit 38- Filed Under Seal, #39 Exhibit 39- Filed Under Seal, #40 Exhibit 40- Filed Under Seal)(Hamburger, Michael) |
Filing 441 MOTION to Exclude Opinion and Proposed Testimony of Dr. Ernest Berndt and Dr. Russell Lamb Regarding Forecast Averages . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Hamburger, Michael) |
Filing 440 DECLARATION of Michael E. Hamburger in Support re: #439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Filed Under Seal, #2 Exhibit 2- Filed Under Seal, #3 Exhibit 3- Filed Under Seal, #4 Exhibit 4- Filed Under Seal, #5 Exhibit 5- Filed Under Seal, #6 Exhibit 6- Filed Under Seal, #7 Exhibit 7- Filed Under Seal, #8 Exhibit 8- Filed Under Seal, #9 Exhibit 9- Filed Under Seal, #10 Exhibit 10- Filed Under Seal, #11 Exhibit 11- Filed Under Seal, #12 Exhibit 12- Filed Under Seal, #13 Exhibit 13- Filed Under Seal, #14 Exhibit 14- Filed Under Seal, #15 Exhibit 15- Filed Under Seal, #16 Exhibit 16- Filed Under Seal, #17 Exhibit 17- Filed Under Seal, #18 Exhibit 18- Filed Under Seal, #19 Exhibit 19- Filed Under Seal, #20 Exhibit 20- Filed Under Seal, #21 Exhibit 21- Filed Under Seal, #22 Exhibit 22- Filed Under Seal, #23 Exhibit 23- Filed Under Seal, #24 Exhibit 24- Filed Under Seal, #25 Exhibit 25- Filed Under Seal, #26 Exhibit 26- Filed Under Seal, #27 Exhibit 27- Filed Under Seal, #28 Exhibit 28- Filed Under Seal, #29 Exhibit 29- Filed Under Seal, #30 Exhibit 30- Filed Under Seal, #31 Exhibit 31- Filed Under Seal, #32 Exhibit 32- Filed Under Seal, #33 Exhibit 33- Filed Under Seal, #34 Exhibit 34- Filed Under Seal, #35 Exhibit 35- Filed Under Seal, #36 Exhibit 36- Filed Under Seal, #37 Exhibit 37- Filed Under Seal, #38 Exhibit 38- Filed Under Seal, #39 Exhibit 39- Filed Under Seal, #40 Exhibit 40- Filed Under Seal)(Hamburger, Michael) |
Filing 439 MOTION to Exclude Opinions and Proposed Testimony of Prof. Einer Elhauge . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Hamburger, Michael) |
Filing 438 DECLARATION of Michae E. Hamburger in Support re: #437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 - Filed Under Seal, #2 Exhibit 2 - Filed Under Seal, #3 Exhibit 3 - Filed Under Seal, #4 Exhibit 4 - Filed Under Seal, #5 Exhibit 5- Filed Under Seal, #6 Exhibit 6- Filed Under Seal, #7 Exhibit 7- Filed Under Seal, #8 Exhibit 8- Filed Under Seal, #9 Exhibit 9- Filed Under Seal, #10 Exhibit 10- Filed Under Seal, #11 Exhibit 11- Filed Under Seal, #12 Exhibit 12- Filed Under Seal, #13 Exhibit 13- Filed Under Seal, #14 Exhibit 14- Filed Under Seal, #15 Exhibit 15- Filed Under Seal, #16 Exhibit 16- Filed Under Seal, #17 Exhibit 17- Filed Under Seal, #18 Exhibit 18- Filed Under Seal, #19 Exhibit 19- Filed Under Seal, #20 Exhibit 20- Filed Under Seal, #21 Exhibit 21- Filed Under Seal, #22 Exhibit 22- Filed Under Seal, #23 Exhibit 23- Filed Under Seal, #24 Exhibit 24- Filed Under Seal, #25 Exhibit 25- Filed Under Seal, #26 Exhibit 26- Filed Under Seal, #27 Exhibit 27- Filed Under Seal, #28 Exhibit 28- Filed Under Seal, #29 Exhibit 29 - Filed Under Seal, #30 Exhibit 30- Filed Under Seal, #31 Exhibit 31- Filed Under Seal, #32 Exhibit 32- Filed Under Seal, #33 Exhibit 33- Filed Under Seal, #34 Exhibit 34- Filed Under Seal, #35 Exhibit 35- Filed Under Seal, #36 Exhibit 36- Filed Under Seal, #37 Exhibit 37- Filed Under Seal, #38 Exhibit 38- Filed Under Seal, #39 Exhibit 39 - Filed Under Seal, #40 Exhibit 40- Filed Under Seal)(Hamburger, Michael) |
Filing 437 MOTION to Exclude Opinions and Proposed Testimony of Janet K. DeLeon . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Hamburger, Michael) |
Filing 436 DECLARATION of Kristen O'Shaughnessy in Support re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 through Exhibit 373 (Filed Under Seal))(O'Shaughnessy, Kristen) |
Filing 435 NOTICE of Filing Under Seal re: #434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 434 MOTION for Summary Judgment / Defendants' Notice of Motion and Motion for Summary Judgment. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(Toto, Martin) |
Filing 433 MEMO ENDORSEMENT on re: #432 Letter, filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc. ENDORSEMENT: OK. (Signed by Judge Colleen McMahon on 11/17/2017) (kgo) |
Filing 432 LETTER addressed to Judge Colleen McMahon from Heather Burke dated November 16, 2017 re: Permission to replace large excel files in the Court's courtesy copies with slipsheets. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
Filing 431 MEMO ENDORSEMENT on re: #430 Letter, filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc. ENDORSEMENT: OK. (Signed by Judge Colleen McMahon on 11/15/2017) (kgo) |
Filing 430 LETTER addressed to Judge Colleen McMahon from Heather Burke dated November 15, 2017 re: Permission to submit multiple CDs to the sealed records office. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
|
|
Filing 427 LETTER addressed to Robert W. Lehrburger from Dan Litvin dated November 13, 2017 re: Motion to Compel Mylan (ECF 214). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 426 MOTION for Leave to File Excess Pages in Opposition to Defendants' Summary Judgment Memoranda. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)(Litvin, Dan) |
Filing 425 MEMO ENDORSEMENT on re: (422 in 1:15-cv-07488-CM-RWL) FOREST'S MOTION TO FILE SUMMARY JUDGMENT MEMORANDA EXCEEDING PAGE LIMITS. ENDORSEMENT: Granted. (Signed by Judge Colleen McMahon on 11/8/2017). Filed In Associated Cases: 1:15-cv-07488-CM-RWL, 1:15-cv-10083-CM, as per Chambers. (rjm) |
|
Filing 423 RESPONSE in Opposition to Motion re: #422 MOTION for Leave to File Excess Pages / Forest's Motion to File Summary Judgment Memoranda Exceeding Page Limits. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 422 MOTION for Leave to File Excess Pages / Forest's Motion to File Summary Judgment Memoranda Exceeding Page Limits. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(O'Shaughnessy, Kristen) |
NOTICE OF REDESIGNATION TO ANOTHER MAGISTRATE JUDGE. The above entitled action has been redesignated to Magistrate Judge Robert W. Lehrburger. Please note that this is a reassignment of the designation only. (jc) |
NOTICE OF REASSIGNMENT OF A REFERRAL TO ANOTHER MAGISTRATE JUDGE. The referral in the above entitled action has been reassigned to Magistrate Judge Robert W. Lehrburger, for General Pretrial (includes scheduling, discovery, non-dispositive pretrial motions, and settlement). Magistrate Judge James C. Francis no longer referred to the case. Motions referred to Magistrate Judge Robert W. Lehrburger. (jc) Modified on 11/7/2017 (kw). |
Filing 421 SEALED DOCUMENT placed in vault.(rz) |
Filing 420 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 419 NOTICE OF APPEARANCE by Eric Majchrzak on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Majchrzak, Eric) |
Filing 418 NOTICE OF APPEARANCE by Kevin X. McGann on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McGann, Kevin) |
Filing 417 MEMORANDUM OF LAW in Opposition re: #400 MOTION to Certify Class . [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
|
Filing 415 MEMO ENDORSEMENT granting #413 Letter Motion for Extension of Time. ENDORSEMENT: Oh stop! No briefing! Just take the 2 extra days. (Signed by Judge Colleen McMahon on 10/19/2017) (kgo) |
Filing 414 MEMORANDUM OF LAW in Support re: #413 EMERGENCY MOTION for Extension of Time . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 413 EMERGENCY MOTION for Extension of Time . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 411 NOTICE of Filing Under Seal re: #410 Declaration in Opposition to Motion,,,. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 410 DECLARATION of Michael E. Hamburger in Opposition re: #400 MOTION to Certify Class .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1 (Filed Under Seal), #2 Exhibit 2 (Filed Under Seal), #3 Exhibit 3- January 13, 2004 Press Release re: Launch of Namenda IR, #4 Exhibit 4 (Filed Under Seal), #5 Exhibit 5- Excerpts from evidentiary hearing NY v. Actavis, plc, #6 Exhibit 6- Namenda XR Package Insert, #7 Exhibit 7- Declaration of William J. Meury, #8 Exhibit 8- Excerpts of Mark Devlin Deposition, #9 Exhibit 9- (Filed Under Seal), #10 Exhibit 10- Declaration of Robert Stewart, #11 Exhibit 11- Settlement Agreement between Forest and NYAG, #12 Exhibit 12- Declaration of Julie Snyder, #13 Exhibit 13 (Filed Under Seal), #14 Exhibit 14 (Filed Under Seal), #15 Exhibit 15 (Filed Under Seal))(McDevitt, Heather) |
Filing 412 SEALED DOCUMENT placed in vault.(rz) |
|
|
Filing 407 MOTION for Blaine Andrew Larson to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14204371. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Declaration of Blaine A Larson, #2 Certificate of Good Standing for Blaine A Larson, #3 Text of Proposed Order)(Larson, Blaine) |
Filing 406 JOINT MOTION for Leave to File Excess Pages / Joint Request to File Memorandum Exceeding Page Limits Relating to DPP's Motion for Class Certification. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Text of Proposed Order)(McDevitt, Heather) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #407 MOTION for Blaine Andrew Larson to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14204371. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (jc) |
|
Filing 404 LETTER addressed to Magistrate Judge James C. Francis IV from Heather K. McDevitt dated October 2, 2017 re: Response to Plaintiffs' letter re privilege document. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(McDevitt, Heather) |
Filing 403 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated October 2, 2017 re: Clarification regarding status of privilege document. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 402 MEMORANDUM OF LAW in Support re: #400 MOTION to Certify Class . [PUBLIC REDACTED VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 401 DECLARATION of Dan Litvin [PUBLIC VERSION] in Support re: #400 MOTION to Certify Class .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1 part 1, #2 Exhibit 1 part 2, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23)(Litvin, Dan) |
Filing 400 MOTION to Certify Class . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Proposed Order)(Litvin, Dan) |
Filing 399 RESPONSE to Motion re: #398 MOTION for Leave to File Sur-reply in opposition to Motion to Compel Macleods. DIRECT PURCHASERS. Document filed by Rochester Drug Co-Operative, Inc.. (Simons, Daniel) |
Filing 398 MOTION for Leave to File Sur-reply in opposition to Motion to Compel Macleods. Document filed by Macleods Pharmaceuticals Ltd.. (Attachments: #1 Exhibit Proposed Surreply Memorandum, #2 Exhibit Ashlesha Declaration)(Conway, Erin) |
|
Filing 396 LETTER addressed to Magistrate Judge James C. Francis IV from Heather K. McDevitt dated September 26, 2017 re: Modifications to the Second Amended Case Management Order and inclosing a [Proposed] Third Amended Case Management Order. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 [Proposed] Third Amended Case Management Order)(McDevitt, Heather) |
Filing 395 REPLY MEMORANDUM OF LAW in Support re: #378 MOTION to Compel Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. to Produce Documents Responsive to Subpoena Request Nos. 1 - 2 . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Simons, Daniel) |
|
Filing 393 SUPPLEMENTAL MEMORANDUM OF LAW in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege. (REDACTED PUBLIC VERSION). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A)(Litvin, Dan) |
Filing 392 NOTICE OF APPEARANCE by Erin R Conway on behalf of Macleods Pharma USA, Inc.. (Conway, Erin) |
Filing 391 MEMORANDUM OF LAW in Opposition re: #378 MOTION to Compel Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. to Produce Documents Responsive to Subpoena Request Nos. 1 - 2 . . Document filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc.. (Conway, Erin) |
Filing 390 NOTICE OF APPEARANCE by Erin R Conway on behalf of Macleods Pharmaceuticals Ltd.. (Conway, Erin) |
|
Filing 388 LETTER addressed to Magistrate Judge James C. Francis IV from Heather K. McDevitt dated September 21, 2017 re: Modification to the Second Amended Case Management Order. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc., Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Text of Proposed Order)(McDevitt, Heather) |
|
Filing 386 DECLARATION of Supplemental Reply Declaration of Dan Litvin (PUBLIC VERSION; SIGNED VERSION) in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 8, #2 Exhibit 9)(Litvin, Dan) |
Filing 385 FILING ERROR - DEFICIENT DOCKET ENTRY - DECLARATION of Supplemental Reply Declaration of Dan Litvin (PUBLIC VERSION) in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 8, #2 Exhibit 9)(Litvin, Dan) Modified on 9/18/2017 (db). |
Filing 384 REPLY MEMORANDUM OF LAW in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege. (CORRECTED PUBLIC VERSION). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 383 DECLARATION of Reply Declaration of Dan Litvin (PUBLIC VERSION) in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7)(Litvin, Dan) |
Filing 382 REPLY MEMORANDUM OF LAW in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege. PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
***NOTICE TO ATTORNEY TO RE-FILE DOCUMENT - DEFICIENT DOCKET ENTRY ERROR. Notice to Attorney Dan Litvin to RE-FILE Document #385 Declaration in Support of Motion. ERROR(S): No signature or s/. (db) |
Filing 381 SEALED DOCUMENT placed in vault.(rz) |
Filing 380 MEMORANDUM OF LAW in Support re: #378 MOTION to Compel Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. to Produce Documents Responsive to Subpoena Request Nos. 1 - 2 . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 379 DECLARATION of Dan Litvin in Support re: #378 MOTION to Compel Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. to Produce Documents Responsive to Subpoena Request Nos. 1 - 2 .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G)(Litvin, Dan) |
Filing 378 MOTION to Compel Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. to Produce Documents Responsive to Subpoena Request Nos. 1 - 2 . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1)(Litvin, Dan) |
Filing 377 DECLARATION of Heather K. McDevitt in Support re: #376 Opposition Brief,. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc., Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1- Filed Under Seal, #2 Exhibit 2- Filed Under Seal, #3 Exhibit 3- Filed Under Seal, #4 Exhibit 4- Filed Under Seal, #5 Exhibit 5- Filed Under Seal, #6 Exhibit 6- Filed Under Seal, #7 Exhibit 7- Filed Under Seal, #8 Exhibit 8- Filed Under Seal)(McDevitt, Heather) |
Filing 376 OPPOSITION BRIEF /Defendants' Opposition to Plaintiffs' Supplemental Memorandum in Support of Direct Purchaser Class Plaintiffs' Motion to Compel Production of Documents Withheld on the Basis of Privilege. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc., Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(McDevitt, Heather) |
Filing 375 SEALED DOCUMENT placed in vault.(mps) |
Filing 374 SEALED DOCUMENT placed in vault.(mps) |
Filing 373 SEALED DOCUMENT placed in vault.(rz) |
Filing 372 SEALED DOCUMENT placed in vault.(rz) |
Filing 371 DECLARATION of Heather K. McDevitt in Support re: #370 Response in Opposition to Motion,. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1- Forest's Disclosures Pursuant to the May 19, 2017 Memorandum and Order, #2 Exhibit 2- Forest's Supplemental Objections and Responses, #3 Exhibit 3- Email from Dan Litvin, #4 Exhibit 4- Email from Heather Burke, #5 Exhibit 5- Filed Under Seal, #6 Exhibit 6- Filed Under Seal, #7 Exhibit 7- Filed Under Seal, #8 Exhibit 8- Filed Under Seal, #9 Exhibit 9- Filed Under Seal, #10 Exhibit 10- Filed Under Seal, #11 Exhibit 11- Filed Under Seal, #12 Exhibit Exhibit 12 - Excerpts from Deposition, #13 Exhibit 13- Declaration of David Solomon, #14 Exhibit 14- Filed Under Seal, #15 Exhibit 15- Filed Under Seal, #16 Exhibit 16- Filed Under Seal, #17 Exhibit 17- Excerpts from Deposition, #18 Exhibit 18- Excerpts from Deposition, #19 Exhibit 19- Filed Under Seal, #20 Exhibit 20- Filed Under Seal, #21 Exhibit 21- Filed Under Seal, #22 Exhibit 22- Filed Under Seal, #23 Exhibit 23- Filed Under Seal, #24 Exhibit 24- Filed Under Seal, #25 Exhibit 25- Filed Under Seal, #26 Exhibit 26- Filed Under Seal, #27 Exhibit 27- Filed Under Seal, #28 Exhibit 28- Filed Under Seal, #29 Exhibit 29- Filed Under Seal, #30 Exhibit 30- Filed Under Seal, #31 Exhibit 31- Filed Under Seal, #32 Exhibit 32- Filed Under Seal, #33 Exhibit 33- Filed Under Seal, #34 Exhibit 34- Filed Under Seal, #35 Exhibit 35- Filed Under Seal, #36 Exhibit 36- Filed Under Seal, #37 Exhibit 37- Filed Under Seal, #38 Exhibit 38- Filed Under Seal, #39 Exhibit 39- Filed Under Seal, #40 Exhibit 40- Filed Under Seal, #41 Exhibit 41- Filed Under Seal, #42 Exhibit 42- Filed Under Seal, #43 Exhibit 43- Filed Under Seal, #44 Exhibit 44- Filed Under Seal, #45 Exhibit 45- Filed Under Seal, #46 Exhibit 46- Filed Under Seal, #47 Exhibit 47- Filed Under Seal, #48 Exhibit 48- Filed Under Seal, #49 Exhibit 49- Filed Under Seal, #50 Exhibit 50- Filed Under Seal, #51 Exhibit 51- Email from Heather McDevitt, #52 Exhibit 52- Email from Heather Burke)(McDevitt, Heather) |
Filing 370 RESPONSE in Opposition to Motion re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege. [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 369 NOTICE of Filing Under Seal. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 368 SEALED DOCUMENT placed in vault.(rz) |
Filing 367 DECLARATION of Dan Litvin in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Exhibit T, #21 Exhibit U, #22 Exhibit V1, #23 Exhibit V2, #24 Exhibit W1, #25 Exhibit W2, #26 Exhibit X1, #27 Exhibit X2)(Litvin, Dan) |
Filing 366 MEMORANDUM OF LAW in Support re: #361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege. [PUBLIC VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 365 NOTICE of of Withdrawal of Appearance. Document filed by JM Smith Corporation. (Perry, Emma) |
|
Filing 363 LETTER MOTION for Extension of Time for Forest to file its opposition to Direct Purchasers Plaintiffs' Motion to Compel the Production of Documents Withheld on the Basis of Privilege #361 addressed to Magistrate Judge James C. Francis IV from Heather M. Burke dated August 30, 2017. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
|
Filing 361 MOTION to Compel Defendants to Produce Documents Withheld on the Basis of Privilege. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)(Litvin, Dan) |
Filing 360 SEALED DOCUMENT placed in vault.(rz) |
Filing 359 NOTICE OF APPEARANCE by Francis Dominic Cerrito on behalf of Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Cerrito, Francis) |
|
Filing 357 MOTION for Eric J. Enger to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14041905. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Declaration of Eric J. Enger, #2 Certificate of Good Standing, #3 Text of Proposed Order)(Enger, Eric) |
Filing 356 NOTICE OF APPEARANCE by Ellen Noteware on behalf of JM Smith Corporation, Rochester Drug Co-Operative, Inc.. Filed In Associated Cases: 1:15-cv-07488-CM-JCF, 1:15-cv-10083-CM(Noteware, Ellen) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #357 MOTION for Eric J. Enger to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14041905. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
|
|
Filing 353 MOTION for Nicholas Urban to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14021804. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Affidavit, #2 Certificate of Good Standing, #3 Text of Proposed Order)(Urban, Nicholas) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #353 MOTION for Nicholas Urban to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14021804. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (jc) |
|
Filing 351 MOTION for Phyllis M. Parker to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Affidavit, #2 Certificate of Good Standing, #3 Text of Proposed Order)(Parker, Phyllis) |
Filing 350 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Phyllis M. Parker to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14009446. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Parker, Phyllis) Modified on 8/14/2017 (ma). |
>>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. #350 MOTION for Phyllis M. Parker to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-14009446. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): MISSING AFFIDAVIT OR DECLARATION PURSUANT TO LOCAL RULE 1.3;. Re-file the motion as a Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (ma) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #351 MOTION for Phyllis M. Parker to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (ma) |
|
|
Filing 347 SUPPLEMENTAL REPLY MEMORANDUM OF LAW in Support re: #267 MOTION to Compel Defendants to Produce Documents [CORRECTED MOTION]. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 346 RESPONSE in Opposition to Motion re: #267 MOTION to Compel Defendants to Produce Documents [CORRECTED MOTION]. /Defendants' Opposition to DPPs' Supplemental Memorandum in Support of June 15, 2017 Motion to Compel Production of Documents. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 345 DECLARATION of Dan Litvin [PUBLIC VERSION] in Opposition re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 9)(Litvin, Dan) |
Filing 344 REPLY MEMORANDUM OF LAW in Opposition re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider. PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 343 SUPPLEMENTAL MEMORANDUM OF LAW in Support re: #267 MOTION to Compel Defendants to Produce Documents [CORRECTED MOTION]. PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
|
Filing 341 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated 7/25/2017 re: Defendants' Subjective Intent Disclosures and Other Discovery Issues. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
Filing 339 LETTER addressed to Magistrate Judge James C. Francis IV from Heather M. Burke dated July 24, 2017 re: briefing schedule. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Burke, Heather) |
Filing 338 SEALED DOCUMENT placed in vault.(mps) |
Filing 337 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 336 MEMORANDUM OF LAW in Support re: #325 EMERGENCY MOTION for Extension of Time . REDACTED PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Litvin, Dan) |
Filing 335 REPORT AND RECOMMENDATION re: #308 MOTION to Disqualify Direct Purchaser Plaintiffs' Proposed Expert Deborah Jaskot. filed by Teva Pharmaceuticals USA, Inc., #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider. filed by Forest Laboratories, Inc., Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Actavis, plc. For the foregoing reasons, I recommend denying both Forest's motion to disqualify Dr. Schneider (Docket no. 269) and Teva's motion to disqualify Ms. Jaskot (Docket no. 308). Pursuant to 28 U.S.C. 636(b)(1) and Rules 72, 6(a), and 6(d) of the Federal Rules of Civil Procedure, the parties shall have fourteen (14) days to file written objections to this Report and Recommendation. Such objections shall be filed with the Clerk of Court, with extra copies delivered to the Chambers of the Honorable Colleen McMahon, Room 2550, and to the Chambers of the undersigned, Room 1960, 500 Pearl Street, New York, New York 10007. Failure to file timely objections will preclude appellate review. (Objections to R&R due by 8/3/2017.) (Signed by Magistrate Judge James C. Francis on 7/20/2017) Copies Transmitted this Date By Chambers. (anc) |
Filing 334 DECLARATION of Dan Litvin in Opposition re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 9)(Litvin, Dan) |
Filing 333 RESPONSE in Opposition to Motion re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider. SURREPLY IN FURTHER OPPOSITION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 332 SEALED DOCUMENT placed in vault.(rz) |
|
Set/Reset Deadlines: Deposition due by 11/3/2017. Expert Discovery due by 11/3/2017. Fact Discovery due by 9/15/2017. Responses due by 12/11/2017. Replies due by 12/29/2017. (ap) |
Filing 330 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated July 14, 2017 re: Joint Proposed Schedule. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A (Proposed Schedule))(Litvin, Dan) |
Minute Entry for proceedings held before Magistrate Judge James C. Francis: Telephone Conference held on 7/13/2017. (Bacchus, Michael) |
Filing 329 NOTICE of Filing Under Seal re: #328 Response in Opposition to Motion,,,,,,,. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 328 RESPONSE in Opposition to Motion re: #325 EMERGENCY MOTION for Extension of Time . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Letter from H. McDevitt to Judge Francis re Discovery Issues (Public Redacted), #2 Exhibit 1-1- Production Letter to DPPs Dec. 27 2016, #3 Exhibit 1-2- Email from D. Litvin to L. Calistri re 2nd Cir Opinion (Public Redacted), #4 Exhibit 1-3- Production Letter to DPPs Jan. 20, 2017, #5 Exhibit 1-4- Letter from K. Adam to E. Leger re Search Protocols (Public Redacted), #6 Exhibit 1-5- Production Letter to DPPs Apr. 3 2017, #7 Exhibit 1-6- Email from N. Silverman to K. Adam re Potential Search Terms (Public Redacted), #8 Exhibit 1-7- Email from N. Silverman to C. Moore and K. Adam re Ongoing Discovery Discussions(Public Redacted), #9 Exhibit 1-8- Production Letter to DPPs May 16 2017, #10 Exhibit 1-9- Production Letter to DPPs Jun. 12 2017, #11 Exhibit 1-10- Production Letter to DPPs Jun. 23 2017, #12 Exhibit 1-11-DPPs Amended First Requests for Production, #13 Exhibit 1-12- DPPs Second Set of RFPs (Public Redacted), #14 Exhibit 2- Email from D. Litvin to L. Calistri and C. Moore re Production, #15 Exhibit 3- Email from D. Litvin to H. McDevitt re Non-Responsiveness Redactions (Public Redacted), #16 Exhibit 4- Email from D. Litvin to H. McDevitt re Additional Custodian (Public Redacted), #17 Exhibit 5- Letter from DPPs to H. McDevitt re NDA, #18 Exhibit 6- Filed Under Seal, #19 Exhibit 7- Filed Under Seal, #20 Exhibit 8- Filed Under Seal, #21 Exhibit 9- Filed Under Seal, #22 Exhibit 10- Proposed Amended CMO)(McDevitt, Heather) |
Filing 327 SEALED DOCUMENT placed in vault.(mps) |
Filing 326 NOTICE OF APPEARANCE by Heather Marie Burke on behalf of Forest Laboratories Holdings Ltd., Forest Laboratories, Inc.. (Burke, Heather) |
Filing 325 EMERGENCY MOTION for Extension of Time . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) Modified on 7/26/2017 (ap). |
Filing 324 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 323 SEALED DOCUMENT placed in vault.(mps) |
Filing 322 REPLY MEMORANDUM OF LAW in Support re: #308 MOTION to Disqualify Direct Purchaser Plaintiffs' Proposed Expert Deborah Jaskot. . Document filed by Teva Pharmaceuticals USA, Inc.. (Weiss, Jordan) |
|
|
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #319 MOTION for Emma Westbrook Perry to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13864523. Motion and supporting papers to be reviewed by Clerk's Office staff., #318 MOTION for Christopher T. Stow-Serge to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
Filing 319 MOTION for Emma Westbrook Perry to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13864523. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Affidavit, #2 Certificate of Good Standing, #3 Text of Proposed Order)(Perry, Emma) |
Filing 318 MOTION for Christopher T. Stow-Serge to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Affidavit with Cert. of Good Standing, #2 Text of Proposed Order)(Stow-Serge, Christopher) |
>>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. #314 MOTION for Christopher T. Stow-Serge to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13860594. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): Pursuant to rule 1.3. please attach and affadavit or Declaration of the Attorney;. Re-file the motion as a Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (wb) |
Filing 317 MEMORANDUM OF LAW in Opposition re: #308 MOTION to Disqualify Direct Purchaser Plaintiffs' Proposed Expert Deborah Jaskot. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1 - Affidavit of Deborah Jaskot)(Litvin, Dan) |
Filing 316 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated June 27, 2017 re: PUBLIC VERSION of previously filed letter regarding discovery. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Litvin, Dan) |
Filing 315 REPLY MEMORANDUM OF LAW in Support re: #267 MOTION to Compel Defendants to Produce Documents [CORRECTED MOTION]. REDACTED PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Litvin, Dan) |
Filing 314 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Christopher T. Stow-Serge to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13860594. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Exhibit Letter of Good Standing, #2 Text of Proposed Order Proposed Order)(Stow-Serge, Christopher) Modified on 7/6/2017 (wb). |
Filing 313 NOTICE of Filing Under Seal. Document filed by Teva Pharmaceuticals USA, Inc.. (Weiss, Jordan) |
Filing 312 LETTER addressed to Magistrate Judge James C. Francis IV from Jordan D. Weiss dated June 30, 2017 re: request for oral argument. Document filed by Teva Pharmaceuticals USA, Inc..(Weiss, Jordan) |
Filing 311 DECLARATION of H. Bruce Gordon in Support re: #308 MOTION to Disqualify Direct Purchaser Plaintiffs' Proposed Expert Deborah Jaskot.. Document filed by Teva Pharmaceuticals USA, Inc.. (Weiss, Jordan) |
Filing 310 DECLARATION of Sarah K. Frederick in Support re: #308 MOTION to Disqualify Direct Purchaser Plaintiffs' Proposed Expert Deborah Jaskot.. Document filed by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Exhibits A-N)(Weiss, Jordan) |
Filing 309 MEMORANDUM OF LAW in Support re: #308 MOTION to Disqualify Direct Purchaser Plaintiffs' Proposed Expert Deborah Jaskot. (REDACTED). Document filed by Teva Pharmaceuticals USA, Inc.. (Weiss, Jordan) |
Filing 308 MOTION to Disqualify Direct Purchaser Plaintiffs' Proposed Expert Deborah Jaskot. Document filed by Teva Pharmaceuticals USA, Inc..(Weiss, Jordan) |
Filing 307 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Teva Pharmaceuticals Ltd. for Teva Pharmaceuticals USA, Inc.. Document filed by Teva Pharmaceuticals USA, Inc..(Weiss, Jordan) |
Filing 306 SEALED DOCUMENT placed in vault.(mps) |
|
|
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #302 MOTION for Sarah K. Frederick to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13846240. Motion and supporting papers to be reviewed by Clerk's Office staff., #301 MOTION for Christopher T. Holding to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13846124. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
Filing 303 NOTICE OF APPEARANCE by Jordan David Weiss on behalf of Teva Pharmaceuticals USA, Inc.. (Weiss, Jordan) |
Filing 302 MOTION for Sarah K. Frederick to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13846240. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Affidavit of Sarah K. Frederick, #2 Text of Proposed Order)(Frederick, Sarah) |
Filing 301 MOTION for Christopher T. Holding to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13846124. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Affidavit of Christopher T. Holding, #2 Text of Proposed Order)(Holding, Christopher) |
Filing 300 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated June 20, 2017 re: PUBLIC VERSION of previously filed letter regarding discovery. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14)(Litvin, Dan) |
Filing 299 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated June 29, 2017 re: Request for Permission to Take Out-of-Time Depositions. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 298 NOTICE of Filing Under Seal re: #297 Letter,,,,,. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 297 LETTER addressed to Magistrate Judge James C. Francis IV from Heather K. McDevitt dated June 27, 2017 re: Response to the Direct Purchaser Plaintiffs' June 20, 2017 letter (Dkt. No. 275). Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Attachment A- Letter from H. McDevitt to D. Litvin, dated December 27, 2016, #2 Attachment B- Email from L. Calistri to D. Litvin, dated January 9, 2017 (Redacted), #3 Attachment C- Letter from H. McDevitt to D. Litvin, dated January 20, 2017, #4 Attachment D- Letter from K. Adam to E. Leger, dated March 30, 2017 (Redacted), #5 Attachment E- Letter from H. McDevitt to D. Litvin, dated April 3, 2017 and related email., #6 Attachment F- Email from N. Silverman to K. Adam, dated April 21, 2017 (Redacted), #7 Attachment G- E-mail from N. Silverman to C. Moore, dated May 2, 2017 (Redacted), #8 Attachment H- Letter from H. McDevitt to D. Litvin, dated May 16, 2017, #9 Attachment I- Letter from C. Moore to D. Litvin, dated June 12, 2017, #10 Attachment J- Letter from C. Moore to D. Litvin, dated June 23, 2017, #11 Attachment K- DPPs Consolidated Amended First Requests for Production, #12 Attachment L- DPPs Second Set of Requests for Production (Redacted))(McDevitt, Heather) |
Filing 296 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 295 SEALED DOCUMENT placed in vault.(rz) |
Filing 294 SEALED DOCUMENT placed in vault.(mps) |
Filing 293 NOTICE of Filing Under Seal re: #292 Declaration in Support of Motion,, #291 Reply Memorandum of Law in Support of Motion,. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 292 DECLARATION of Heather K. McDevitt [Public Version] in Support re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit K (Filed Under Seal), #2 Exhibit L (Filed Under Seal), #3 Exhibit M (Filed Under Seal), #4 Exhibit N (Filed Under Seal), #5 Exhibit O (Filed Under Seal), #6 Exhibit P (Filed Under Seal), #7 Exhibit Q- June 25, 2017 Email from D. Litvin to H. McDevitt)(McDevitt, Heather) |
Filing 291 REPLY MEMORANDUM OF LAW in Support re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider. [Public Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 290 SEALED DOCUMENT placed in vault.(rz) |
Filing 289 SEALED DOCUMENT placed in vault.(rz) |
Filing 288 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 287 SEALED DOCUMENT placed in vault.(mps) |
Filing 285 SEALED DOCUMENT placed in vault.(rz) |
Filing 284 NOTICE of Filing Under Seal re: #283 Declaration in Opposition to Motion,,. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 283 DECLARATION of Heather K. McDevitt in Opposition re: #267 MOTION to Compel Defendants to Produce Documents [CORRECTED MOTION].. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Email from Kevin C. Adam, dated April 18, 2017, #2 Exhibit 2- Letter from Charles Moore, dated June 6, 2017 (Public Redacted), #3 Exhibit 3- Letter from Charles Moore, dated June 16, 2017 (Public Redacted), #4 Exhibit 4- Filed Under Seal)(McDevitt, Heather) |
Filing 282 RESPONSE in Opposition to Motion re: #267 MOTION to Compel Defendants to Produce Documents [CORRECTED MOTION]. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 281 MEMORANDUM OF LAW in Support re: #265 MOTION to Compel Production DIRECT PURCHASER CLASS PLAINTIFFS NOTICE OF MOTION AND MOTION TO COMPEL PRODUCTION OF DOCUMENTS. PUBLIC VERSION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Litvin, Dan) |
Filing 280 SEALED DOCUMENT placed in vault.(rz) |
Filing 279 NOTICE of Filing Under Seal re: 278 Sealed Document. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 278 SEALED DOCUMENT placed in vault.(mps) |
|
Transmission to Sealed Records Clerk. Transmitted re: #277 Order to the Sealed Records Clerk for the sealing or unsealing of document or case. (anc) |
|
Filing 275 SEALED DOCUMENT placed in vault.(rz) |
Filing 274 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 273 SEALED DOCUMENT placed in vault.(rz) |
Filing 272 SEALED DOCUMENT placed in vault.(rz) |
Filing 271 DECLARATION of Heather K. McDevitt [Redacted] in Support re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A (Filed Under Seal), #2 Exhibit B (Filed Under Seal), #3 Exhibit C (Filed Under Seal), #4 Exhibit D (Filed Under Seal), #5 Exhibit E (Filed Under Seal), #6 Exhibit F (Filed Under Seal), #7 Exhibit G (Filed Under Seal), #8 Exhibit H (Filed Under Seal), #9 Exhibit I (Filed Under Seal), #10 Exhibit J (Filed Under Seal))(McDevitt, Heather) |
Filing 270 MEMORANDUM OF LAW in Support re: #269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider. [Redacted]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 269 MOTION to Disqualify / Defendants' Notice of Motion to Disqualify Dr. Lon Schneider. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(McDevitt, Heather) |
Filing 268 NOTICE of Filing Under Seal. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 267 MOTION to Compel Defendants to Produce Documents [CORRECTED MOTION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 266 NOTICE of NOTICE OF FILING UNDER SEAL re: #265 MOTION to Compel Production DIRECT PURCHASER CLASS PLAINTIFFS NOTICE OF MOTION AND MOTION TO COMPEL PRODUCTION OF DOCUMENTS.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 265 MOTION to Compel Production DIRECT PURCHASER CLASS PLAINTIFFS NOTICE OF MOTION AND MOTION TO COMPEL PRODUCTION OF DOCUMENTS. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
|
Filing 263 LETTER addressed to Magistrate Judge James C. Francis IV from Heather K. McDevitt dated May 30, 2017 re: In response to Direct Purchaser Plaintiffs' May 26, 2017 letter. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(McDevitt, Heather) |
Filing 262 NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a ARGUMENT proceeding held on 5/5/17 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:15-cv-07488-CM-JCF, 1:15-cv-10083-CM(McGuirk, Kelly) |
Filing 261 TRANSCRIPT of Proceedings re: ARGUMENT held on 5/5/2017 before Judge Colleen McMahon. Court Reporter/Transcriber: Linda Fisher, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/20/2017. Redacted Transcript Deadline set for 6/30/2017. Release of Transcript Restriction set for 8/28/2017.Filed In Associated Cases: 1:15-cv-07488-CM-JCF, 1:15-cv-10083-CM(McGuirk, Kelly) |
Filing 260 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated May 30, 2017 re: Third Party Confidentiality Issues. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 259 NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a Oral Argument proceeding held on 05/18/2017 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days.(rro) |
Filing 258 TRANSCRIPT of Proceedings re: Oral Argument held on 5/18/2017 before Magistrate Judge James C. Francis IV. Court Reporter/Transcriber: Carole Ludwig, (212) 420-0771. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/20/2017. Redacted Transcript Deadline set for 6/30/2017. Release of Transcript Restriction set for 8/28/2017.(rro) |
Filing 257 REPLY MEMORANDUM OF LAW in Support re: #245 MOTION to Compel JM Smith Corporation and Rochester Drug Co-Operative, Inc. to Produce /Forest's Notice of Motion and Motion to Compel the Production of Documents by the Direct Purchaser Plaintiffs. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 256 LETTER MOTION to Compel Defendants to produce a list of material withheld from prior patent litigation addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated May 26, 2017. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 255 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated May 26, 2017 re: Third Party Confidentiality Issues. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 254 RESPONSE in Opposition to Motion re: #245 MOTION to Compel JM Smith Corporation and Rochester Drug Co-Operative, Inc. to Produce /Forest's Notice of Motion and Motion to Compel the Production of Documents by the Direct Purchaser Plaintiffs. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 286 INTERNET CITATION NOTE: Material from decision with Internet citation re: #253 Order on Motion for Miscellaneous Relief, Order on Motion for Summary Judgment,, Order on Motion for Partial Summary Judgment, Order on Motion for Leave to File Document. (vf) |
|
Filing 252 SEALED DOCUMENT placed in vault.(mps) |
Filing 251 NOTICE OF FILING OF OFFICIAL TRANSCRIPT Notice is hereby given that an official transcript of a argument proceeding held on 5/5/17 has been filed by the court reporter/transcriber in the above-captioned matter. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely electronically available to the public without redaction after 90 calendar days...Filed In Associated Cases: 1:15-cv-07488-CM-JCF, 1:15-cv-10083-CM(McGuirk, Kelly) |
Filing 250 TRANSCRIPT of Proceedings re: argument held on 5/5/2017 before Judge Colleen McMahon. Court Reporter/Transcriber: Linda Fisher, (212) 805-0300. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/9/2017. Redacted Transcript Deadline set for 6/19/2017. Release of Transcript Restriction set for 8/17/2017.Filed In Associated Cases: 1:15-cv-07488-CM-JCF, 1:15-cv-10083-CM(McGuirk, Kelly) |
|
Set/Reset Deadlines: Motions due by 10/24/2017. Responses due by 11/24/2017. Replies due by 12/11/2017. (anc) |
|
Minute Entry for proceedings held before Magistrate Judge James C. Francis: Oral Argument held on 5/18/2017 re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents . filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation. (Bacchus, Michael) |
Filing 247 DECLARATION of Michael E. Hamburger in Support re: #245 MOTION to Compel JM Smith Corporation and Rochester Drug Co-Operative, Inc. to Produce /Forest's Notice of Motion and Motion to Compel the Production of Documents by the Direct Purchaser Plaintiffs.. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit 1- Direct Purchaser Plaintiffs' Objections and Responses to Defendants' First Request for Production)(Hamburger, Michael) |
Filing 246 MEMORANDUM OF LAW in Support re: #245 MOTION to Compel JM Smith Corporation and Rochester Drug Co-Operative, Inc. to Produce /Forest's Notice of Motion and Motion to Compel the Production of Documents by the Direct Purchaser Plaintiffs. . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 245 MOTION to Compel JM Smith Corporation and Rochester Drug Co-Operative, Inc. to Produce /Forest's Notice of Motion and Motion to Compel the Production of Documents by the Direct Purchaser Plaintiffs. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(McDevitt, Heather) |
Filing 244 NOTICE OF CHANGE OF ADDRESS by Jack Pace on behalf of Actavis, plc, Forest Laboratories LLC. New Address: White & Case LLP, 1221 Avenue of the Americas, New York, NY, 10020, (212) 819-8200. (Pace, Jack) |
Filing 243 JOINT LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated May 17, 2017 re: case schedule. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A - Proposed Amended Case Management Order)(Litvin, Dan) |
Filing 242 NOTICE OF APPEARANCE by Charles Moore on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Moore, Charles) |
Filing 241 BRIEF re: #230 MOTION for Leave to File Sur-reply Memorandum of Law in Support of Motion for Partial Summary Judgment on Count Five. (REDACTED PUBLIC VERSION OF EXHIBIT 1 TO MOTION FOR LEAVE TO FILE SUR-REPLY (ECF NO. 230). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 240 LETTER addressed to Judge Colleen McMahon from Ryan P. Johnson dated May 1, 2017 re: The parties' motions for summary judgment on the pediatric exclusivity issue [Public Redacted Version]. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(Johnson, Ryan) |
Filing 239 REPLY AFFIDAVIT of Dan Litvin in Support re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1)(Litvin, Dan) |
Filing 238 REPLY MEMORANDUM OF LAW in Support re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
|
Filing 236 LETTER addressed to Magistrate Judge James C. Francis IV from Heather K. McDevitt dated May 5, 2017 re: the Direct Purchaser Plaintiffs' May 3, 2017 letter #228 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(McDevitt, Heather) |
Filing 235 MOTION Entry of Stipulation governing depositions . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Exhibit A - Stipulation governing depositions)(Litvin, Dan) |
Filing 234 AMENDED CALENDAR NOTICE: Please take notice that the above captioned matter has been scheduled for a Oral argument on Friday, May 5, 2017 at 9:45 A.M. before the Honorable Colleen McMahon, United States District Judge in Courtroom 24A, U.S. District Court, 500 Pearl Street, New York, New York 10007. Oral Argument set for 5/5/2017 at 09:45 AM in Courtroom 24A, 500 Pearl Street, New York, NY 10007 before Judge Colleen McMahon. (Signed by Judge Colleen McMahon on 5/4/2017) (kgo) |
***DELETED DOCUMENT. Deleted document number #234 ORDER. The document was incorrectly filed in this case. (kgo) |
Filing 233 DECLARATION of Kevin C. Adam in Opposition re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents .. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Attachments: #1 Exhibit A- April 12, 2017 Letter from K. Adam, #2 Exhibit B- April 17, 2017 Email from N. Silverman, #3 Exhibit C- April 18, 2017 Email N. Silverman, #4 Exhibit D- Lioderm Order, #5 Exhibit E- K-Dur Order, #6 Exhibit F- Cipro Order)(Adam, Kevin) |
Filing 232 RESPONSE in Opposition to Motion re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents . . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (McDevitt, Heather) |
Filing 231 NOTICE of Filing Under Seal re: #230 MOTION for Leave to File Sur-reply Memorandum of Law in Support of Motion for Partial Summary Judgment on Count Five.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 230 MOTION for Leave to File Sur-reply Memorandum of Law in Support of Motion for Partial Summary Judgment on Count Five. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 229 SEALED DOCUMENT placed in vault.(mps) |
Filing 228 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated May 3, 2017 re: redactions on the basis of relevancy. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 227 NOTICE OF APPEARANCE by Kristen O'Shaughnessy on behalf of Forest Laboratories Holdings Ltd., Forest Laboratories, Inc.. (O'Shaughnessy, Kristen) |
Filing 226 NOTICE OF APPEARANCE by Kevin Charles Adam on behalf of Forest Laboratories Holdings Ltd., Forest Laboratories, Inc.. (Adam, Kevin) |
Filing 225 NOTICE OF APPEARANCE by Ryan Philip Johnson on behalf of Forest Laboratories Holdings Ltd., Forest Laboratories, Inc.. (Johnson, Ryan) |
Filing 224 NOTICE OF APPEARANCE by Martin Michael Toto on behalf of Forest Laboratories Holdings Ltd., Forest Laboratories, Inc.. (Toto, Martin) |
Filing 223 NOTICE OF APPEARANCE by Heather McDevitt on behalf of Forest Laboratories Holdings Ltd., Forest Laboratories, Inc.. (McDevitt, Heather) |
|
Filing 221 NOTICE of Filing Under Seal. Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Johnson, Ryan) |
Filing 220 LETTER addressed to Magistrate Judge James C. Francis IV from Heather K. McDevitt dated May 2, 2017 re: the Direct Purchaser Plaintiffs' May 1, 2017 letter #218 . Document filed by Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc..(McDevitt, Heather) |
Filing 219 SEALED DOCUMENT placed in vault.(mps) |
Filing 218 LETTER addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated May 1, 2017 re: Request for Oral Argument and Telephonic Status Conference. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 217 LETTER MOTION for Extension of Time to File Response/Reply as to #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents . addressed to Magistrate Judge James C. Francis IV from Dan Litvin dated May 1, 2017. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 216 NOTICE OF APPEARANCE by Michael Eugene Hamburger on behalf of Actavis, plc, Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Forest Laboratories, Inc.. (Hamburger, Michael) |
Filing 215 DECLARATION of Dan Litvin in Support re: #214 MOTION to Compel Third Party Mylan Pharmaceuticals, Inc. to Produce Documents Responsive to Subpoena Request No. 12 .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 214 MOTION to Compel Third Party Mylan Pharmaceuticals, Inc. to Produce Documents Responsive to Subpoena Request No. 12 . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)(Litvin, Dan) |
Filing 213 NOTICE of Filing Under Seal re: 212 Sealed Document. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 212 SEALED DOCUMENT placed in vault.(rz) |
Filing 211 CALENDAR NOTICE: Please take notice that the above captioned matter has been scheduled for a: Oral argument to Friday, May 5, 2017 at 11:00 A.M. before the Honorable Colleen McMahon, United States District Judge in Courtroom 24A, U.S. District Court, 500 Pearl Street, New York, New York 10007. Any scheduling difficulties must be brought to the attention of the Court in writing and faxed to Chambers at (212) 805-6326. (Oral Argument set for 5/5/2017 at 11:00 AM in Courtroom 24A, 500 Pearl Street, New York, NY 10007 before Judge Colleen McMahon.) (Signed by Judge Colleen McMahon on 4/25/2017) (ap) |
|
Filing 209 MOTION for Russell A. Chorush to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Certificate of Good Standing, #2 Affidavit, #3 Text of Proposed Order)(Chorush, Russell) |
Filing 208 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Russell Allan Chorush to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13569648. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Chorush, Russell) Modified on 4/21/2017 (ma). |
>>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. #208 MOTION for Russell Allan Chorush to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-13569648. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): MISSING AFFIDAVIT OR DECLARATION PURSUANT TO LOCAL RULE 1.3;. Re-file the motion as a Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (ma) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #209 MOTION for Russell A. Chorush to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (ma) |
Filing 207 STIPULATION: The Complaint is hereby deemed amended to name Forest Laboratories, Inc. and Forest Laboratories Holdings Ltd. as defendants to Counts 3, 4, and 5 of the Complaint. Merz GmbH & Co. KGaA, Merz Pharma GmbH & Co. KGaA, and Merz Pharmaceuticals GmbH are hereby dismissed as defendants to this action subject to the following terms herein. Forest Laboratories, Inc. and Forest Laboratories Holdings Ltd. added. Merz Pharmaceuticals GmbH, Merz GmbH & Co. KGaA. and Merz Pharma GmbH & Co. KGaA terminated. (Signed by Judge Colleen McMahon on 4/20/2017) (kgo) |
Filing 206 LETTER addressed to Judge Colleen McMahon from Daniel C. Simons dated 4/19/2017 re: Stipulation. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A - Proposed Stipulation)(Simons, Daniel) |
|
Filing 204 JOINT MOTION for Protective Order / Notice of Motion for Entry of Stipulated Amended Protective Order. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit 1 - Text of [Proposed] Stipulated Amended Protective Order)(McDevitt, Heather) |
Filing 203 DECLARATION of Dan Litvin (PUBLIC VERSION) in Support re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit PUBLIC EX 1, #2 Exhibit PUBLIC EX 2, #3 Exhibit PUBLIC EX 3 (REDACTED), #4 Exhibit PUBLIC EX 4, #5 Exhibit PUBLIC EX 5 (REDACTED), #6 Exhibit PUBLIC EX 6, #7 Exhibit PUBLIC EX 7(REDACTED))(Litvin, Dan) |
Filing 202 MEMORANDUM OF LAW in Support re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents . [REDACTED PUBLIC VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 201 LETTER addressed to Magistrate Judge James C. Francis IV from Kevin C. Adam dated April 18, 2017 re: Agreement to Suspend Forest's Opposition to DPPs' Motion to Compel. Document filed by Actavis, plc, Forest Laboratories LLC.(Adam, Kevin) |
Filing 200 DECLARATION of Dan Litvin in Support re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 199 SEALED DOCUMENT placed in vault.(rz) |
Filing 198 DECLARATION of Dan Litvin in Support re: #197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents .. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 197 MOTION to Compel Forest Laboratories, LLC and Actavis, PLC to Produce Documents . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order Proposed Order)(Litvin, Dan) |
Filing 196 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
|
Filing 194 LETTER addressed to Judge Colleen McMahon from Ryan Johnson dated April 11, 2017 re: Response to April 6, 2017 Order (ECF 187). Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Johnson, Ryan) |
Filing 193 NOTICE OF APPEARANCE by Noah H. Silverman on behalf of JM Smith Corporation. (Silverman, Noah) |
Filing 192 NOTICE OF APPEARANCE by Bruce E. Gerstein on behalf of JM Smith Corporation. (Gerstein, Bruce) |
|
Filing 190 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated April 11, 2017 re: Direct Purchaser Class Plaintiffs' Request for Referral of a Discovery Dispute to a Magistrate Judge. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 189 NOTICE OF APPEARANCE by Ryan Philip Johnson on behalf of Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Johnson, Ryan) |
Filing 188 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated April 6, 2017 re: Plaintiffs' Motion for Partial Summary Judgment (Dkt. No. 138). Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
|
Filing 186 RULE 56.1 STATEMENT. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 185 REPLY MEMORANDUM OF LAW in Support re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One. [REDACTED PUBLIC VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 184 REPLY AFFIDAVIT of Dan Litvin in Support re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Ex 1, #2 Exhibit Ex 2, #3 Exhibit Ex 3, #4 Exhibit Ex 4, #5 Exhibit Ex 5, #6 Exhibit Ex 6, #7 Exhibit Ex 7, #8 Exhibit Ex 8, #9 Exhibit Ex 9, #10 Exhibit Ex 10, #11 Exhibit Ex 11, #12 Exhibit Ex 12, #13 Exhibit Ex 13, #14 Exhibit Ex 14, #15 Exhibit Ex 15, #16 Exhibit Ex 16, #17 Exhibit Ex 17, #18 Exhibit Ex 18, #19 Exhibit Ex 19, #20 Exhibit Ex 20, #21 Exhibit Ex 21, #22 Exhibit Ex 22, #23 Exhibit Ex 23, #24 Exhibit Ex 24, #25 Exhibit Ex 25)(Litvin, Dan) |
Filing 183 COUNTER STATEMENT TO #141 Rule 56.1 Statement. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 182 REPLY MEMORANDUM OF LAW in Support re: #138 MOTION for Summary Judgment on Claim Three. [REDACTED PUBLIC VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 181 REPLY MEMORANDUM OF LAW in Support re: #161 CROSS MOTION for Partial Summary Judgment /Notice of Forest's Cross-Motion for Partial Summary Judgment on Count Three. . Document filed by Actavis, plc, Forest Laboratories LLC. (Toto, Martin) |
Filing 180 MEMO ENDORSEMENT on re: #179 Letter filed by Rochester Drug Co-Operative, Inc., JM Smith Corporation. ENDORSEMENT: We will hold oral argument but I am not ready to schedule it until my law clerk and I wade through the papers and decide what questions we have. (Signed by Judge Colleen McMahon on 4/4/2017) (kgo) |
Filing 179 LETTER addressed to Judge Colleen McMahon from Bruce E. Gerstein dated April 3, 2017 re: Request for Oral Argument. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Gerstein, Bruce) |
Filing 178 RULE 56.1 STATEMENT. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 177 REPLY AFFIDAVIT of Dan Litvin in Support re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 176 REPLY MEMORANDUM OF LAW in Support re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 175 SEALED DOCUMENT placed in vault.(mps) |
Filing 174 SEALED DOCUMENT placed in vault.(mps) |
Filing 173 NOTICE OF CHANGE OF ADDRESS by Kristen O'Shaughnessy on behalf of Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. New Address: White & Case LLP, 1221 Avenue of the Americas, New York, NY, 10020, (212) 819-8200. (O'Shaughnessy, Kristen) |
Filing 172 NOTICE OF CHANGE OF ADDRESS by Martin Michael Toto on behalf of Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. New Address: White & Case LLP, 1221 Avenue of the Americas, New York, NY, 10020, (212) 819-8200. (Toto, Martin) |
Filing 171 DECLARATION of Heather K. McDevitt (Public Redacted Version) in Opposition re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One.. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1- FDA Webpage on Pediatric Exclusivity Under 505A, #2 Exhibit 2- Excerpts of the Evidentiary Hearing in People v. Actavis, plc., #3 Exhibit 3- FDA Orange Book, #4 Exhibit 4- Napoleon Clark Declaration, #5 Exhibit 5- Jason Harper Deposition, #6 Exhibit 6- Jerry A. Hausman Declaration, #7 Exhibit 7- Dr. E.M. Kolassa Declaration, #8 Exhibit 8- Pierre Cremieux Deposition, #9 Exhibit 9- U.S. Pharmacist Article, #10 Exhibit 10- Bruce D. Korhman Deposition, #11 Exhibit 11- Jason Harper Hearing Transcript, #12 Exhibit 12- Dr. E.M. Kolassa Deposition, #13 Exhibit 13- Ernst R. Berndt Declaration, #14 Exhibit 14- NYAG-Forest Settlement Agreement, #15 Exhibit 15- May 18, 2015 Press Release, #16 Exhibit 16- Ernst R. Berndt Deposition, #17 Exhibit 17- James J. Lah Deposition, #18 Exhibit 18- Barry Reisberg Deposition, #19 Exhibit 19- Pierre-Yves Cremieux Declaration, #20 Exhibit 20- Barry William Rovner Deposition, #21 Exhibit 21- Presentation Under Seal, #22 Exhibit 22-Presentation Under Seal, #23 Exhibit 23- Presentation Under Seal, #24 Exhibit 24- Steven H. Ferris Declaration, #25 Exhibit 25- Pharmacist Survey Oct. 2013, #26 Exhibit 26- Physicians Survey October 2013, #27 Exhibit 27 David Stitt Deposition, #28 Exhibit 28 NY Reply to Defendants Post-Hearing Proposed Findings of Fact, #29 Exhibit 29 November 25, 2015 Press Release, #30 Exhibit 30 Forest-Foundation Care Master Services Agreement, #31 Exhibit 31 Dan Blakeley Deposition, #32 Exhibit 32 William P. Kane Deposition, #33 Exhibit 33 Jerry A. Hausman Reply Declaration, #34 Exhibit 34 Jerry A. Hausman Deposition, #35 Exhibit 35 Namenda XR Package Insert 2., #36 Exhibit 36 NYAG Amended Complaint, #37 Exhibit 37 - NYs Proposed Findings of Fact, #38 Exhibit 38 Sept. 23, 2014 Letter, #39 Exhibit 39 November 13, 2014 Letter, #40 Exhibit 40 NYs Memorandum of Law in Support of its Motion for Preliminary Injunction, #41 Exhibit 41 Order Granting NYs Preliminary Injunction, #42 Exhibit 42 Evidentiary Hearing Excerpts, #43 Exhibit 43 Mark Devlin Deposition)(McDevitt, Heather) |
Filing 170 RESPONSE /Defendants' Responses to Direct Purchaser Class Plaintiffs' Statement of Material Facts on Count One (Public Redacted Version). Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 169 RESPONSE in Opposition to Motion re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One. (Public Redacted Version). Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 168 COUNTER STATEMENT TO Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 167 DECLARATION of Kevin C. Adam (Public Redacted Version) in Opposition re: #138 MOTION for Summary Judgment on Claim Three.. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1- Namenda XR Label, #2 Exhibit 2- FDA's Pediatric Exclusivity FAQs, #3 Exhibit 3- Jan. 25, 2012 Letter, #4 Exhibit 4- Excerpt B. Saunders Depo, #5 Exhibit 5- Taglietti Declaration, #6 Exhibit 6- FDAs Pediatric Exclusivity Granted List, #7 Exhibit 7- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 418 (D. Del.), #8 Exhibit 8- Forest-Cobalt Oct. 2009 Settlement Agreement, #9 Exhibit 9- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 439 (D. Del.), #10 Exhibit 10- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 464 (D. Del.), #11 Exhibit 11- Under Seal, #12 Exhibit 12- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 502 (D. Del.), #13 Exhibit 13- Stipulation and Order, Forest Labs., Inc. v. Lupin Pharms., Inc., 08-cv-021, D.I. 500 (D. Del.), #14 Exhibit 14- Stipulation and Order, Forest Labs., Inc. v. Orgenus Pharma Inc., 09-cv-5105, D.I. 26 (D.N.J.), #15 Exhibit 15- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 434 (D. Del.), #16 Exhibit 16- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 452 (D. Del.), #17 Exhibit 17-Forest-UpsherSmith Sept. 2009 Settlement Agreement, #18 Exhibit 18- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 416 (D. Del.), #19 Exhibit 19- Under Seal, #20 Exhibit 20- July 31, 2015 letter, #21 Exhibit 21- Forest-Wockhardt USA, LLC & Wockhard Ltd. Sept. 2009 Settlement Agreement, #22 Exhibit 22- Stipulation and Order, Forest Labs., Inc. v. Cobalt Labs., Inc., 08-cv-021, D.I. 419 (D. Del.), #23 Exhibit 23- Under seal, #24 Exhibit 24- September 4, 2015 letter, #25 Exhibit 25- Excerpt, FDA 2015 Orange Book, #26 Exhibit 26- January 28, 2004 letter, #27 Exhibit 27- Oct. 26, 2009 Torrent-Forest Letter, #28 Exhibit 28- Forest-Torrent Dec. 2009 Settlement Agreement, #29 Exhibit 29- Drugs@FDA Listing)(Adam, Kevin) |
Filing 166 DECLARATION of Kevin C. Adam in Opposition re: #138 MOTION for Summary Judgment on Claim Three.. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Adam, Kevin) |
Filing 165 DECLARATION of Kevin C. Adam (Filed Under Seal) in Opposition re: #138 MOTION for Summary Judgment on Claim Three.. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1-29 (Filed Under Seal))(Adam, Kevin) |
Filing 164 COUNTER STATEMENT TO Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 163 RESPONSE in Opposition to Motion re: #138 MOTION for Summary Judgment on Claim Three. /Forest's Combined Memorandum of Law Supporting Forest's Motion for Partial Summary Judgment (Count 3) and Defendants' Opposition to Plaintiffs' Motion for Partial Summary Judgment (Count 3). Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 162 NOTICE of of Filing Under Seal. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 161 CROSS MOTION for Partial Summary Judgment /Notice of Forest's Cross-Motion for Partial Summary Judgment on Count Three. Document filed by Actavis, plc, Forest Laboratories LLC.(McDevitt, Heather) |
Filing 160 DECLARATION of Heather K. McDevitt in Opposition re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One.. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 159 DECLARATION of Heather K. McDevitt (Filed Under Seal) in Opposition re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One.. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1-43 (Filed Under Seal))(McDevitt, Heather) |
Filing 158 RESPONSE /Defendants' Responses to Direct Purchaser Class Plaintiffs' Statement of Material Facts on Count One (Filed Under Seal). Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 157 RESPONSE in Opposition to Motion re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One. . Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 156 NOTICE of of Filing Under Seal. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 155 SEALED DOCUMENT placed in vault.(rz) |
Filing 154 SEALED DOCUMENT placed in vault.(rz) |
|
Filing 152 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated March 15, 2017 re: stipulation regarding evidence. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A)(Litvin, Dan) |
|
Filing 150 LETTER MOTION for Extension of Time to File Response/Reply as to #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One., #138 MOTION for Summary Judgment on Claim Three. addressed to Judge Colleen McMahon from Dan Litvin dated February 23, 2017. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Proposed Stipulation)(Litvin, Dan) |
Filing 149 DECLARATION of Dan Litvin [UNSEALED PUBLIC VERSION] in Support re: #138 MOTION for Summary Judgment on Claim Three.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibits 2, 3, 8, 11, 12, 13, 15, 16, and 17 FILED UNDER SEAL, #2 Ex 1, #3 Ex 4, #4 Ex 5, #5 Ex 6, #6 Ex 7, #7 Ex 9, #8 Ex 10, #9 Ex 14)(Litvin, Dan) |
Filing 148 MEMORANDUM OF LAW in Support re: #138 MOTION for Summary Judgment on Claim Three. [UNSEALED PUBLIC VERSION]. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 147 REDACTION to #141 Rule 56.1 Statement in Support of Motion for Partial Summary Judgment on Count Three [PUBLIC VERSION] by JM Smith Corporation, Rochester Drug Co-Operative, Inc.(Litvin, Dan) |
Filing 146 REDACTION to #135 Declaration in Support of Motion, for Collateral Estoppel and Partial Summary Judgment on Count One [PUBLIC VERSION] by JM Smith Corporation, Rochester Drug Co-Operative, Inc. (Attachments: #1 Ex 1, #2 Ex 1 - part 2, #3 Ex. 1 - part 3, #4 Ex 1 - part 4, #5 Ex 2, #6 Ex 3, #7 Ex 4, #8 Ex 5, #9 Ex 6 - part 1, #10 Ex 7, #11 Ex 8, #12 Ex 9, #13 Ex 10, #14 Ex 11, #15 Ex 12, #16 Ex 13 part 1, #17 Ex 13 part 2, #18 Ex 13 part 3, #19 Ex 13 part 4, #20 Ex 14, #21 Ex 15 part 1, #22 Ex 15 part 2, #23 Ex 15 part 3, #24 Ex 16, #25 Ex 17, #26 Ex 18, #27 Ex 19, #28 Ex 20, #29 Ex 21, #30 Ex 22, #31 Ex 23, #32 Ex 24, #33 Ex 25 - part 1, #34 Ex 25 - part 2, #35 Ex 26, #36 Ex 27, #37 Ex 28, #38 Ex 29, #39 Ex 30 - part 1, #40 Ex 30 - part 2, #41 Ex 31, #42 Ex 32 part 1, #43 Ex 32 part 2, #44 Ex 33, #45 Ex 34, #46 Ex 35, #47 Ex 36, #48 Ex 37, #49 Ex 38, #50 Ex 39, #51 Ex 40, #52 Ex 41, #53 Ex 42, #54 Ex 43, #55 Ex 44, #56 Ex 45 part 1, #57 Ex 45 part 2, #58 Ex 46, #59 Ex 47, #60 Ex 48, #61 Ex 49, #62 Ex 50, #63 Ex 51, #64 Ex 52, #65 Ex 53, #66 Ex 54 part 1, #67 Ex 54 part 2, #68 Ex 55, #69 Ex 56, #70 Ex 57 part 1, #71 Ex 57 part 2, #72 Ex 57 part 3, #73 Ex 58, #74 Ex 59, #75 Ex 60, #76 Ex 61, #77 Ex 62, #78 Ex 63, #79 Ex 64, #80 Ex 65, #81 Ex 66, #82 Ex 67, #83 Ex 68, #84 Ex 69, #85 Ex 70, #86 Ex 71, #87 Ex 72, #88 Ex 73, #89 Ex 74, #90 Ex 75, #91 Ex 76, #92 Ex 77, #93 Ex 78, #94 Ex 79, #95 Ex 80, #96 Ex 81, #97 Ex 82, #98 Ex 6 - part 2)(Litvin, Dan) |
Filing 145 REDACTION to #137 Rule 56.1 Statement in Support of Motion for Collateral Estoppel and Partial Summary Judgment on Count One [PUBLIC] by JM Smith Corporation, Rochester Drug Co-Operative, Inc.(Litvin, Dan) |
Filing 144 REDACTION to #136 Memorandum of Law in Support of Motion for Collateral Estoppel and Partial Summary Judgment on Count One [PUBLIC] by JM Smith Corporation, Rochester Drug Co-Operative, Inc.(Litvin, Dan) |
Filing 143 SEALED DOCUMENT placed in vault.(rz) |
Filing 142 SEALED DOCUMENT placed in vault.(mps) |
Filing 141 RULE 56.1 STATEMENT. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 140 MEMORANDUM OF LAW in Support re: #138 MOTION for Summary Judgment on Claim Three. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 139 DECLARATION of Dan Litvin in Support re: #138 MOTION for Summary Judgment on Claim Three.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit)(Litvin, Dan) |
Filing 138 MOTION for Summary Judgment on Claim Three. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 137 RULE 56.1 STATEMENT. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 136 MEMORANDUM OF LAW in Support re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 135 DECLARATION of Dan Litvin in Support re: #134 MOTION for Collateral Estoppel . MOTION for Summary Judgment on Claim One.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit)(Litvin, Dan) |
Filing 134 MOTION for Collateral Estoppel ., MOTION for Summary Judgment on Claim One. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..(Litvin, Dan) |
Filing 133 NOTICE of Filing Under Seal. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
Filing 132 NOTICE of of Compliance with Rules 6(a) and 6(b) of the Court's Rules Governing Electronic Discovery. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 131 NOTICE of Compliance with Rules 6(a) and 6(b) of the Court's Rules Governing Electronic Discovery. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Litvin, Dan) |
|
Filing 129 MOTION Amend Caption to Reflect Consolidation . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)(Simons, Daniel) |
|
Set/Reset Deadlines: Amended Pleadings due by 4/7/2017. Expert Discovery due by 10/17/2017. Fact Discovery due by 6/29/2017. Joinder of Parties due by 4/7/2017. Motions due by 10/24/2017. Pretrial Order due by 12/22/2017. Responses due by 11/24/2017 Replies due by 12/11/2017. (kgo) |
Filing 127 MOTION Joint Motion for Entry of Proposed Case Management Order . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order Ex A - Proposed Case Management Order)(Gerstein, Bruce) |
|
|
Minute Entry for proceedings held before Judge Colleen McMahon: Telephone Conference held on 12/16/2016. Decision: Telephone Conference held. The parties are to submit a revised case management plan by next week. This case must be trial-ready by January 2018 and the parties pre-trial order is due by December 22, 2017. Plaintiffs motion to appoint interim class counsel (Dkt. #113) will be granted, as there was no opposition. Since the parties could not reach agreement on their ESI protocol (see Dkt. #119, #121), they are to follow the Courts Individual Rules of Practice and Rules Governing Electronic Discovery. Submitted by: Robert Gianchetti. (mde) |
|
|
Filing 122 MEMORANDUM OF LAW in Support re: #121 MOTION for Entry of Defendants' Proposed ESI Protocol . . Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 121 MOTION for Entry of Defendants' Proposed ESI Protocol . Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit A - [Defendants' Proposed] Order Regarding the Protocol for Production of Electronically Stored Information and Hard Copy Documents)(McDevitt, Heather) |
Filing 120 MEMORANDUM OF LAW in Support re: #119 MOTION Entry of ESI Protocol . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Gerstein, Bruce) |
Filing 119 MOTION Entry of ESI Protocol . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order Proposed ESI Protocol)(Gerstein, Bruce) |
Filing 118 RULE 26(f) DISCOVERY PLAN REPORT.Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order Proposed CMO)(Gerstein, Bruce) |
Filing 117 JOINT MOTION for Protective Order STIPULATED QUALIFIED PROTECTIVE ORDER FOR PROTECTED HEALTH INFORMATION. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order STIPULATED QUALIFIED PROTECTIVE ORDER FOR PROTECTED HEALTH INFORMATION)(Gerstein, Bruce) |
|
Filing 115 JOINT MOTION for Protective Order and Federal Rule of Evidence 502(d) Order. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order Stipulated Proposed Protective Order, #2 Text of Proposed Order Stipulated Proposed Federal Rule of Evidence 502(d) Order)(Gerstein, Bruce) |
Filing 114 MEMORANDUM OF LAW in Support re: #113 MOTION to Appoint Counsel . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B)(Gerstein, Bruce) |
Filing 113 MOTION to Appoint Counsel . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order Proposed Order)(Gerstein, Bruce) |
Filing 112 NOTICE OF APPEARANCE by Kevin Charles Adam on behalf of Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Adam, Kevin) |
Filing 111 NOTICE OF APPEARANCE by Kevin Charles Adam on behalf of Actavis, plc, Forest Laboratories LLC. (Adam, Kevin) |
Filing 110 NOTICE OF APPEARANCE by Heather McDevitt on behalf of Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (McDevitt, Heather) |
Filing 109 NOTICE OF APPEARANCE by Heather McDevitt on behalf of Actavis, plc, Forest Laboratories LLC. (McDevitt, Heather) |
Filing 108 ANSWER to #29 Amended Complaint, with JURY DEMAND. Document filed by Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Toto, Martin) |
Filing 107 ANSWER to #29 Amended Complaint, with JURY DEMAND. Document filed by Actavis, plc, Forest Laboratories LLC.(Toto, Martin) |
|
Filing 105 NOTICE OF CHANGE OF ADDRESS by Miranda Yan Jones on behalf of JM Smith Corporation. New Address: Heim, Payne & Chorush, 1111 Bagby St., Suite 2100, Houston, Texas, United States 77002, 7132212000. (Jones, Miranda) |
|
|
Filing 102 AMENDED MOTION for Peter R. Kohn to Appear Pro Hac Vice and Proposed Order. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)(Kohn, Peter) |
Filing 101 AMENDED MOTION for Joseph T. Lukens to Appear Pro Hac Vice and Proposed Order. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)(Lukens, Joseph) |
Filing 100 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Peter R. Kohn to Appear Pro Hac Vice and Proposed Order. Filing fee $ 200.00, receipt number 0208-12548135. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)Filed In Associated Cases: 1:15-cv-07488-CM, 1:15-cv-10083-CM(Kohn, Peter) Modified on 7/18/2016 (bcu). |
Filing 99 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Joseph T. Lukens to Appear Pro Hac Vice and Proposed Order. Filing fee $ 200.00, receipt number 0208-12548037. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Text of Proposed Order)Filed In Associated Cases: 1:15-cv-07488-CM, 1:15-cv-10083-CM(Lukens, Joseph) Modified on 7/18/2016 (bcu). |
>>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. (19 in 1:15-cv-10083-CM) MOTION for Joseph T. Lukens to Appear Pro Hac Vice and Proposed Order. Filing fee $ 200.00, receipt number 0208-12548037. Motion and supporting papers to be reviewed by Clerk's Office staff., (20 in 1:15-cv-10083-CM) MOTION for Peter R. Kohn to Appear Pro Hac Vice and Proposed Order. Filing fee $ 200.00, receipt number 0208-12548135. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): the motion to appear pro hac vice was spread to multiple civil cases; Motions for Pro Hac Vice must be filed in each case individually along with fees per case.;. Re-file the motion as a Corrected Motion to Appear Pro Hac Vice in the lead case and a separate Motion to Appear Pro Hac Vice in each case and pay the filing fee for each motion - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. Filed In Associated Cases: 1:15-cv-07488-CM, 1:15-cv-10083-CM(bcu) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #102 AMENDED MOTION for Peter R. Kohn to Appear Pro Hac Vice and Proposed Order. Motion and supporting papers to be reviewed by Clerk's Office staff., #101 AMENDED MOTION for Joseph T. Lukens to Appear Pro Hac Vice and Proposed Order. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
|
|
Filing 96 MOTION for Daniel C. Simons to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-12537595. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Simons, Daniel) |
Filing 95 MOTION for David F. Sorensen to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-12537475. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Sorensen, David) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #96 MOTION for Daniel C. Simons to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-12537595. Motion and supporting papers to be reviewed by Clerk's Office staff., #95 MOTION for David F. Sorensen to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-12537475. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
|
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #93 AMENDED MOTION for Miranda Y. Jones to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (sdi) |
Filing 93 AMENDED MOTION for Miranda Y. Jones to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Jones, Miranda) |
>>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. #92 MOTION for Miranda Y. Jones to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-12367768. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): missing Certificate of Good Standing from Supreme Court of Texas;. Re-file the motion as a Corrected Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (sdi) |
Filing 92 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Miranda Y. Jones to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-12367768. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Jones, Miranda) Modified on 6/2/2016 (sdi). |
|
|
Filing 89 AMENDED MOTION for Chris Letter to Appear Pro Hac Vice Filing Fee $200 Receipt # 0208-11993685. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Exhibit Certificate of Good Standing, #2 Text of Proposed Order Proposed Order Granting Motion to Enroll)(Letter, Chris) |
Filing 88 AMENDED MOTION for Dan Chiorean to Appear Pro Hac Vice Filing Fee $200 Receipt # 0208-11993827. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Exhibit Certificate of Good Standing, #2 Text of Proposed Order Proposed Order Granting Motion to Enroll)(Chiorean, Dan) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #88 AMENDED MOTION for Dan Chiorean to Appear Pro Hac Vice Filing Fee $200 Receipt # 0208-11993827. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #89 AMENDED MOTION for Chris Letter to Appear Pro Hac Vice Filing Fee $200 Receipt # 0208-11993685. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
Filing 87 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Chris Letter to Appear Pro Hac Vice Filing Fee $200 Receipt # 0208-11993685. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Text of Proposed Order Proposed Order for Motion to Enroll Pro Hac Vice, #2 Exhibit Certificate of Good Standing Chris Letter)(Letter, Chris) Modified on 3/9/2016 (bcu). |
Filing 86 FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Dan Chiorean to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Text of Proposed Order Proposed Order for Motion to Enroll Pro Hac Vice, #2 Exhibit Certificate of Good Standing)(Chiorean, Dan) Modified on 3/9/2016 (bcu). |
>>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. #87 MOTION for Chris Letter to Appear Pro Hac Vice Filing Fee $200 Receipt # 0208-11993685. Motion and supporting papers to be reviewed by Clerk's Office staff., #86 MOTION for Dan Chiorean to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): missing Certificate of Good Standing from Supreme Court of Louisiana;. Re-file the motion as a Corrected Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Proposed Order.. (bcu) |
Filing 85 ACKNOWLEDGMENT OF SERVICE. Document filed by JM Smith Corporation. (Hennings, Kimberly) |
Filing 84 ACKNOWLEDGMENT OF SERVICE. Document filed by JM Smith Corporation. (Hennings, Kimberly) |
Filing 83 ACKNOWLEDGMENT OF SERVICE. Document filed by JM Smith Corporation. (Hennings, Kimberly) |
|
Filing 81 DECLARATION of Bruce E. Gerstein in Support re: #79 MOTION to Strike Document No. [76, 77] . MOTION for Leave to File Surreply in Further Opposition to Defendants' Motion to Dismiss.. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Exhibit 1 - Proposed Surreply)(Gerstein, Bruce) |
Filing 80 MEMORANDUM OF LAW in Support re: #79 MOTION to Strike Document No. [76, 77] . MOTION for Leave to File Surreply in Further Opposition to Defendants' Motion to Dismiss. . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Gerstein, Bruce) |
Filing 79 MOTION to Strike Document No. [76, 77] .( Responses due by 3/4/2016), MOTION for Leave to File Surreply in Further Opposition to Defendants' Motion to Dismiss. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Attachments: #1 Exhibit Exhibit 1 - Proposed Order)(Gerstein, Bruce) |
Filing 78 SEALED DOCUMENT placed in vault.(mps) Modified on 2/19/2016 (dn). |
Filing 77 DECLARATION of Kristen O'Shaughnessy in Support re: #55 MOTION to Dismiss .. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 17, #2 Exhibit 18, #3 Exhibit 19, #4 Exhibit 20, #5 Exhibit 21, #6 Exhibit 22)(O'Shaughnessy, Kristen) |
Filing 76 REPLY MEMORANDUM OF LAW in Support re: #55 MOTION to Dismiss . / Reply Memorandum in Further Support of Defendants Forest and Merz's Motion to Dismiss Indirect Purchaser Plaintiffs' Class Action Complaint and Direct Purchaser Plaintiffs' First Amended Class Action Complaint. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Toto, Martin) |
|
|
|
Filing 72 MOTION for Joseph T. Lukens to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11908515. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Certificate of Good Standing, #2 Certificate of Good Standing, #3 Text of Proposed Order)(Lukens, Joseph) |
Filing 71 MOTION for Neill W. Clark to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11908426. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Clark, Neill) |
Filing 70 MOTION for Peter R. Kohn to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11908074. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Rochester Drug Co-Operative, Inc.. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Kohn, Peter) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #70 MOTION for Peter R. Kohn to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11908074. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (sdi) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #72 MOTION for Joseph T. Lukens to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11908515. Motion and supporting papers to be reviewed by Clerk's Office staff., #71 MOTION for Neill W. Clark to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11908426. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
Filing 69 MEMORANDUM OF LAW in Opposition re: #55 MOTION to Dismiss . CORRECTED TO ADDRESS TYPOGRAPHICAL ERRORS ONLY. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Gerstein, Bruce) |
Filing 68 MEMORANDUM OF LAW in Opposition re: #55 MOTION to Dismiss . . Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc.. (Gerstein, Bruce) |
|
Filing 66 LETTER MOTION to Seal Document (request to redact reference to Defendants' confidential material) addressed to Judge Colleen McMahon from Dan Litvin dated January 27, 2016. Document filed by JM Smith Corporation, Rochester Drug Co-Operative, Inc..Filed In Associated Cases: 1:15-cv-07488-CM, 1:15-cv-10083-CM(Litvin, Dan) |
|
Filing 64 LETTER RESPONSE in Opposition to Motion addressed to Judge Colleen McMahon from Martin M. Toto dated January 21, 2016 re: #60 AMENDED LETTER MOTION for Local Rule 37.2 Conference CORRECTED regarding redacted judicial opinions addressed to Judge Colleen McMahon from Bruce E. Gerstein dated January 19, 2016. . Document filed by Actavis, plc, Forest Laboratories LLC. (Toto, Martin) |
Filing 63 MEMO ENDORSEMENT on re: #61 Letter filed by JM Smith Corporation. ENDORSEMENT: OK to remove letter. (Signed by Judge Colleen McMahon on 1/21/2016) (kgo) |
***DELETED DOCUMENT. Deleted document number 59 LETTER MOTION. The document was incorrectly filed in this case. (kgo) |
|
Filing 61 LETTER addressed to Judge Colleen McMahon from Dan Litvin dated January 20, 2016 re: Erroneous Filing. Document filed by JM Smith Corporation.(Litvin, Dan) |
Filing 60 AMENDED LETTER MOTION for Local Rule 37.2 Conference CORRECTED regarding redacted judicial opinions addressed to Judge Colleen McMahon from Bruce E. Gerstein dated January 19, 2016. Document filed by JM Smith Corporation. (Attachments: #1 Exhibit Ex A, #2 Exhibit CORRECTED Ex B)(Gerstein, Bruce) |
Filing 58 SEALED DOCUMENT placed in vault.(rz) |
Filing 57 MEMORANDUM OF LAW in Support re: #55 MOTION to Dismiss . . Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Toto, Martin) |
Filing 56 DECLARATION of Kristen O'Shaughnessy in Support re: #55 MOTION to Dismiss .. Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16)(O'Shaughnessy, Kristen) |
Filing 55 MOTION to Dismiss . Document filed by Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Text of Proposed Order)(Toto, Martin) |
|
Filing 53 MOTION for Peter J. Carney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11766457. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Carney, Peter) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #53 MOTION for Peter J. Carney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11766457. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (wb) |
Filing 52 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Merz Pharma GmbH & Co. KGaA for Merz Pharmaceuticals GmbH; Corporate Parent Merz Holding GmbH & Co. KG for Merz GmbH & Co. KGaA.; Corporate Parent Merz GmbH & Co. KGaA. for Merz Pharma GmbH & Co. KGaA. Document filed by Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH.(Pace, Jack) |
Filing 51 NOTICE OF APPEARANCE by John Mark Gidley on behalf of Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Gidley, John) |
Filing 50 NOTICE OF APPEARANCE by Kristen O'Shaughnessy on behalf of Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (O'Shaughnessy, Kristen) |
Filing 49 NOTICE OF APPEARANCE by Martin Michael Toto on behalf of Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Toto, Martin) |
Filing 48 NOTICE OF APPEARANCE by Jack Pace on behalf of Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH. (Pace, Jack) |
Filing 47 NOTICE OF APPEARANCE by Dan Litvin on behalf of JM Smith Corporation. (Litvin, Dan) |
|
|
|
Filing 43 LETTER MOTION to Seal Document addressed to Judge Colleen McMahon from Martin M. Toto dated December 17, 2015. Document filed by Actavis, plc, Forest Laboratories LLC.(Toto, Martin) |
|
Filing 41 JOINT MOTION for Leave to File Consolidated Briefing on Defendants' Motion to Dismiss . Document filed by Actavis, plc, Forest Laboratories LLC, JM Smith Corporation. (Attachments: #1 Text of Proposed Order)(Toto, Martin) |
Filing 40 MOTION for David C. Raphael, Jr. to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11685158. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Exhibit Certificate of Good Standing, #2 Text of Proposed Order)(Raphael, David) |
Filing 39 MOTION for Erin R. Leger to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11684878. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by JM Smith Corporation. (Attachments: #1 Exhibit Certificate of Good Standing, #2 Text of Proposed Order)(Leger, Erin) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #40 MOTION for David C. Raphael, Jr. to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11685158. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (bcu) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #39 MOTION for Erin R. Leger to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11684878. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (sdi) |
Minute Entry for proceedings held before Judge Colleen McMahon: Initial Pretrial Conference held on 11/20/2015. Decision: Initial conference held. ANDA settlement agreements must be produced to plaintiffs by Monday, November 23, 2015. Briefing schedule set: motion to dismiss must be filed by December 22, 2015, opposition by January 29, 2016, and reply by February 12, 2016. Submitted By: Sarah M. Evans. (mde) |
Filing 38 ELECTRONIC SUMMONS ISSUED as to Merz Pharma GmbH & Co. KGaA. (jom) |
Filing 37 ELECTRONIC SUMMONS ISSUED as to Merz Pharmaceuticals GmbH. (jom) |
Filing 36 ELECTRONIC SUMMONS ISSUED as to Merz GmbH & Co. KGaA.. (jom) |
|
Filing 34 REQUEST FOR ISSUANCE OF AMENDED SUMMONS as to Merz Pharma GmbH & Co. KGaA, re: #29 Amended Complaint,. Document filed by JM Smith Corporation. (Hennings, Kimberly) |
Filing 33 REQUEST FOR ISSUANCE OF SUMMONS as to Merz Pharmaceuticals GmbH, re: #29 Amended Complaint,. Document filed by JM Smith Corporation. (Hennings, Kimberly) |
Filing 32 REQUEST FOR ISSUANCE OF SUMMONS as to Merz GmbH & Co. KgaA, re: #29 Amended Complaint,. Document filed by JM Smith Corporation. (Hennings, Kimberly) |
Filing 31 LETTER MOTION for Extension of Time to File Answer re: #29 Amended Complaint, addressed to Judge Colleen McMahon from Kimberly Hennings dated 10/19/2015. Document filed by JM Smith Corporation.(Hennings, Kimberly) |
Filing 30 WAIVER OF SERVICE RETURNED EXECUTED. Actavis, plc waiver sent on 10/13/2015, answer due 1/11/2016. Document filed by JM Smith Corporation. (Hennings, Kimberly) |
Filing 29 FIRST AMENDED COMPLAINT amending #26 Amended Complaint, against Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH with JURY DEMAND.Document filed by JM Smith Corporation. Related document: #26 Amended Complaint, filed by JM Smith Corporation.(Hennings, Kimberly) |
Filing 28 FILING ERROR - DEFICIENT PLEADING - FILER ERROR - FIRST AMENDED COMPLAINT amending #26 Amended Complaint, against Actavis, plc, Forest Laboratories LLC, Merz GmbH & Co. KGaA., Merz Pharma GmbH & Co. KGaA, Merz Pharmaceuticals GmbH with JURY DEMAND.Document filed by JM Smith. Related document: #26 Amended Complaint, filed by JM Smith.(Hennings, Kimberly) Modified on 10/14/2015 (dgo). |
***NOTICE TO ATTORNEY REGARDING DEFICIENT PLEADING. Notice to Attorney Kimberly Hennings to RE-FILE Document No. #26 Amended Complaint. The filing is deficient for the following reason(s): the wrong filer/filers were selected for the pleading. Re-file the pleading using the event type Amended Complaint found under the event list Complaints and Other Initiating Documents - attach the correct signed PDF - select the individually named filer/filers - select the individually named party/parties the pleading is against. (moh) |
Filing 27 REQUEST FOR ISSUANCE OF SUMMONS as to Merz GmbH & Co. KgaA; Merz Pharma GmbH & Co. KgaA; Merz Pharmaceuticals GmbH, re: #26 Amended Complaint,. Document filed by JM Smith. (Hennings, Kimberly) |
Filing 26 FILING ERROR - DEFICIENT PLEADING - FILER ERROR - - FIRST AMENDED COMPLAINT amending #10 Complaint against Actavis, plc, Forest Laboratories LLC, Merz Pharma GmbH & Co. KGaA, Merz GmbH & Co. KGaA., Merz Pharmaceuticals GmbH with JURY DEMAND.Document filed by JM Smith. Related document: #10 Complaint filed by JM Smith.(Hennings, Kimberly) Modified on 10/14/2015 (moh). |
|
Filing 24 ACKNOWLEDGMENT OF SERVICE. Forest Laboratories LLC served on 9/29/2015, answer due 10/20/2015. Service was accepted by Andrea Alfano. Document filed by JM Smith. (Hennings, Kimberly) |
Filing 23 NOTICE OF APPEARANCE by Joseph Opper on behalf of JM Smith. (Opper, Joseph) |
Filing 22 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Actavis plc, Corporate Parent Allergan plc for Forest Laboratories LLC. Document filed by Actavis, plc, Forest Laboratories LLC.(Pace, Jack) |
Filing 21 MOTION for Peter J. Carney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11487221. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Actavis, plc, Forest Laboratories LLC. (Attachments: #1 Certificate of Good Standing, #2 Text of Proposed Order)(Carney, Peter) |
Filing 20 NOTICE OF APPEARANCE by Kristen O'Shaughnessy on behalf of Actavis, plc, Forest Laboratories LLC. (O'Shaughnessy, Kristen) |
Filing 19 NOTICE OF APPEARANCE by Martin Michael Toto on behalf of Actavis, plc, Forest Laboratories LLC. (Toto, Martin) |
Filing 18 NOTICE OF APPEARANCE by Jack Pace on behalf of Actavis, plc, Forest Laboratories LLC. (Pace, Jack) |
>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. #21 MOTION for Peter J. Carney to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-11487221. Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (sdi) |
Filing 17 NOTICE OF APPEARANCE by Kimberly Marion Hennings on behalf of JM Smith. (Hennings, Kimberly) |
|
NOTICE OF CASE ASSIGNMENT to Judge Colleen McMahon. Judge Unassigned is no longer assigned to the case. (sdi) |
CASE ACCEPTED AS RELATED. Create association to 1:15-cv-06549-CM. Notice of Assignment to follow. (sdi) |
Magistrate Judge James C. Francis IV is so designated. (sdi) |
Filing 15 ELECTRONIC SUMMONS ISSUED as to Merz Pharma GmbH & Co. KGaA. (pc) |
***NOTICE TO ATTORNEY REGARDING PARTY MODIFICATION. Notice to attorney Bruce E. Gerstein. The party information for the following party/parties has been modified: Merz Pharmaceuticals GmbH & Co. KGaA. The information for the party/parties has been modified for the following reason/reasons: party text contained a typographical error;. (laq) |
Filing 14 REQUEST FOR ISSUANCE OF SUMMONS as to Merz Pharma GmbH & Co. KGaA, re: #10 Complaint. Document filed by Merz Pharmaceuticals GmbH & Co. KGaA. (Gerstein, Bruce) |
Filing 13 ELECTRONIC SUMMONS ISSUED as to Merz Pharmaceuticals GmbH & Co. KGaA. (dgo) |
Filing 12 ELECTRONIC SUMMONS ISSUED as to Forest Laboratories LLC. (dgo) |
Filing 11 ELECTRONIC SUMMONS ISSUED as to Actavis, plc. (dgo) |
Filing 10 COMPLAINT against Actavis, plc, Forest Laboratories LLC, Merz Pharmaceuticals GmbH & Co. KGaA. Document filed by JM Smith.(Gerstein, Bruce) |
Filing 9 STATEMENT OF RELATEDNESS re: that this action be filed as related to 15-cv-06549. Document filed by JM Smith.(Gerstein, Bruce) |
Filing 8 CIVIL COVER SHEET filed. (Gerstein, Bruce) |
Filing 7 FILING ERROR - DEFICIENT PLEADING - FILER ERROR - COMPLAINT against Merz Pharmaceuticals GmbH & Co. KGaA, Actavis, plc, Forest Laboratories LLC. Document filed by Merz Pharmaceuticals GmbH & Co. KGaA, Actavis, plc, Forest Laboratories LLC.(Gerstein, Bruce) Modified on 9/23/2015 (dgo). |
***NOTICE TO ATTORNEY REGARDING DEFICIENT RELATED CASE STATEMENT. Notice to attorney Bruce E. Gerstein to RE-FILE Document No. #2 Notice (Other). The filing is deficient for the following reason(s): the wrong event type was used to file the related case statement;. Re-file the document using the event type Statement of Relatedness found under the event list Other Documents - select the correct filer - enter the related case number when prompted - and attach the correct PDF. (dgo) |
***NOTICE TO ATTORNEY TO ELECTRONICALLY FILE CIVIL COVER SHEET. Notice to Attorney Bruce E. Gerstein. Attorney must electronically file the Civil Cover Sheet. Use the event type Civil Cover Sheet found under the event list Other Documents. (dgo) |
***NOTICE TO ATTORNEY REGARDING DEFICIENT PLEADING. Notice to Attorney Bruce E. Gerstein to RE-FILE Document No. #1 Complaint,. The filing is deficient for the following reason(s): the All Defendant radio button was selected;. Re-file the pleading using the event type Complaint found under the event list Complaints and Other Initiating Documents - attach the correct signed PDF - select the individually named filer/filers - select the individually named party/parties the pleading is against. (dgo) |
***NOTICE TO ATTORNEY REGARDING DEFICIENT PLEADING. Notice to Attorney Bruce E. Gerstein to RE-FILE Document No. #7 Complaint. The filing is deficient for the following reason(s): the wrong party/parties whom the pleading is against were selected; Choose only JM SMITH as the filer, and Merz Pharmaceuticals GmbH & Co. KGaA, Actavis, plc, Forest Laboratories LLC as the parties to be filed against. Re-file the pleading using the event type Complaint found under the event list Complaints and Other Initiating Documents - attach the correct signed PDF - select the individually named filer/filers - select the individually named party/parties the pleading is against. (dgo) |
***NOTICE TO ATTORNEY REGARDING PARTY MODIFICATION. Notice to attorney Bruce E. Gerstein. The party information for the following party/parties has been modified: JM Smith. The information for the party/parties has been modified for the following reason/reasons: party text was omitted; alias party name was omitted;. (dgo) |
CASE REFERRED TO Judge Colleen McMahon as possibly related to 15cv6549. (dgo) |
Case Designated ECF. (dgo) |
CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Unassigned. (dgo) |
Filing 6 REQUEST FOR ISSUANCE OF SUMMONS as to Merz Pharmaceuticals GmbH & Co. KGaA, re: #1 Complaint. Document filed by JM Smith. (Gerstein, Bruce) |
Filing 5 REQUEST FOR ISSUANCE OF SUMMONS as to Forest Laboratories, LLC, re: #1 Complaint. Document filed by JM Smith. (Gerstein, Bruce) |
Filing 4 REQUEST FOR ISSUANCE OF SUMMONS as to Actavis, plc, re: #1 Complaint. Document filed by JM Smith. (Gerstein, Bruce) |
Filing 3 RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by JM Smith.(Gerstein, Bruce) |
Filing 2 FILING ERROR - WRONG EVENT TYPE SELECTED FROM MENU - NOTICE of Related Case Statement. Document filed by JM Smith. (Gerstein, Bruce) Modified on 9/23/2015 (dgo). |
Filing 1 FILING ERROR - DEFICIENT PLEADING - FILED AGAINST PARTY ERROR COMPLAINT against All Defendants. (Filing Fee $ 400.00, Receipt Number 0208-11418839)Document filed by JM Smith. (Attachments: #1 Civil Cover Sheet)(Gerstein, Bruce) Modified on 9/23/2015 (dgo). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.